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Abstract 
An In-Vivo Structural MRI Investigation of Newborn Infants’ Brains: Preterm Infants and 
Infants born with Intrauterine Growth Restriction. Jessica Joanne Atkinson. 
Introduction: It is well documented that preterm infants are less developed than term 
infants at term age and infants with IUGR are said to be of higher vulnerability. Fractional 
Anisotropy (FA) and Apparent Diffusion Coefficient (ADC) are sensitive to micro structural 
abnormalities and increases in anisotropy associated with premyelination are the earliest 
indications of the beginning processes of myelination. Furthermore reductions in brain 
volumes have been found in preterm infants compared to controls and IUGR infants. 
Thyroxine (T4) is necessary for normal growth and development of the central nervous 
system. Infants born preterm miss out on the maternal transfer of T4 that occurs during the 
third trimester and are born with an underdeveloped thyroid gland that is not yet producing 
sufficient amounts of T4. 
Method:  Sixty nine infants (51 preterm, 9 IUGR and 9 controls) were imaged on a 1.5 Telsa 
MRI Scanner. DTI analysis was performed using medical imaging software (DTIstudio). FA 
and ADC maps were used to draw regions of interest around the posterior limb of the 
internal capsule (PLIC), corpus callosum (CC), frontal lobes (FL) and occipital lobes (OL). The 
software Brain Voyager QX (version 1.9.10) was used for image realignment and 
demarcation of T2 Weighted images and the images were analysed using medical imaging 
software for structure- specific brain volume measurements (Easymeasure). Statistical 
analysis was conducted with repeated measures ANOVA using SPSS version 18. 
Results: A significant interaction when investigating anterior vs. posterior structures and 
laterality of structures with treatment in the frontal lobes and posterior limb of the internal 
capsule was found suggesting a group difference between infants treated with 
levothyroxine and those receiving placebo. IUGR infants generally had lower FA and ADC 
than the control group. Generally lower structural volumes were found in the placebo and 
IUGR group. 
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Conclusion: Administration of levothyroxine affects the structures on different sides of the 
brain differently and raises structural volumes. Levothyroxine may be of particular benefit 
to infants with low levels of thyroxine in their blood (hypothyroxinemia) and male preterm 
infants. Preterm infants born with intrauterine growth restriction are of higher vulnerability 
than appropriate for gestational age preterm infants with lower FA, higher ADC and lower 
structural volumes. Further research is required to fully explore asymmetries in the preterm 
and IUGR brain and should look at administering levothyroxine to infants with low levels of 
thyroxine in their blood. 
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CHAPTER 1 
Introduction 
 
With advances in neonatal care over the last few decades preterm infants and infants with 
intrauterine growth restriction are more likely to survive. Preterm infants and infants born 
with intrauterine growth restriction are known to have later developmental problems in 
comparison to infants born at term of appropriate for gestational age.  
These infants are more likely to repeat a grade at school and have special educational needs 
and are less likely to continue into higher education. The differences seen between term, 
preterm and intrauterine growth restriction infants’ development has largely been 
attributed to differences in brain development and maturation. 
This thesis begins by exploring the literature on the development of the brain within the 
foetus on a cellular level. Next the implications of preterm birth and intrauterine growth 
restriction (IUGR) on brain development are reviewed. 
Following this my thesis will go on to explore the anatomical brain using DTI and stereology 
on a sample of infants born preterm and a sample of infants with intrauterine growth 
restriction. 
The results are discussed in the light of with previous research on DTI and Stereology in 
infants born preterm and infants born with IUGR. Conclusions are drawn and further 
research is suggested. 
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Chapter 2: Development of the Neonatal Brain 
This chapter discusses previous literature on brain development beginning with formation 
of the neural tube, development within the fore brain, cellular proliferation and migration. 
The chapter then moves on to discuss formation of the mantle, development of the 
marginal zone and the neocortex. The cells produced within the ventricular layer, 
neurotransmitters and neuromodulators are also introduced. Next the discussion moves on 
to maturation of white matter and myelination which is of particular interest for the DTI 
measures of this thesis. 
Next the chapter discusses how this brain development has been found to be different in 
infants born preterm in previous research and how brain development is linked to diffusion 
tensor imaging (DTI) and Stereology. Further differences within brain development are then 
explored including sex differences, asymmetry and motor difficulties. 
Finally the role of thyroxine in brain development is considered and development in infants 
born with intrauterine growth restriction (IUGR) is discussed. 
 
Chapter 3: Magnetic Resonance Imaging and Image Analysis. 
This chapter introduces the reader to the physics behind a magnetic resonance imaging 
(MRI) machine including a brief introduction to MRI, magnetic moment, precessional 
frequency, larmour frequency and gradients. Moving on to discuss pulse sequence, image 
contrast, T1 and T2 weighting as well as spin echo sequences. 
Next the chapter introduces diffusion weighted and diffusion tensor imaging, the latter 
which is to be used in this thesis. Within this fractional anisotropy (FA) and apparent 
diffusion coefficient (ADC) are discussed. 
Finally the chapter introduces the image analysis method Stereology using cavalieri’s 
principle and point counting. 
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Chapter 4: Methodology 
This chapter outlines the method for data acquisition used in the studies. Firstly details of 
the preterm infant sample and secondly the intrauterine growth restriction sample are 
discussed, followed by information on the MRI sequences used and image analysis 
procedures for DTI and Stereology. Finally the statistical analysis is presented with the 
hypotheses. 
 
Chapter 5: DTI Results and Thyroxine 
In this chapter the DTI results for preterm and intrauterine growth restriction infants are 
presented. The results explored differences in DTI measures between structures of interest, 
between anterior and posterior structures, between left and right hemispheres and 
interaction with treatment of levothyroxine in the preterm infants. In the IUGR cohort 
differences between IUGR and a control group are explored. Further to initial analysis 
further analysis explored differences between total thyroxine (T4), free thyroxine (F4) and 
total triiodothyronine in placebo and thyroxine treated groups in the preterm cohort. 
 
Chapter 6: Stereology Results 
In this chapter the stereology results for preterm and intrauterine growth restriction infants 
are presented. The results explored differences in structural volumes between the 
structures of interest, between dorsal and orbital structures, between lateral and medial 
structures and between left and right hemispheres. Total hemisphere and prefrontal cortex 
volumes were also explored as was the interaction with treatment of levothyroxine in the 
preterm infants. In the IUGR cohort differences between IUGR and a control group were 
explored. 
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Chapter 7: Discussion 
In this chapter the results are discussed and interpreted in line with the previous research 
and the hypotheses made. Firstly the results of DTI in the preterm cohort are discussed in 
line with previous research in normal development and DTI in preterm infants including 
research that also considers future neurodevelopment. Secondly the DTI results in 
intrauterine growth restriction are discussed. Thirdly and finally the stereology results in the 
preterm infants are discussed, followed by the stereology results in intrauterine growth 
restriction infants. 
 
Chapter 8: Conclusions and future research. 
Chapter 8 concludes the thesis with a brief final interpretation of the results in the light of 
previous research, and goes on to suggest possible future research ideas based on this 
thesis and the work that precedes it.  
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CHAPTER 2 
Development of the Neonatal Brain 
 
Aim of Chapter 
This chapter aims to provide an overview of the literature on the development of the 
neonatal brain, brain development in preterm and IUGR infants and the role of thyroxine in 
brain development. 
 
During foetal development the brain goes through organised structural changes (Huang 
2010) which are demonstrated in figure 2.1. These changes begin early in uterine 
development where ectoderm is the predecessor for the central nervous system (CNS) 
(Richards, Plachez & Ren 2004). There are three basic processes in which ectoderm develop 
into the internal structures of the CNS: migration of neuroblasts, fusion of the neural plate 
into a neural tube and the division of the cells in the forebrain (prosencephalon) into 
separate regions including the cerebral hemispheres (Yakovlev 1959). 
The regions of the central nervous system begin to form with initial clustering of the 
embryonic cells to form the fore-mid-and hind-brain. As the neural tube becomes fully 
formed, patterning (subdivision into distinct brain areas by gene expression) is seen in the 
rostro-caudal axis and along the dorsal-ventral axis (Lagercrantz 2002). 
Brain Development in Embryo 
Formation of the Neural Tube 
Conversion of the neural plate into the neural tube takes place during the third and fourth 
week of gestation (Fenichel 1990). Formation of the neural tube involves changes in cell 
shape and cell- cell interactions of ecto-dermal cells. At this stage of development cellular 
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proliferation has a minor contribution. The ectoderm forms the neural plate in a process 
called neural induction. The neural plate then bends to form the neural groove. Neural folds 
are developed from the edges of the neural plate thickening (Lagercrantz 2002).  On day 22 
of gestation these neural folds  begin to adhere so that the cells from the two neural folds 
merge (Schoenwolf 2009). This closes the neural groove and forms the neural tube 
(Lagercrantz 2002). 
The neural tube will later differentiate to form the brain and spinal cord. Gene expression 
determines which regions of the neural tube will differentiate into the specific structures 
and cells of the nervous system. The development of the midline of the nervous system is 
also regulated by the same genetic patterning events and the formation of this midline is 
crucial for the later formation of the midline comissures such as the corpus callosum 
(Richards, Plachez & Ren 2004). 
Development within the Forebrain 
Initially the forebrain contains a single vesicle (the proscenphalon) although shortly after the 
proscenphalon has formed cellular proliferation and migration contributes to development 
either side of the single vesicle to form two hemispheres (Lagercrantz 2002). This occurs 
during the fifth week and the two vesicles that are formed are known as the telencephalon 
and diaencephalon (Schoenwolf 2009). Cellular projections include proliferation, migration 
and differentiation of cells into neurons and glia. These cellular projections work within the 
developing cortex to produce the six layers which make up the mature cortex (Richards, 
Plachez & Ren 2004). 
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 Figure 2.1 Timeline of events in Neonatal Brain development
22 Days Week 5 Week 12 Week 14 Week 24 Week 31-32 Week 34 Week 35 Week 36 9-12 
Months 
11-14 
Months 
Formation 
of the 
neural 
tube 
Formation of 
the 
telencephalon 
and 
diaencephalon 
Hypothalamus, 
pituitary and 
adrenal glands 
activated. 
 
Axons cross 
between the 
two 
hemispheres. 
 
Production 
of neurons 
 Increased 
number of 
gyri and 
sulci 
appears 
 Myelination 
begins 
 White 
matter 
matures in 
the 
occipital 
lobe 
White 
matter 
matures 
in the 
frontal 
lobes 
  Migration of neurons to the neocortex  Cerebral cortex further thickens and 
more sulci develop 
  
Convultions of the cerebral cortex are not fully formed and 
the brain appears smooth. 
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Cellular Proliferation 
Cellular proliferation occurs in the ventricular zone (Richards, Plachez & Ren 2004; 
Schoenwolf 2009). The closed neural tube contains proliferating cells which are 
involved in self-renewal and production of neurons and glial cells (Lagercrantz 
2002). The first cells to be produced in the ventricular layer are known as post 
mitotic neurons, these neurons migrate to form the next layer known as the mantle 
(Schoenwolf 2009). Proliferative events including the production of neurons occur 
between 8 and 16 weeks (Volpe 1987).  Neurons migrate to the neocortex between 
12 and 24 weeks (Sandrine Passemard et al. 2010). 
Migration 
Migration is a complex step which occurs early in embryonic and foetal 
development; in humans migration of neurons to the neocortex occurs between the 
third and fifth month of gestation (Lagercrantz 2002; Volpe 2008). The cell layer of 
the neural tube is initially a single layer and converted to a multilayer structure via 
migration. Stem cells are confined to the inner layer known as the ventricular layer 
and the newly formed cells migrate to separate layers of the cortical plate and 
spinal cord. During migration neurons are guided by the specialised cells known as 
radial glial cells (Lagercrantz 2002). 
Formation of the Mantle 
As cellular proliferation of stem cells is sustained in the developing CNS, there are 
more and more newly formed cells which migrate out of the ventricular layer 
forming a second layer around the neural tube. This second layer becomes thicker 
as more cells are added to it and is known as the mantle or intermediate zone 
(Lagercrantz 2002). 
Development of the Marginal Zone 
In the intermediate zone there are postmitotic neurons which establish a pattern of 
axonal connections (Lagercrantz 2002). Other nerve fibres involved in connecting 
neurons in the CNS include dendrites and synapses which with axons form the 
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complicated neuronal circuits which transmit nerve pulses (Tang 2003). Eventually 
many of these axons will be coated in myelin sheaths by the glial cells known as 
oligodendrocytes (Lagercrantz 2002; Schoenwolf 2009). The process in which axons 
are coated in myelin sheaths is known as myelination. The process of myelination 
improves connectivity in neuronal circuits allowing nerve pulses to transmit faster. 
The region which contains these axonal networks which arise from the neurons is 
the outermost layer of the developing brain and spinal cord known as the marginal 
zone (Lagercrantz 2002). This zone later makes up the white matter in the CNS 
(Schoenwolf 2009). 
Further development within the Brain 
These three layers discussed (the ventricular zone, the mantle/ intermediate zone 
and the marginal zone) remain throughout development of the spinal cord and 
medulla (Lagercrantz 2002). However in development of the mammalian brain 
these three layers have further evolved  to become  the six layers  of the highly 
organised neocortex (ventricular, sub-ventricular, intermediate zone, sub plate, 
cortical plate and marginal plate) (Lagercrantz 2002; Richards, Plachez & Ren 2004).  
After mitosis the surviving neurons continue to grow and differentiate (Richards, 
Plachez & Ren 2004), the initial neurons form layers closet to the ventricular zone 
and subsequent neurons migrate further through preceding layers to form the 
external layers of the cerebral cortex (Lagercrantz 2002). 
Cells produced within the Ventricular Layer 
Once the production of neurons is reduced a new cell type known as glioblast are 
produced. Glioblasts differentiate into glia which provides structural support for the 
CNS. The glia found within the CNS are known as astrocytes and oligodendrocytes 
(Schoenwolf 2009). The interaction between astrocytes and neurons which involves 
the exchange of metabolites and neurotransmitters are a prerequisite for normal 
brain function and therefore proper function of the CNS in adulthood depends on 
proper development of astrocytes during embryogenesis (Lagercrantz 2002). 
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The ependymal cells are the last cells to be produced by the ventricular layer, these 
cells line the ventricles and are involved in the production of cerebrospinal fluid 
(CSF) which protects and supports the brain (Schoenwolf 2009). 
Neurotransmitters and Neuromodulators 
The action of neurotransmitters and neuromodulators play a role in the detailed 
wiring of neuronal circuits. Signals passed on to neurons can be promoted, 
amplified, blocked, inhibited or attenuated by neurotransmitters and 
neuromodulators and therefore they give rise to signalling patterns between many 
neuronal networks (Lagercrantz 2002). 
Their markers in CNS development generally initially appear in the caudal part of 
the brain and levels increase at the same time as synapse formation. In the healthy 
newborn it is hypothesised that there is a surge of excitatory neurotransmitters and 
a down regulation of inhibitory ones. Early insult such as prenatal stress at a critical 
period can result in long term changes in the structure and function of the brain. 
Prenatal and perinatal stress such as hypoxia can affect the expression of 
neurotransmitters and neuromodulators as well as their receptors, which can lead 
to long term behavioural effects (Lagercrantz 2002). 
Maturation of White Matter 
First Trimester 
Different parts of the brain mature at different rates (Marshall 1968) demonstrated 
by differences seen in the degree of myelination among adjacent white matter sites 
(Brody 1987) and the variation in anisotropy in different white matter regions 
(Pierpaoli et al. 1996). At the beginning of the 5
th week of the embryo’s 
development in the intrauterine environment each cerebral hemisphere arises. As 
development continues, the cerebral hemispheres grow. First the anterior 
hemisphere which forms the frontal lobe, followed by laterally and superiorly to 
form the parietal lobes.  Lastly the posterior and inferior hemisphere grow 
producing the occipital and temporal lobes (Snell 2010). By the end of the first 
trimester the foetal hypothalamus, pituitary and adrenal glands have been 
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activated (Okada et al. 2011). At the end of the first trimester/ beginning of the 
second (around 12 weeks) axons begin to cross between the two hemispheres 
(Marin-Padilla 1997).  
Commissures are a bundle of nerve fibres which cross the midline of the CNS to 
connect similar structures in the brain from different sides to one another (Martin 
1994). The third commissure to develop is the corpus callosum (the second and first 
being the optic chiasm and anterior commissure) (Huang 2010; Snell 2010). The 
corpus callosum is the largest fibre tract in the brain and connects neurons in both 
cerebral hemispheres (Richards, Plachez & Ren 2004) to share learning and memory 
(Cooke & Abernethy 1999). It connects  both sides of the frontal lobe (Snell 2010) 
and is formed by cortical axons which are attracted to the midline by glial cells, with 
the genu developing prior to the splenium. At 9 weeks gestation the earliest 
components of the corpus callosum appear, by 12 weeks it is definable as an 
independent structure (Volpe 2008) and by 18 can be seen on ultrasound (Marin-
Padilla 1997). The corpus callosum then further develops over the next few weeks 
in both the anterior and posterior directions. By 19 weeks the anterior corpus 
callosum has become more dominant (Huang et al. 2006) suggesting there is more 
development within the anterior corpus callosum over the 15-19 week gestation 
period (Huang 2010). By 20 weeks the basic structure is completed (Volpe 2008) 
and by 22 weeks the structure has adult features (Marin-Padilla 1997). 
While various masses of grey matter develop within the cerebral hemispheres 
elsewhere in the nervous system neurons are maturing. These maturing neurons 
send axons to or from the cortex and these axons form the large ascending and 
descending tracts that make up the internal capsule (Snell 2010)  A structure which 
can be visualised in DTI at 13 weeks gestation. By 13 weeks the limbic fibres are also 
visible, as are the projection fibres which develop further to the peripheral regions 
over the second trimester. The next tracts to begin development within the second 
trimester are some of the commissural and association tracts (Huang 2010). 
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Second Trimester 
During the second trimester the adrenal cortex (Okada et al. 2011), association 
fibres of the corpus callosum and internal capsule are developing significantly 
(Huang 2010) and are well visible by 19 weeks (Huang et al. 2006). By contrast the 
inferior fronto- occipital fasciculus, inferior longitudinal fasciculus and uncinate 
fasciculus do not and are un-traceable until 19 weeks (Huang 2010) and even at 19-
20 weeks they cannot be well appreciated (Huang et al. 2006). 
By 19 weeks the limbic fibres are well developed, as is the cerebral peduncle and 
the anterior commissure. At 19-20 weeks gestational age the temporal lobe is 
visible and the basal ganglia and hippocampus can be clearly identified, although 
the brain has a smooth surface and the sylvian fissure is the only sulcus in view. 
From this time to term the whole brain volume increases 17 times over (Huang et 
al. 2006). 
At 20 weeks the corpus callosum is more advanced in the frontal lobe rather than 
the occipital lobe where as callosal fibres are not well developed and enlargement 
of the genu is visible (Huang et al. 2006). 
In the cerebral hemisphere the anterior limb of the internal capsule is well 
developed and the proportion of the internal capsule shows the anterior region to 
be more developed than the posterior limb of the internal capsule (Huang et al. 
2006). 
Third Trimester 
White matter development continues from 21-24 weeks to term (Huang 2010) and 
microstructural changes that occur between 28 and 40 weeks gestation include 
fibre development such as myelination (Huppi et al. 1998; Marin-Padilla 1997). 
Although myelination may begin as early as 24 weeks gestation in the fibres of the 
basal ganglia (Snell 2010).  
In terms of the development of white matter tracts, the limbic fibres are first to 
develop, the commissural and projection fibres develop from the core to the 
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periphery and from anterior to posterior. The association fibres are last to develop 
(Huang 2006, 2010; Marin-Padilla 1997). As development of white matter tracts 
follows an antero-posterior gradient, at any prenatal age, the frontal regions of the 
WM are more developed than the parieto-occipital regions (Marin-Padilla 1997). 
Post-natal 
The last process to occur is the maturation of white matter (Lagercrantz 2002) 
which forms from the core of the brain to the periphery and from the anterior to 
posterior regions (Huang et al. 2006). Therefore maturation proceeds from the 
frontal region anteriorly to the occipital and temporal lobes.  
White matter consists of the axonic fibres that connect the different regions of the 
cerebral hemispheres. In addition to axonic fibres white matter is made up of myelin 
sheaths and neurofibrils which make up  axonal systems consisting of large groups 
of myelinated axons (Beaulieu 2002). Although Drobyshevsky et al believe an 
increase in oligodendrocytes that occurs during the premyelination period may be 
important in defining the structural and functional maturation of white matter 
(Drobyshevsky et al. 2005). 
 
Development of Myelination 
Preparatory Changes 
Prior to myelination there are changes in the development of fibre tracts in central 
white matter which are related to the ‘early wrapping of axons by oligodendroglial 
processes’ (Barrett 2010; Huppi et al. 1998; Remahl & Hildebrand 1990; Snell 2010). 
Axons make up white matter and are mostly surrounded by myelin sheaths which in 
part are produced by the neuroglial cells (Barrett 2010; Marshall 1968; Snell 2010). 
There are four types of neuroglial cells one of which is oligodendrocytes which are 
believed to be involved in the process of forming myelin in the central nervous 
system (Barrett 2010; Snell 2010). In the optic nerve of rats, ensheathment (the 
process by which the axons are surrounded by myelin sheaths) has been found to 
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begin six days post birth when the axons are large. Prior to myelination clusters of 
vesiculotubular profiles are present within the axon (Hildebrand & Waxman 1984). 
These vesiculotubular profiles fuse with the membrane in a way that contributes to 
membrane growth by addition of phospholipids to the axon membrane (Waxman 
1985). This is a type of lipid and a component of membrane which can form lipid 
bilayers. Membrane synthesis involves the transportation of lipid bilayers in 
vesiculotubular profiles via the axonal system. Vesiculotubular profiles travel to the 
axon where they fuse with the membrane as mentioned above. Differentiation of 
the axon membrane may then occur in situ altering the axolemmal structure which 
may be a basis for the development of myelination into a highly organised structure 
(Waxman 1985). 
Antenatal Myelination 
Neuroglial cells are small cells that are present among nerve cells (Marshall 1968; 
Snell 2010) and they account for nearly half (40%) of the total brain volume (Bayer 
2005; Snell 2010). Sites of glial cell growth are present throughout grey and white 
matter during the second trimester. Within the fibre tracts glial cells develop and 
divide prior to myelination (Bayer 2005). These sites are known as myelination 
gliosis and remain present in the third trimester (Bayer 2004). Myelin sheaths start 
forming before birth and continue to form post birth for the first year. Myelination 
is a systematic process where different nerve fibres myelinate at different times. It  
begins around the 16th week of intrauterine life and by 37 weeks gestation the 
surface of the brain hemispheres show myelin  (Snell 2010). At 28 weeks gestation 
the corpus callosum remains unmyelinated (Huppi et al. 1998) and once 
myelination begins the process is slow (Dudink 2007; Kinney 1988). Whereas at this 
time period the internal capsule is in the process of myelination (Huppi et al. 1998) 
and is still myelinating rapidly at term (Cowana & de Vriesb 2005; Huppi et al. 1998; 
Kinney 1988; O'Shea et al. 2005; Rutherford et al. 1998). At term age the 
corticospinal tracts are arising in the postcentral gyrus and enter the posterior limb 
of the internal capsule (Rutherford et al. 1998). At 44 post-conceptional weeks 
(gestational plus postnatal) 50% of infants have mature myelin in the posterior limb 
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and 90% by 103 weeks whereas myelination in the posterior frontal white matter is 
not present until 47 post-conceptional weeks (Kinney 1988). 
Microstructural changes that occur between 28 and 40 weeks gestation include 
fibre development such as myelination (Huppi et al. 1998). Myelination is the 
process by which nerve fibres are coated with thin layers of lipid called myelin, the 
layers of this lipid being disposed in a spiral. The axon must be ensheathed by a 
secondary cell (Bunge 1968); glial lamellae (Remahl & Hildebrand 1990). Spiralling 
of the ensheathment process occurs and the layers of this process must be 
compacted. When myelination has completed and the nerve fibres are coated 
sufficiently with myelin this coating is known as the myelin sheath. Myelin acts as 
electrical insulation and increases the efficiency of nerve fibres and the myelinated 
axon has been referred to as the “superhighway of the nervous system” (Bunge 
1968). Large groups of myelinated axons are known as axonal systems which are 
made up of myelin sheaths, axonal membranes and neurofibrils. These axonal 
systems connect various regions in the brain and are known collectively as white 
matter (Beaulieu 2002). 
Postnatal Myelination 
The myelination process is slow so post-birth the brain is still largely unmyelinated 
and the corticobulbar, corticospinal, tectrospinal and corticopontocerebellar fibres 
begin to myelinate (Snell 2010). By three months post-birth; myelination is most 
advanced in some of the motor and sensory areas followed by auditory and visual 
areas (Marshall 1968). Six months post-birth the corticospinal fibres start to 
myelinate and their myelination is mostly complete by the end of two years. 
Myelination continues until all the major nerve fibres are myelinated which occurs 
by the time the infant is walking (Snell 2010). Two years post-birth, the progress of 
myelination throughout the nervous system continues and will continue through 
puberty, maturity and into old age (Dubois et al. 2006; Marshall 1968; Snell 2010). 
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Definitions 
Infants that are said to be small for gestational age are infants whose birth weight is 
below the 10th centile. Their growth is low at all gestational ages but they are 
otherwise healthy. Preterm infants are infants born before 37 weeks gestation. Low 
birth weight infants are infants born below 2500 grams. Those infants born with an 
especially low birth weight are said to suffer from intrauterine growth restriction 
(IUGR) and this can be defined as a birth weight below the 10th percentile predicted 
for gestational age or a birth weight two standard deviations below the mean. With 
IUGR growth is normal in the early part of pregnancy but slows in utero by at least 
two measurements. 
Brain Development in Preterm Infants 
At 24-40 weeks gestation multiple developmental events take place which involve 
pre-oligodendrocytes, microglia, axons, subplate neurons, the cerebral dorsal 
subventricular zone and ventral germinative of the ganglionic eminence, thalamus, 
cortex and cerebellum. During the premature period cerebral white matter axons 
such as the projection, commissural and association fibres are rapidly growing  and 
ensheathement of axons by pre-oligodendrocytes occurs although mature myelin 
producing oligodendrocytes do not become wide spread in cerebral white matter 
until after term (Volpe 2009). In the development of the preterm infant myelin is 
evident in numerous grey and white matter tracts under 28 weeks gestational age. 
Between 30 and 36 weeks this myelination continues to increase in the areas 
already identified but there is no myelination in new sites until 36 weeks gestation 
when myelin becomes evident in the posterior limb of the internal capsule (Counsell 
et al. 2002). 
It is well documented that preterm infants are less developed than term infants at 
term age (Abernethy LJ et al. 2003; Dudink 2008; Huppi et al. 1998; Nosarti 2008; 
Woodward 2005). In very preterm infants fibre organisation and myelination during 
the period between preterm birth and term age may not match that of term infants 
still in the intrauterine environment (Counsell & Boardman 2005; Nosarti 2008). 
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This slower development in preterm infants continues throughout the first year of 
life (Cole & Cole 1997).  
Brain Development and DTI (see Chapter 3 for more information on DTI) 
Maturation of white matter including the development of myelination can be 
determined by changes in DTI parameters such as the anisotropy parameter of  
apparent diffusion coefficient (ADC) and fractional anisotropy (FA) (Dubois et al. 
2008; Dudink 2008; Huppi et al. 1998; Neil et al. 1998; Wimberger 1995). FA and 
ADC are sensitive to micro structural abnormalities(Murakami 2007) and increases 
in anisotropy associated with premyelination are the earliest indications of the 
beginning processes of myelination (Neil 2002).  
ADC 
ADC characterises the diffusion of water; diffusion is reduced by biological barriers 
in the brain and therefore by measuring ADC we get an insight into biological 
barriers (i.e. structures) in the brain. A high ADC value means more water diffusion, 
i.e. the higher the ADC value the further the water molecules have travelled per unit 
time. The further the water molecules are travelling the less brain structure there is 
acting as a barrier to diffusion (Tofts 2003). 
FA 
FA looks at the direction of water diffusion and whether it its isotropic i.e. travelling 
the same distance in all directions. When FA is isotropic (low FA) there are no or 
limited barriers to diffusion allowing the water to diffuse to the same degree in all 
directions. When FA is anisotropic i.e. the water molecules are travelling different 
distances in different directions (high FA) there are barriers limiting the diffusion in 
certain directions.  
ADC and FA During Development 
ADC and anisotropy measures are shown to change dramatically during 
development (Cascio, Gerig & Piven 2007; Drobyshevsky et al. 2005; Dubois et al. 
2006; Neil 2002) which reflects the changes in tissue water content and 
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cytoarchitecture. These changes are occurring more rapidly in early development 
and in particular in the first year of life. Measurements taken from adult brains 
differ to those from paediatric brains and the parameters vary with age (Neil 2002). 
ADC decreases with age whereas FA increases (Drobyshevsky et al. 2005). These 
changes offer an insight into the maturation of the human brain (Neil 2002). 
Anisotropy becomes more evident with the increasing maturation of white matter 
(Wimberger et al. 1995).  Thus I hypothesise that Infants FA and ADC measures will 
be significantly correlated with weight and gestational age at birth.  
Gestational Age and Birth weight 
 Importance in looking at birth weight and gestational age at birth is demonstrated 
by previous research which found differences in the prevalence of 
neurodevelopment disability according to gestational age at birth (Hack & Fanaroff 
1999). They found 30% to be severely disabled when born at 23 weeks, a range of 
17%-45% when born at 24 weeks and a range of 12% - 35% at 25 weeks. They also 
found cognitive disability to be evident in 15%-31% of preterm infants born at 27 
weeks gestation (Hack & Fanaroff 1999). Measures of motor and visual motor skills 
have been found to significantly correlate with gestational age at birth and birth 
weight. Children who performed poorly on three different measures of motor skills 
were found to have lower gestation and birth weight (LA Foulder-Hughes 2003). 
Furthermore Rose et al argue that gestational age is known to influence brain 
structure abnormalities and disabilities associated with cerebral palsy (Rose et al. 
2009). 
FA and ADC in Brain Regions 
The different areas/ structures of the brain mature at different times and rates as 
mentioned earlier. Changes in anisotropy and myelination also occur in this manner 
(Drobyshevsky et al. 2005; Dubois et al. 2006) with striking differences in degree of 
myelination in different white matter sites (Brody 1987). Changes in ADC occur 
more rapidly in projection fibres such as the internal capsule compared to changes 
in commissural fibres such as the corpus callosum which are slower to change 
(Drobyshevsky et al. 2005).There is earlier maturation in the motor and sensory 
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tracts compared to the cortico-cortical tracts (Dubois et al. 2006) and changes in 
anisotropy occur earlier in white matter underlying the visual cortex than other sub 
cortical white matter and are low in occipital white matter at 26 weeks but increase 
at 40 weeks gestation (Neil 2002). In the white matter of rats there is an increase in 
the number of myelinated and unmyelinated axons towards the posterior regions 
and a significant difference between the number of myelinated and unmyelinated 
axons in the frontal compared to occipital regions (Ginus Partadiredja 2003). 
Although other research has found significant difference between anterior and 
posterior commissures with significantly more myelin axons in the anterior 
commissure and a significant difference between myelinated axons in the genu 
(anterior) and splenium (posterior) of the corpus callosum in the rat brain (Sargon 
et al. 2003).This leads to the hypothesis that higher FA and lower ADC will be 
found in the posterior part of the internal capsule and corpus callosum.  
FA and ADC Prior to Myelination 
There seems to be two phases to the increasing anisotropy values in white matter 
during infant development. The first includes changes to the structure prior to 
myelination (Huppi et al. 1998; Wimberger 1995) and the second is associated with 
the appearance of myelin and its maturation. This has been demonstrated in central 
cerebral white matter where there are increases in anisotropy  and decreases in 
ADC between 28 and 40 weeks gestation (Huppi et al. 1998) even though central 
cerebral white matter does not begin to myelinate until term (Kinney 1988). 
Furthermore high anisotropy values were found in the corpus callosum of preterm 
infants even though it is mostly unmyelinated (Partridge et al. 2004) and both the 
unmyelinated corpus callosum at 28 weeks gestation and the posterior limb of the 
internal capsule which at 28 weeks gestation is in the process of myelination 
demonstrated anisotropy indicating that anisotropy may be linked to myelination 
processes but myelination is not the only process causing anisotropic diffusion 
(Huppi et al. 1998). Drobyshevsky et al believe diffusion anisotropy in development 
relates to the increase in premyelinating oligodendrocytes (Drobyshevsky et al. 
2005). 
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These measures (FA and ADC) relate to behavioural measures such as cognitive and 
motor abilities in both clinical and healthy children (Cascio, Gerig & Piven 2007). 
Brain Development and Stereology in Preterm Infants 
Stereology is an unbiased method of estimating the volumes of an irregular shape 
and can be applied to MRI images using Cavalieri’s principle in combination with 
point counting. It provides accurate estimation of the volume of an arbitrary object 
from a few systematic sections and has been applied to measure foetal volume in 
utero (Roberts et al. 1994). Stereology is an efficient method to make a bias free 
estimation of a structure without needing a detailed assumption of its shape 
(Roberts, Puddephat & McNulty 2000b).  
Stereology has been useful in the measure of foetal development in the womb via 
an estimation of foetal volume (Roberts et al. 1994) and in the study of brain 
structure volumes in preterm infants (Allin et al. 2001; Lancefield et al. 2006; 
Nosarti et al. 2002b). Preterm infants have been found to have a reduction in whole 
brain volume, grey matter volume and hippocampal volumes (Nosarti et al. 2002b) 
as well as smaller white matter volume, corpus callosum, cerebellum (Escobar-
Morreale et al. 2005) and smaller cerebellar volume although not significantly (Shah 
et al. 2006). Reduced grey matter included the temporal, frontal, occipital cortices 
and cerebellum and white matter loss in the brain stem, internal capsule, temporal 
and frontal regions and the major fasiculi (Nosarti et al. 2008). Other research has 
found significantly lower cerebral volumes (Allin et al. 2001; Lancefield et al. 2006), 
premotor, sensorimotor and occipital parietal regions in preterm infants and 
significantly larger prefrontal regions (Lancefield et al. 2006). Similarly reduced 
volumes of parieto-occipital grey matter but increased volumes of mid-body, 
occipital horns and temporal horns of lateral ventricles has been found in preterm 
infants in addition to larger anterior cortices (including: dorsal prefrontal, orbital 
prefrontal, premotor, subgenual and mid temporal regions) and smaller sensori 
motor and posterior cortices (Peterson et al. 2003; Thompson et al. 2007). In 
addition Thompson et al (2007) found reductions in the orbitofrontal and premotor 
regions in preterm infants. In general there seems to be a consensus that there are 
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several regional disruptions to preterm infants’ cerebral development by term age, 
as summarised by Thompson et al (2007). In addition to reductions in grey and 
white matter volume discussed above other anatomical changes have been 
demonstrated including an increase in the grey matter in the temporal and frontal 
lobes, and white matter excess in temporal, parietal and frontal regions (Nosarti et 
al. 2008). 
Stereology and Later Development 
The cerebellum is known to be involved in co-ordination of movement and cognitive 
processes and Allin et al, 2001 found significant associations between cerebellar 
volume and cognitive test scores. They argue that the cognitive deficits associated 
with preterm birth may be related to dysfunction in several neural systems 
including the cerebellum. The thalamus anatomically connects the cerebellum to 
the dorsal lateral and dorsal medial prefrontal cortex (Allin et al. 2001), thus similar 
reductions in volume and dysfunction may be also associated with these areas. 
Furthermore a meta analysis found reductions in volume of preterm infants to be 
associated with decreased general cognitive functioning (Escobar-Morreale et al. 
2005) and the mental subscale of Baileys at 18 to 20 months corrected age 
correlated significantly with neonatal white matter(Peterson et al. 2003). 
Disturbances in cerebral development of the preterm infant have also been found 
to impact later working memory (infants aged two), specifically reductions in total 
tissue volumes of dorsolateral prefrontal cortex, sensorimotor, parietooccipital and 
premotor regions (Woodward et al. 2005). Preterm infants that exhibited working 
memory deficits at age two were found to have smaller hippocampi than children 
with a intact working memory and children who failed to learn or persist with the 
working memory task (Beauchamp et al. 2008). Aged two, preterm infants 
demonstrated differences in cognitive and psychomotor development compared to 
term controls with less preterm infants scoring within the normal range and 
increases in preterm infants scoring mild and serious cognitive and motor delay. 
This poor performance in mental and motor performance of preterm infants was 
significant (Woodward et al. 2005). Very preterm infants scored lower on measures 
of language and executive function and were more likely to show cognitive 
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impairment in adolescence than term controls and this cognitive impairment was 
associated with decreased grey and white matter volume (Nosarti et al. 2008). 
Gestational Age and Birth weight 
Associations between gestational age and brain structural volume have been found 
with a reduction in myelinated white matter fibres in older adults (74 years) and 
younger adults (female 38 years, males 21.8 years) (Tang 2003). Similarly elder 
subjects have been found to have a lower volume of white matter and myelinated 
fibres in comparison to young subjects but this difference was not significant (Tang 
et al. 1997) and an inverse relationship between age and number of neurons in the 
hippocampus has been found (West & Gundersen 1990). Similar associations with 
gestational age were found in preterm infants with the more premature the infant 
the smaller the white matter volume (Nosarti et al. 2002b) and increasing 
immaturity was found to be associated with poorer multisearch multilocation task 
performance which is associated with working memory (Woodward et al. 2005). 
Cognitive impairment in very preterm adolescents has been found to be associated 
with gestational age and language and executive function score was positively 
associated with gestational age (Nosarti et al. 2008). Contradictory to this other 
research in preterm infants found regional volumes to not correlate with age (Kesler 
et al. 2008; Peterson et al. 2003) and there was no relationship between cerebellar 
volume and gestational age (Shah et al. 2006). Despite claiming degree of 
immaturity was not related to regional brain structure in their abstract Thompson 
et al (2007) did find a small effect of immaturity and region specific differences 
according to gestational age. I hypothesise that smaller brain structural volumes 
will be found in infants with lower birth weight and gestational age at birth and 
with which they will significantly correlate. 
Prefrontal Cortex Regions 
In the prefrontal cortex dorsal regions have been found to be larger than orbital 
regions with dorsal lateral being the largest sub-region of the prefrontal cortex 
(Howard 2003). 
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Sex Differences 
In addition to changes in ADC and FA measures during development and differences 
between structures in the brain, sex differences have been observed. There is 
numerous evidence of gender differences in the maturation of the foetal and young 
child’s brain (Petty 1999). Sex differences were found in the splenium of the corpus 
callosum, right posterior limb of the internal capsule and frontal lobes,  males had 
lower FA in the splenium of the corpus callosum (Rose et al. 2009; Schmithorst, 
Holland & Dardzinski 2008) higher ADC in the splenium of the corpus callosum, 
lower FA and higher ADC in the right posterior limb of the internal capsule 
suggesting delayed development of these structures in males (Rose et al. 2009), 
although they had higher FA in associative white matter regions including the 
frontal lobes (Schmithorst, Holland & Dardzinski 2008).Other research has also 
found sex differences in brain abnormalities  including the splenium of the corpus 
callosum and right posterior limb of the internal capsule. Males had a lower FA and 
a higher ADC suggesting delayed development of these structures in males. 
Furthermore males were more likely to have abnormal neurodevelopment and had 
a higher incidence of cerebral palsy. Neurodevelopment was abnormal in more than 
four times as many males than females. Gestational age at birth has been found to 
be lower in males rather than females (Kesler et al. 2008; Rose et al. 2009). In a rat 
model of preterm infant brain injury males were found to be more sensitive to 
insult (NuÑEz & McCarthy 2003). Other earlier research has demonstrated a smaller 
corpus callosum in males compared to females (Kesler et al. 2008; WITELSON 1989) 
and later research found greater volume loss in mouse male hippocampus 
compared to females (Mayoral, Omar & Penn 2009). Sex differences in the sub 
regions of the corpus callosum have also been found in preterm infants (Peterson 
Bs & et al. 2000). Research has found male brains to be larger in volume, females 
had less cerebral white matter but larger cortical volume than males (Filipek et al. 
1994). Similarly Thompson et al (2007) found males to have larger volumes in all 
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brain regions and in particular in posterior regions whilst females had lower total 
tissue volumes in the inferior occipital and dorsal prefrontal region. Furthermore 
larger cerebellar volumes in male compared to female preterm infants has been 
found (Shah et al. 2006).  However other research has found preterm males to have 
significantly lower white matter volumes (bilateral cingulum, corpus callosum, 
corticospinal tract, prefrontal cortex superior and inferior longitudinal fasiculi) and 
grey matter volumes (prefrontal cortex, basal ganglia and temporal lobe) whereas 
females did not differ significantly between term and preterm (Kesler et al. 2008). 
Contradictory to the above others have found no sex difference in prefrontal cortex 
volume (Gur Re & et al. 2000) and regional volumes (Eckerman, Sturm & Gross 
1985). Thus I hypothesise that there will be a difference in DTI and stereology 
measures between males and females. 
Asymmetry 
Functional asymmetries such as handedness have been well established and 
researched (Petty 1999; Westerhausen et al. 2004; WITELSON 1989), however in 
addition there is structural differences between the two sides of the brain (Petty 
1999). In a study of East African skulls asymmetry was found in 98% of the skulls 
with the largest asymmetry present in the parietal and occipital regions with the 
right frontal being larger than left and left occipital larger than right (Gundara & 
Zivanovic 1968).  The left occipital lobe is often wider than the right and the right 
frontal lobe usually extends further than the left (Le May & Kido 1978) i.e.  the left 
occipital lobe is larger than the right and the right frontal lobe is larger than the left 
(Petty 1999). This has been confirmed by Weinberger et al who also found the right 
frontal lobe and left occipital lobe to be larger in the majority of brains measured. 
These asymmetries were observed in foetuses as young as 20 weeks gestation 
indicating that this asymmetry is an early manifestation of human brain 
development (Weinberger et al. 1982). Another area of marked asymmetries is in 
parts of the dorsal lateral prefrontal cortex (Petty 1999) with right dorsal lateral 
larger than left (Gur Re & et al. 2000; Howard 2003). Right prefrontal, premotor and 
sensorimotor cortices have been also been found to be larger in the right compared 
to left in preterm infants (Lancefield et al. 2006). Furthermore altered lateralisation 
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of white matter in the parietal occipital region of preterm infants has been found 
with larger left and smaller right sided structures (Eckerman, Sturm & Gross 1985). 
By contrast in the whole sample from one study including both premature and term 
born infants the cerebellar volume was larger in the left hemisphere (Shah et al. 
2006). 
 
In contrast to this other research has found brain structures to be symmetrical, and 
asymmetry to be a sign of abnormality. Snook et al found very little hemispheric 
asymmetry in ADC and FA values (Snook et al. 2005) and other research has 
reported all structures to be symmetric or nearly symmetric in volume (Filipek et al. 
1994). Furthermore hemispheric weight was found to not be significantly different 
between the left and right hemispheres and there was no significant difference 
between right and left sides in any region (Ginus Partadiredja 2003). Patients with 
schizophrenia and delusional disorder had a larger left lateral ventricle than the 
right which is not seen in controls (Howard et al. 1994), furthermore Petty argue 
disturbances in asymmetry are particularly striking in patients with schizophrenia 
(Petty 1999) suggesting asymmetry to be a sign of abnormality. Furthermore 
asymmetry of the posterior limb of the internal capsule has been associated with 
hemiplegia (Cowana & de Vriesb 2005). Rose et al found FA in the right posterior 
limb of the internal capsule to be lower than left in children with abnormal 
neurodevelopment and the opposite to be true in children with normal 
development (Rose et al. 2009). This result has not been replicated and is not in 
agreement with other research which has found asymmetry to be a sign of 
abnormal development such as hemiplegia and schizophrenia (Cowana & de Vriesb 
2005; Howard et al. 1994; Petty 1999). 
I hypothesise that generally there will be no asymmetries present in the structures 
measured. 
Motor Difficulties in Preterm Infants 
In the prematurely born infant, white matter injury is often seen (Drobyshevsky et 
al. 2005) and the brain tissue most susceptible to injury includes the fragile area 
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surrounding the ventricles. The white matter tracts related to motor functions 
travel through this vulnerable region of the brain, and movement difficulty affecting 
the legs is a frequent consequence of brain injury in the preterm infant. It has been 
postulated that injuries of the motor white matter tracts are due to an incomplete 
state of development of the vascular supply to the cerebral white matter and the 
maturation-dependent vulnerability of the oligodendroglial precursor cells (Huppi et 
al. 1998; Neil 2002; Volpe 2001).  
DTI has been recently applied to imaging the newborn brains and can be used to 
identify damages to various areas of the brain, which contributes to movement 
difficulties  (Neil et al. 1998) [for reviews see (Neil 2002)]. The major form of 
perinatal brain injury is periventricular leukomalacia (PVL) (Hoon Jr et al. 2009) 
which is most often found in preterm infants (Neil 2002). PVL is strongly associated 
with impaired movement, especially in the legs. The medical diagnosis given when 
the significant movement problems do not resolve as the child develops is cerebral 
palsy (CP) (Hoon Jr et al. 2009). Preterm infants are most at risk for CP 
(Drobyshevsky et al. 2005). 
Previous DTI study of PVL patients revealed that limbic fibres are well preserved, 
while posterior regions of the corpus callosum, corona radiate and sagittal stratum 
are most severely affected (Hoon Jr et al. 2009). By comparing the DTI derived 
metrics, FA and ADC values, Thomas et al have found the significant difference of 
these values between CP patients and normal controls is mainly  associated with the 
white matter tracts related to motion, for example, corticospinal tract and 
corticobulbar tract (Thomas 2005). 
Other structures have also been linked to motor development. Abnormalities within 
the posterior limb of the internal capsule have been associated with motor deficits. 
Rutherford et al found that an abnormal signal within the posterior limb of the 
internal capsule is able to predict poor neurodevelopment outcome in infants with 
Hypoxic-Ischemic Encephalopathy (HIE), although the exact relationship between 
the posterior limb of the internal capsule and motor deficit is unclear (Rutherford et 
al. 1998). Furthermore an asymmetrical posterior limb of the internal capsule has 
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been shown to predict an abnormal neurological assessment (L. S. De Vries F. 
Groenendaal I. C. van Haastert 1999). 
The Role of Thyroxine in Development 
Thyroxine (T4) is necessary for normal growth, development of the central nervous 
system and normal brain development (Caroline Delahunty 2001; Morreale de 
Escobar 2001; Ng et al. 2008; Van Wassenaer 2002; Williams, Visser & Hume 2006). 
The reactions and products of thyroxine in animals and humans influence 
carbohydrate metabolism, protein synthesis/ breakdown, cardiovascular, renal and 
brain function (Wilson 1995). T4 levels increase with increasing gestational age 
(Bernard, Oddie & Fisher 1977; Oddie et al. 1977; Rapaport, Rose & Freemark 2001) 
and when gestational age is constant T4 levels increase with birth weight, 
particularly when gestational age is 39 weeks or higher (Bernard, Oddie & Fisher 
1977).  
Thyroxine levels are important for the development of the hippocampus, 
cerebellum, caudate and corpus callosum as shown from animal studies (Abernethy 
LJ et al. 2003) and have been found to be lower in preterm infants compared to 
controls (den Ouden 1996; Osborn 2001; VAN WASSENAER et al. 1997b).  Low levels 
of thyroxine results in transient hypothyroxinemia, a common finding in premature 
infants (Caroline Delahunty 2001; Reuss et al. 1996; Van Wassenaer 2002; Williams, 
Visser & Hume 2006). Transient hypothyroxinemia in preterm infants has been 
associated with developmental problems (Briet et al. 2001) including 
neurodevelopmental deficits and long term effects for brain development (Caroline 
Delahunty 2001; Ng et al. 2008; Van Wassenaer 2002; Williams, Visser & Hume 
2006). 
However although thyroid dysfunction is common among preterm infants Chung et 
al argue that it generally does not affect neurodevelopmental outcome (Chung et al. 
2011). Despite this Van Wassenaer et al (2008) found thyroxine treatment to be 
associated with improved mental, motor and neurological outcomes in infants <28 
weeks gestation, but with worse mental and neurological outcome in infants of 29 
weeks gestation (van Wassenaer & Kok 2008). However Sze et al (2013) found 
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supplementing all babies below 28 weeks’ gestation with LT4 had no apparent 
effect on brain size and argued their results do not support routine 
supplementation with LT4 for all babies born below 28 weeks’ gestation (Sze M Ng. 
2013). 
Generally research on thyroxine supplementation has found it to have no effect and 
claimed its unsuccessful (van Wassenaer et al. 1997a; Williams, Visser & Hume 
2006) although thyroxine supplementation has been found to raise TT4 levels in 
comparison to placebo infants early on during supplementation but by week 3 
levels were close between levothyroxine and placebo groups (Vanhole et al. 1997) 
and FT4 levels have been found to be significantly higher in a thyroxine compared to 
placebo group (van Wassenaer et al. 1997a).  
Benefit has been found in administering thyroxine supplementation in the more 
premature infants (under 27 weeks) (Briet et al. 1999; van Wassenaer et al. 1997a). 
Possibly infants born earlier are more likely to have a lack of thyroxine and be more 
likely to benefit from supplementation. 
Williams et al argued that thyroxine substitution therapy should only be applied to 
infants who suffer with hypothyroxinemia (Williams, Visser & Hume 2006). The 
sample of premature infants receiving levothyroxine supplementation was under 28 
weeks gestation so within the age range of the subgroup of premature infants that 
were shown to have benefit from thyroxine supplementation (van Wassenaer et al. 
1997a). Thus I hypothesise that FT4 levels will show a temporary increase 
following thyroxine supplementation in comparison to the placebo group but that 
levels will stabilise between groups over time. T4 levels will positively correlate 
with gestational age and birth weight. Higher FA and lower ADC will be found in 
infants treated with levothyroxine and smaller brain structural volumes will be 
found in infants receiving placebo. 
 Intrauterine Growth Restriction 
Preterm infants are smaller than term infants at birth and a low birth weight is 
classified as below 2500 grams. Those infants born with an especially low birth 
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weight for their gestational age are said to suffer from foetal or IUGR (Cole 1997). 
IUGR is defined as a birth weight below the 10th percentile predicted for gestational 
age (Cole 1997; Guellec et al. 2011; Merialdi & de Onis 2005; Resnik 2002) or a birth 
weight that is at least two standard deviations below the mean (Fang 2005).   
It was the World Health Organisation that first made a distinction between low birth 
weight (less than 2500g) and born prematurely (born at less than 37 weeks 
gestation). Small for gestational age (SGA) was later introduced and better 
describes infants with intrauterine growth restriction (IUGR) (Merialdi & de Onis 
2005).  
IUGR and Later Development 
Infants born preterm or with a low birth weight are of an increased risk for later 
developmental problems (Cole 1997) and IUGR infants are said to be of higher 
vulnerability (Esteban et al. 2010). IUGR can be caused by maternal disease such as 
infection, malnutrition, high blood pressure, smoking and alcoholism, poor 
socioeconomic conditions, multiple pregnancy and foetal disease. These have also 
been associated with preterm birth (Martin 1994). Effects of IUGR may persist after 
infancy and have been associated with the development of disorders in adulthood 
such as cardiovascular disease (Merialdi & de Onis 2005; Ozanne, Fernandez-Twinn 
& Hales 2004), hypertension, osteoporosis, schizophrenia, depression, breast 
cancer, polycystic ovary syndrome (Ozanne, Fernandez-Twinn & Hales 2004), high 
blood pressure, obstructive lung disease, diabetes, high cholesterol concentrations 
and renal damage (Sanz-Cortes et al. 2010a). Birth weight has also be established as 
a risk factor for autism although the causal effect is unknown i.e. it is unknown 
whether low birth weight is a cause or consequence of autism (Burd 2005). 
FA and ADC in IUGR Infants 
IUGR presents a complex pattern of brain reorganisation which is already present at 
birth (Eixarch et al. 2012; Zimine 2002). It has specific structural and functional 
consequence for cortical brain development (Tolsa et al. 2004). A study of IUGR in 
rabbits reported that the normal inverse relationship between FA and ADC was not 
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seen. The authors claim the lack of significance in the higher ADC may be due to the 
sample size. FA differences were observed in multiple regions of grey and white 
matter including the frontal, insular, occipital and temporal cortex, the 
hippocampus, putamen, thalamus, claustrum, medial septal nucleus, anterior 
commissure, internal capsule, fimbria of hippocampus, medial lemniscus and 
olfactory tract (Eixarch et al. 2012). Similarly a significant increase in ADC values in 
the internal capsule and thalamus and a decrease in relative anisotropy in the 
corpus callosum, thalamus and unmyelinated white matter has been found at term 
age in IUGR infants (Zimine 2002). Despite this relative anisotropy and ADC changes 
between the first and second examination were similar to that of normal 
development (Drobyshevsky et al. 2005) with a reduction in ADC in the internal 
capsule and thalamus of IUGR and preterm infants and an increase in ADC between 
the first and second examination (Zimine 2002). 
IUGR and Stereology 
IUGR has been associated with  significant reductions in brain volume (Eixarch et al. 
2012) and especially in posterior regions(Thompson et al. 2007). Specific structural 
brain and developmental differences in IUGR infants has been found (Esteban et al. 
2010). In particular IUGR was associated with deficits in the inferior and and 
parieto-occipital and cerebellar regions (Thompson et al. 2007). In terms of global 
grey matter volume, IUGR infants were found to have non-significant reductions in 
comparison to appropriate for gestational age infants and term infants (Sanz-Cortes 
et al. 2010a). Significant reductions in intracranial volume and cerebral cortex grey 
matter has been found within two weeks of birth with IUGR and these changes 
persisted at term age (Tolsa et al. 2004). In addition infants with IUGR have been 
found to have significantly reduced volumes of insular and temporal lobes 
compared to term infants (Padilla et al. 2011; Sanz-Cortes et al. 2010a), reduced 
grey matter in temporal, parietal, frontal and insular regions but increases in white 
matter in temporal regions compared to appropriate for gestational age (AGA) 
infants and increases in white matter in frontal, parietal, occipital and insular 
regions compared to term. Reductions in white matter in IUGR infants were 
observed in the cerebellum. Differences in volumes of brain structures between the 
 
  
59 
 
different groups (preterm-IUGR, preterm-AGA and term) are demonstrated in table 
2.1 (Padilla et al. 2011). However Tolsa et al (2004) found white matter to not be 
affected by IUGR. Other research has found significant reduction in fractional 
dimension of grey and white matter in an IUGR group compared to preterm and 
term groups where as there was no significant difference between preterm and 
term groups. Fractional dimension was related to gestational age and IUGR  
(Esteban et al. 2010). I hypothesise higher FA and lower ADC will be found in 
Preterm IUGR infants compared with preterm non-IUGR infants. 
FA, ADC, Volume and Later Development 
Changes in FA measures found in IUGR correlated with poor outcome in 
neurobehavioral tests (Eixarch et al. 2012). Similarly IUGR infants showed a 
reduction in neurodevelopment which positively correlated with grey matter in 
various regions (Padilla et al. 2011). They were also found to score less maturely on 
a measure of behaviour (Lodygensky et al. 2008).  Volume of the temporal and 
insular lobe was found to significantly positively correlated with neonatal birth 
weight, length and head circumference (Sanz-Cortes et al. 2010a). At term age 
cerebral cortical grey matter volume correlated with attention interaction capacity 
score which was significantly less mature in infants with IUGR (Tolsa et al. 2004). 
Grey matter volume of IUGR infants in the left precuneus and right superior frontal 
gyras positively correlated with motor scores. Grey matter volume of IUGR infants 
in the right superior parietal gyrus positively correlated with fine motor subscale 
and the adaptive behaviour score. There were no correlations between structural 
volume and neurodevelopmental scores in the preterm cohort (Padilla et al. 2011). 
Sanz-Cortes et al (2010) also found IUGR infants to score lower on adaptive behaviour as 
well as on motor and fine motor compared to a term group. 
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Preterm-IUGR compared to term. Preterm-IUGR compared to preterm-AGA. 
Decreased GM 
Volume: 
Bilateral temporal 
lobe 
Decreased GM 
Volume: 
Bilateral distribution 
involving left 
temporal lobe 
Bilateral insular lobe Bilateral insular lobe 
Bilateral parietal 
lobe 
Bilateral parietal lobe 
Right frontal lobe Left frontal lobe 
Decrease white 
matter: 
Cerebellum 
(significant) 
 Right hippocampus 
(not significant) 
Greater white 
matter: 
Left parietal lobe 
 Left  occipital lobe 
 Left insular lobe 
Table 2.1 Table of changes in white and grey matter in IUGR infants compared to term and preterm 
appropriate for gestational age infants. Adapted from Padilla et al 2011 (Padilla et al. 2011).  
In a rabbit model of IUGR it has been associated with significantly poorer 
neurobehavioral performance (Eixarch et al. 2012) and an assessment of preterm 
behaviour found less mature scores in IUGR infants compared to controls (Tolsa et 
al. 2004). Furthermore IUGR infants have been found to have significant reductions 
in neurodevelopmental scores including motor, fine motor and adaptive behaviour 
scores (Esteban et al. 2010; Padilla et al. 2011; Sanz-Cortes et al. 2010a) and these 
scores positively correlated with grey matter in various regions (Padilla et al. 2011), 
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including correlations between adaptive behaviour and the insular lobe (Sanz-
Cortes et al. 2010a). The significant reductions seen in IUGR infants were not 
present in the preterm (without IUGR) compared to term infants and thus it seems 
IUGR adds to the effects of prematurity on brain structure and makes the 
differences more pronounced i.e. reductions went from not significant in preterm 
compared to term to significant comparing IUGR preterm to term infants (Esteban 
et al. 2010). Sanz-Cortez et al (2010) concluded that IUGR causes structural changes 
regardless of prematurity that persist age one and are associated with 
developmental difficulties and Eixarch et al (2012) concluded that IUGR has a 
complex pattern of brain reorganisation which is already present at birth. I 
hypothesise that smaller brain structural volumes will be found in preterm IUGR 
infants compared with preterm non-IUGR infants. 
IUGR and Later Education 
Children born very preterm after IUGR are at an increased risk of cognitive 
impairment at early school age compared to other preterm infants (Morsing et al. 
2011) and are associated with mortality, behavioural outcomes and school 
difficulties. Even infants born between 29 and 32 weeks gestation when combined 
with a birth weight that classifies them as small for gestational age have a 
significant increase in educational disadvantages (Guellec et al. 2011). Similarly 
infants with a birth weight under 750 grams were found to obtain lower scores than 
term controls on measures of reading and mathematics and they also scored more 
poorly than infants with a birth weight between 705 and 1499 grams on perceptual 
planning, reading and mathematics. Furthermore the 750 gram group had lower IQs 
and scored less well on neuropsychological and achievement measures than 
controls (Taylor et al. 2002). Further down the line in education Very low birth 
weight (VLBW) young adults had lower mean IQ and lower academic achievement 
scores. Significantly more VLBW had repeated a grade at school and significantly 
fewer had graduated high school. Thus the educational disadvantage associated 
with VLBW persists into early adulthood. VLBW young adults also had higher rates 
of neurosensory impairments, subnormal height but demonstrated less risk taking 
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behaviours including less alcohol and drug use and lower rates of pregnancy (Hack 
et al. 2002). 
Cognitive impairment, defined as a full scale IQ below 70, was found to be 
significantly more prevalent in preterm infants with IUGR than preterm infants that 
are appropriate for gestational age (Morsing et al. 2011), although birth weight has 
been found to not be associated with any cognitive, behavioural or motor outcomes 
at the age of 5 or school performance outcome at age 8. Despite this children born 
between 29 and 32 weeks gestation that were small for their gestational age were 
found to be at a higher risk of mortality, minor cognitive deficits, inattention-
hyperactive symptoms and school difficulties compared to appropriate-for-
gestational-age children. This study also had a group of infants which they classified 
as mildly small for gestational age (birth weight between the 10th and 20th centile) 
who demonstrated an increased risk of minor cognitive difficulties and behavioural 
difficulties (Guellec et al. 2011). 
IUGR has been found to have later academic effects such as significantly lower 
scores on verbal and full scale IQ when compared to a preterm appropriate for 
gestational age (AGA) group and a term AGA group. The preterm AGA group also 
differed in IQ from the term AGA group. Performance IQ was found not to differ 
between IUGR and AGA preterm infants but was significantly lower than the term 
AGA (Morsing et al. 2011). 
Gestational age was found to not be related to full scale IQ in either the preterm 
AGA or the preterm IUGR group (Morsing et al. 2011). 
Sex Differences 
As with research into preterm infants discussed earlier similar sex differences have 
also been found in infants born with IUGR. Boys have been found to score lower in 
verbal and full scale IQ than females within a preterm-IUGR group and the authors 
concluded that boys may be especially vulnerable to the influence of IUGR and 
preterm birth (Morsing et al. 2011). Furthermore VLBW males but not females were 
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significantly less likely to be enrolled in post secondary study  and scores on applied 
problems had a greater difference in males compared to females (Hack et al. 2002). 
Causes of IUGR 
Maternal factors that can cause IUGR include both alcohol abuse and smoking 
(Eixarch et al. 2012; Fang 2005). Nicotine exposure during in utero development can 
influence foetal growth (Sizonenko et al. 2006) and maternal smoking may decrease 
foetal weight by 135-300g as can alcohol use (Resnik 2002). 
Summary of Hypothesis 
I hypothesise that Infants FA and ADC will be significantly correlated with weight 
and gestational age at birth. 
  I hypothesis that higher FA and lower ADC will be found in the posterior part of 
the internal capsule and corpus callosum 
I hypothesise that smaller brain structural volumes will be found in infants with 
lower birth weight and gestational age at birth and with which they will 
significantly correlate. 
I hypothesise that there will be a difference in DTI and stereology measures 
between males and females.  
I hypothesise that generally there will be no asymmetries present in the structures 
measured. 
 I hypothesise that FT4 levels will show a temporary increase following thyroxine 
supplementation in comparison to the placebo group but that levels will stabilise 
between groups over time. T4 levels will positively correlate with gestational age 
and birth weight. Higher FA and lower ADC will be found in infants treated with 
levothyroxine and smaller brain structural volumes will be found in infants 
receiving placebo. 
I hypothesise that higher FA and lower ADC will be found in Preterm IUGR infants 
compared with preterm non-IUGR infants. 
I hypothesise that smaller brain structural volumes will be found in preterm IUGR 
infants compared with preterm non-IUGR infants. 
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CHAPTER 3 
Magnetic Resonance Imaging (MRI) and 
Image Analysis 
 
Aim of Chapter 
This chapter aims to explore the workings of an MRI machine and goes on to discuss 
the MRI techniques and image analysis used in this study: 
a) MRI Physics 
b) Diffusion Weighted Imaging and Diffusion Tensor Imaging  
c) Stereology 
 
MRI Physics 
MRI is an imaging technique used in hospitals and research facilities to produce 
images of internal tissues in the human body non-invasively (McRobbie 2005). MRI 
contains three electromagnetic components; a set of magnet coils, three gradient 
coils and an integral radiofrequency transmitter coil. These coils generate different 
types of magnetic field and are applied to a patient in combination. Resultantly they 
produce magnetic resonance signals that form MR images (Ridgway 2010). 
The human body is made up of trillions of atoms which act as tiny magnetic fields 
which interact with each other. MRI uses the resonance of these atoms within the 
body. The atoms resonate due to the applied radio waves from the MRI scanner. 
The resonating atoms produce an MR signal that produces anatomical information 
(McRobbie 2005). 
 
 
 
  
65 
 
The Atom 
The atom consists of a nucleus spinning on its own axis and electrons that orbit the 
nucleus and spin on their own axis.  The nucleus consists of two particles: protons 
that have a positive charge and neutrons that have no net charge. Because the 
nucleus is positively charged and is spinning, it develops magnetic properties and 
has magnetic moment (figure 3.1) which means it will interact with an external 
magnetic field (Chavhan 2007; Haacke et al. 1999).  
 
 
Figure 3.1. Illustration of the magnetic moment produced by an electron orbiting 
the nucleus and that produced by the spin of the electron taken from 
http://www.doitpoms.ac.uk/tlplib/ferromagnetic/why_magnetic.php?printable=1 
© DoITPoMS, University of Cambridge 
 
In the majority of MRI and this thesis, we only consider the MR signal arising from 
the hydrogen nuclei in water, which contains a single proton. Because of the spin 
characteristics of the hydrogen proton, when it is placed in the bore of the external 
magnetic field, the magnetic moment of the proton will either align parallel or anti-
parallel with the direction of the magnetic field (B0) (Chavhan 2007; Haacke et al. 
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1999). The magnetic moment of the proton will also precess at some frequency 
around the direction of the external field (Sands & Levitin 2004). 
 
The Precessional Frequency 
The frequency of the proton’s precession depends on the strength of the 
surrounding magnetic field. The precession frequency ω is directly proportional to 
the strength of the external magnetic field (B0) and is defined by the Larmor 
Equation: 
 
                                                                      
Where w0 is known as the precessional, Larmor or resonance frequency. The symbol 
 refers to the gyromagnetic ratio, which is a constant unique to every atom. For 
hydrogen protons,  = 42.56 MHz per Tesla. Therefore the precessional frequency of 
the hydrogen proton at 3 Tesla is ω0 = 128 MHz. The precessional frequency can be 
increased by increasing the strength of the magnetic field (Chavhan 2007; Haacke et 
al. 1999). 
 When placing many protons in a magnetic field, the majority align parallel and 
slightly less align anti parallel (Sands & Levitin 2004). The parallel protons have a 
slightly lower energy state. Increasing the strength of the magnetic field will 
increase the proportion of protons in the parallel direction. It is this excess of 
protons in the lower energy state that are accessible to us in an MRI experiment. 
Using an MRI system with a stronger magnetic field will allow us to gain access to 
more protons, so increasing the signal in our measurements (Chavhan 2007; Haacke 
et al. 1999). 
The magnetisation of the protons in the antiparallel direction will cancel an equal 
amount of magnetisation from protons in the parallel direction. The remaining 
magnetisation will be parallel to the direction of (B0). This is the net magnetization 
vector (NMV) (Chavhan 2007). The NMV is composed of two components of 
magnetization; one the magnitude of the magnetization in the direction of B0 is 
referred to as the longitudinal magnetization, and the other one in the 
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magnetization orthogonal to B0 is known as the transverse magnetization (Haacke 
et al. 1999). 
 
Pulse Sequences 
In simple terms a pulse sequence consists of pulses, signals and recovery periods of 
precession. The main characteristics of a pulse sequence are repetition time (TR) 
and echo time (TE) (McRobbie 2005; Westbrook 2005). TR is the time between RF 
pulses and it determines the amount of precession. TE is the time from the RF pulse 
and the peak of the signal (i.e. echo) (McRobbie 2005; Westbrook 2005). Contrast in 
MR images is produced  by applying the RF pulse at certain TR times and receiving 
the signal at certain TE times (Westbrook 2005). 
 
Diffusion Weighted Imaging and Diffusion Tensor Imaging 
Diffusion Weighted Imaging (DWI) is an MRI technique that uses the motion of 
magnetic moments to produce signal changes (McRobbie 2005). Diffusion can be 
influenced by molecular weight, intermolecular interactions and temperature. The 
cellular microstructure of human tissues influences the diffusion of the molecules as 
intracellular, extracellular, neurons, glial cells and axons within the tissue act as 
barriers (Beaulieu 2002; Hajnal et al. 1991). 
In DWI gradients with equal amplitude and opposite polarity are applied over a set 
period of time (Liney 2006). Magnetic moments that have moved during the time 
period will dephase and lose signal. Those which remained stationary had equal 
dephasing and rephasing. As gradients with high amplitude are used the sequence is 
sensitive to the diffusion of water and other motion at the microscopic level. The 
reduction in signal will depend on the extent of diffusion and the gradient strength 
and timing known as the b- factor (Liney 2006).  
Images can be acquired with at least two different values of b so that apparent 
diffusion coefficient (ADC) can be calculated. A Tensor also has to be calculated to 
receive a three-dimensional image of diffusion. The Tensor requires B=0 and at least 
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6 gradient pairs. This is known as Diffusion Tensor Imaging and it is able to 
distinguish between anisotropy as there is more diffusion along structures and 
fibres such as in white-matter tracts (Liney 2006). DTI images can be obtained from 
the eigenvalues of the diffusion tensor. The eigenvalues (λ1, λ2, and λ3) are the 
lengths of the longest, middle and shortest axis and the eigenvectors (V1, V2 and 
V3) are there orientations (Huang 2010). 
 
DTI enables imaging of unique structural information which  may make it possible to 
detect white matter injuries in specific tracts much earlier (Huang 2010; Neil et al. 
2002) especially with the advancement of tractography where the trajectory 
between brain regions of white matter fibres are predicted (Cascio, Gerig & Piven 
2007). 
DTI is more advanced than DWI due to its lack of dependence on patient positioning 
in the scanner. With DWI the ADC measurement is dependent on the individual’s 
orientation; in the scanner for example measuring the Corpus Callosum on the x 
direction can give slightly different measurements if the individual’s head is tilted to 
one side. This makes comparisons between individual’s and scan-rescan tests not as 
accurate as one would like (Tofts 2003). DTI is not dependent on exact positioning 
of the individual in the scanner or the applied magnetic field gradient coordinate 
system and therefore can be reproduced more accurately than DWI (Tofts 2003). 
DTI looks at anisotropy in different directions more than in DWI. This does result in 
longer scanning times but allows measures of FA as well as ADC to be acquired. The 
direction of the diffusion can be observed which is usually along white matter tracts 
as the tracts act as a barrier to diffusion. DTI can map out white matter tracts and 
neurology and damage to white matter tracts can also be observed (Liney 2006). 
In diffusion imaging the b- factor controls how much the ADC of a tissue contributes 
to the image weighting. With a long TR and TE and B=0 the image becomes T2 
weighted, whereas if the B factor is increased the weighting becomes diffusion 
weighted which means areas with high signal have a high signal because they have a 
low ADC rather than because there is a long T2 time. Different gradients in DWI can 
map out the anatomy of white matter pathways (Westbrook 2005) and DWI and 
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other quantified diffusion measurements are being used as diagnostic and research 
tools (Tofts 2003). It has been used to map out myelination in preterm infants 
(Westbrook 2005) and demyelination in intracranial disease processes. High 
diffusion is shown as dark areas on the DWI but as bright on the diffusion map 
(Tofts 2003). 
With the diffusion of molecules, the distance travelled may not be equal in all 
directions due to barriers. Where no barriers exist or barriers are not coherently 
orientated, the diffusion is equal in all directions and is termed isotropic. Where 
there are highly orientated barriers to diffusion, the diffusion is not equal and 
termed anisotropic. This anisotropy is related to the geometry of fibres. The size, 
shape, composition of barriers and spacing between barriers will determine the 
degree of diffusion (Beaulieu 2002). 
FA is a measure used to characterise the anisotropy of the tensor, i.e. how 
directionally dependent it is. The formula for this is (Huang 2010; Westin et al. 
2002) 
FA =  
 
FA values range from 0 to 1 (Huang 2010). When FA is 0 water diffusion is isotropic, 
equal in all directions implying there are no barriers to its diffusion. A high FA (the 
highest being 1) means the water diffusion is directionally dependent suggesting 
there are barriers such as brain structures preventing equal water diffusion. 
ADC is defined as the average of the three eigenvalues (Huang 2010): 
ADC = (λ1+ λ2+λ3)/3 
ADC is a physical value and usually has the unit of 10-3 mm2/s (Huang 2010) that 
represents the number of directions the water diffuses, a high ADC the more 
directions the water diffuses in suggesting there is less structural barriers. The ADC 
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value is dependent on the interactions of the diffusing molecule with the cellular 
structures and active processes within the tissue (Beaulieu 2002). 
Water molecules are more likely to diffuse along the length of axons, as when 
diffusing perpendicular to them there are barriers such as the myelin sheath 
(Beaulieu 2002; Hajnal et al. 1991). Thomsen et al reported regional variations in 
ADC in normal human white matter and suggested these differences may be due to 
the degree of myelination or the orientation of myelin sheaths in the white matter 
tracts (Thomsen, Henriksen & Ring 1987). In normal development where highly 
ordered structures are present diffusion should be anisotropic as found in the 
human spinal cord (Hajnal et al. 1991) and corpus callosum in the rat (King et al. 
1991). Mean diffusivity and ADC decrease whereas anisotropy increases with 
maturation (Beaulieu 2002; Huppi et al. 1998; Neil et al. 1998; Nomura et al. 1994; 
Sakuma et al. 1991).  
DTI and Myelin 
Changes in ADC and anisotropy accompany brain maturation (Dubois et al. 2008; 
Neil et al. 2002) and are useful for assessing for cerebral white matter development 
(Kroenke et al. 2005). It is clear that diffusion occurs along orientated fibres due to 
less resistance but the specific causes for the anisotropic diffusion was unknown 
(Beaulieu 2002; Cascio, Gerig & Piven 2007; Dubois et al. 2006; Most-ley, Wendland 
& Kucharczyk 1991; Prayer et al. 1997; Westin et al. 2002). Hindrance to diffusion 
could be by myelin sheaths or axonal membranes (Dubois et al. 2006). Myelination 
in the nerve fibres and white matter are undoubtedly related to the anisotropic 
diffusion (Beaulieu 2002; Drobyshevsky et al. 2005; Kroenke et al. 2005; Most-ley, 
Wendland & Kucharczyk 1991; Westin et al. 2002). The lipid bilayers of myelin have 
limited permeability to water so they are expected to hinder diffusion across fibres. 
This led to the thought that the myelin sheath encasing the axons is the cause of 
lack of diffusion perpendicular to fibres. (Beaulieu 2002; Most-ley, Wendland & 
Kucharczyk 1991; Westin et al. 2002). However it is also clear myelin is not the only 
cause of anisotropic diffusion. In assumption that myelin is the only source of 
anisotropic diffusion it was hypothesised that diffusion would be more isotropic in 
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fibre tracts without myelin (Beaulieu 2002). Beaulieu and Allen refuted this 
hypothesis by finding anisotropic diffusion in a non-myelinated nerve of the garfish 
(Beaulieu 2002; Beaulieu & Allen 1994a). More recently research has supported the 
finding that myelin is not the only component of anisotropic diffusion. In central 
cerebral white matter where there are increases in anisotropy and decreases in ADC 
between 28 and 40 weeks gestation (Huppi et al. 1998) even though central 
cerebral white matter does not begin to myelinate until term (Kinney 1988). High 
anisotropy has been found in the corpus callosum (Huppi et al. 1998; Partridge et al. 
2004) and the anterior limb of the internal capsule (Beaulieu 2002; Neil et al. 1998) 
of preterm and term infants even though it is mostly unmyelinated. Furthermore 
Drobyshevsky et al found increases in anisotropy to be most rapid prior to 
myelination in rabbits (Drobyshevsky et al. 2005). Other microstructural 
components of axons within white matter such as the axonal membrane and the 
neurofibrils could contribute to the anisotropic diffusion in reducing diffusion 
perpendicular to fibres (Beaulieu 2002). Although other research has found the 
neurofibrils (specifically neurofilaments) to not have a significant role in anisotropy 
thus axonal membranes or myelin are the primary determinant in anisotropy 
(Beaulieu 2002; Beaulieu & Allen 1994b).  
Myelination may still contribute to the anisotropic diffusion and it has been 
demonstrated that myelination modulates the degree of anisotropy (Thomsen, 
Henriksen & Ring 1987). Furthermore when comparing myelinated and 
unmyelinated fibre tracts of similar size and density it’s expected that anisotropy 
would be higher in the myelinated fibre and that myelination would have caused a 
greater hindrance of diffusion perpendicular to the fibre.  However the extent of 
the myelination contribution to anisotropy is unknown (Beaulieu 2002). 
Development 
Anisotropy in white matter develops prior to myelination (Beaulieu 2002; Prayer et 
al. 1997; Wimberger et al. 1995). The development of anisotropy prior to 
myelination could be due to changes in the development of fibre tracts in central 
white matter which could be related to the ‘early wrapping of axons by 
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oligodendroglial processes’ (Barrett 2010; Huppi et al. 1998; Remahl & Hildebrand 
1990; Snell 2010). Anisotropy continues to develop in white matter as myelin forms 
although at some point anisotropy levels seem to reach an optimum level and do 
not continue to increase further with increasing age and myelination (Beaulieu 
2002). 
Changes in diffusion are related to the increases in myelination, reduction in brain 
water, increasing compactness of fibre tracts and reduced extra-axonal space that 
are involved in white matter maturation. Assumptions that anisotropy relates only 
to myelination are oversimplified and ignore the many different processes that 
effect the diffusion of water within the brain (Beaulieu 2002; Wimberger et al. 
1995). 
In Summary  
Although the specifics have been argued there is a consensus that there is an 
increase in anisotropy and decrease in overall diffusion with increasing age and 
therefore it seems increased anisotropy and decreased diffusion represent further 
matured white matter bundles (Cascio, Gerig & Piven 2007) whether it be due to 
increased myelination (Beaulieu 2002; Drobyshevsky et al. 2005; Kroenke et al. 
2005; Most-ley, Wendland & Kucharczyk 1991; Westin et al. 2002), axonal 
membrane changes (Beaulieu 2002; Neil 2002) compactness of fibre tracts or 
multiple factors (Beaulieu 2002; Wimberger et al. 1995).  
Stereology 
Stereology is an efficient method for quantifying three dimensional structures and 
provides reliable data from sections of three dimensional structures (Gundersen et 
al. 1988). This structure may be of biological matter such as brain tissue or could be 
pieces of steel or flake of rock. Stereology is widely used not only in biological 
sciences but also by material scientists and geologists to investigate the internal 
structure of objects aided by microscopy (Reed 1998). Stereology can be applied to 
T1 weighted and T2 weighted MRI imaging discussed earlier in the chapter. It 
involves applying mathematical theory specifically Cavalieri method to estimate the 
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volume of arbitrary structures by splitting the structures into slices equal distance 
apart and measuring the area of each section then multiply by number of slices and 
distance apart. Bonaventura Cavalieri was the first to consider measuring volume by 
dividing a three dimensional object into equal sections and analysing these sections 
The Cavalieri method provides estimates of a shapes volume that are 
mathematically unbiased (Roberts, Puddephat & McNulty 2000b) and guarantees 
accurate estimation of the volume of an arbitrary object (Roberts et al. 1994).  
V= T (A1, A2 +.....+ An) 
where V equals volume, T equals distance between each slice and A1, A2..... equals 
the area of each section summed (figure 3.3). 
 
 
 
Figure 3.2 Diagram of Cavalieri method taken from 
http://www.mikepuddephat.com/Page/1599/Single-object-stereology-(part-1) 
 
MRI is a useful tool for sectioning the brain into the various slices/sections and in 
combination with tools such as analyse, the sections can be demarcated for the 
specific structures of interest. The imaging software Easymeasure which was 
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developed by Puddephat can be used to apply point counting method to each of the 
slices. The image is overlayed with an array of test points (figure 3.3) and 
thenumber of points which fall within the boundary of the region of interest are 
counted (Puddephat 1999). The point counting method is demonstrated within the 
structures of interest in the followingMethodology section. 
 
Figure 3.3 Array of test points arranged over a T2 weighted image. 
With the application of point counting the equation for volume becomes: 
V= T (a) (P1 + P2+.....Pn) 
                p 
  
whereas before V equals volume, T equals distance between each slice and P1, P2..... 
represents the points counted and (a/p) represents the area of each point. Volume 
calculation involves a two step process involving sectioning and point counting 
(Roberts, Puddephat & McNulty 2000b).  
Coefficient of error is the margin of error made when estimating a volume using 
Cavalieri and point counting methods, and in stereology the aim is to maintain the 
coefficient of error below 5%. Coefficient of error when stereology has been 
performed with point counting can be predicted by the following formula: 
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(Cruz-Orive 1999). 
 
The parameters for stereology of the prefrontal cortex (PFC) in order to maintain a 
coefficient error below 5% are represented in table 3.1 (Howard 2003; Keller 2004). 
 
Structure Grid Size Pixels Slice Gap Shape Coefficients 
Medial Orbital PFC 4 7x7 2 5.19 
Lateral Orbital PFC 4 7x7 2 5.48 
Dorsal Medial PFC 6 10x10 2 5.99 
Dorsal Lateral PFC 6 10x10 2 5.65 
 Table 3.1 Parameters for volume estimation. 
 
The different areas of the prefrontal cortex (PFC) have been well demonstrated 
inlateral, frontal and medial views in Howard et al (2003) demonstrated below in 
figure 3.5 and table 3.2. 
 
Figure 3.4 Demonstration of PFC subfields in lateral, frontal and medial views. Dorsal lateral is  
represented in red, dorsal medial in yellow, orbital lateral in green and orbital medial in blue. 
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Prefrontal cortex subfield Gyri Brodmann area 
Dorsal medial Superior frontal gyrus, 
frontal pole, cingulated 
gyrus 
8,9, 10,24 ,32,6 
Dorsal lateral Middle and inferior frontal 
gyri, superior frontal gyrus, 
frontal pole 
8,9, 10, 44, 45,46 
Orbital medial Gyrus rectus, medial orbital 
gyrus, anterior and posterior 
orbital gyri, cingulated gyrus, 
frontal pole 
10,11, 12,24,25, 32 
Orbital lateral Lateral, anterior and 
posterior orbital gyri, 
inferior and middle frontal 
gyri, frontal pole 
10,11,47 
 Table 3.2 Gyral neuroanatomy and Brodmann areas for the prefrontal cortex sub regions. 
 
Stereology technique in combination with point counting methods is a well  
established and used methodology in autopsy (Ginus Partadiredja 2003; Tang 1997; 
Tang et al. 1997; Yang 2008) and MRI investigations (Howard 2003). The Cavalieri  
principle with point counting is more efficient than region drawing (Howard 2003) 
and provides unbiased volume estimation (Howard 2003; Roberts, Puddephat & 
McNulty 2000a). Advantages of the Cavalieri priniciple include high efficiency and  
easy  implementation (Howard 2003). 
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CHAPTER 4 
Methodology 
 
Aim of Chapter 
This chapter presents the general design of the study. Demographics of the infants 
taking part of the study are presented with details of the MRI procedure and image 
analysis. 
 
Participants 
Sixty nine infants (51 preterm; 9 infants born with intrauterine growth restriction 
and 9 controls) for whom consent was obtained to perform MRI (Figure 4.1). 
Preterm infants were recruited as part of a wider study (Ng et al. 2008) from five 
centres (Liverpool Women’s Hospital, Saint Mary’s Hospital Manchester, Arrowe 
Park Hospital, Hope Hospital and Royal Preston Hospital) through the time period of 
September 2007 to May 2009. Ethical approval was granted by the North West 
Research Ethics Committee, and approved by the Research Governance Group at 
Liverpool Women’s Hospital. The IUGR infants were also part of a larger research 
trial and ethical approval was approved by Oldham Local Research Ethics 
Committee. 
Infants born under 28 weeks gestation, who reached the inclusion criteria for the 
TIPIT protocol (Figure 4.2) and whose parents consented to MRI at 40 weeks 
corrected gestation were included (N= 51). 
Inclusion criteria were infants born with gestational age under 28 weeks at birth 
based on the estimate available in obstetric notes at the time of delivery, infants 
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were recruited within five days of birth and both single and multiple births were 
included. 
Infants born to a mother with known thyroid disease or on antithyroid medications 
during pregnancy and mothers on amiodarone during pregnancy were excluded. 
Infants diagnosed with major congenital or chromosomal abnormalities known to 
affect thyroid function or brain development and maternal death during or within 
five days after childbirth were excluded. 
Treatment 
Infants were randomized and allocated to treatment with two forms of the active 
medication: intravenous levothyroxine (trade name: Levothyroid) and oral 
levothyroxine solution (trade name: Evotrox) or corresponding placebos. 
In the initial phase, infants received either intravenous Levothyroid or placebo (5% 
dextrose) within the first 5 days after birth. The treatment regime followed the 
dosage at 8mcg/kg birth weight/day single daily dose. 
In the next phase, once enteral feeds were fully established, oral solution Evotrox or 
placebo (carrier solution without active drug) was given at 8mcg/kg birth 
weight/day single daily dose until the baby reaches 32 weeks CGA.  
Randomization codes were computer generated using the statistical package STATA 
with random variable block size of two and four. Randomisation was stratified by 
centre, and gestational age at birth (under 25 weeks’ gestation, 25-26 weeks’ 
gestations, 27-27weeks 6 days gestation). Allocation concealment was provided by 
pharmacy departments of the respective hospitals. Multiple births followed the 
randomisation process as per singleton births, such that siblings would receive the 
same allocation. 
Parents, clinicians involved in patient care and individuals assessing study end-
points were blinded to the study treatments. Levothyroxine and its placebo were 
presented identically.  
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Intrauterine Growth Restriction 
Intrauterine Growth Restriction infants were part of a wider study where 31 babies 
born between 28 and 36 weeks were studied (19 IUGR and 12 Controls). 
Individualised birth weight of IUGR infants was below the 3rd centile and the 12 
infants who were appropriately grown individualized birth weight were between 
the 25th and 75th centile. The infants whom MRI was performed were included in 
this thesis and MRI was performed at term equivalent age. 
MRI  
TIPIT 
All TIPIT infants were scanned on the same a 1.5 Tesla Achieva Nova MRI Scanner 
(Phillips Medical Systems, Best, Netherlands) using a phased-array SENSE head coil 
(8 channel) to facilitate the production of high quality MR images with high signal-
to-noise ratio (SNR). The preterm cohort were scanned at term equivalent age in 
natural sleep following a feed using a “feed and wrap” technique. Sedation was not 
used. Careful positioning by the radiographer ensured the comfort of the infants. 
Hearing protection with President putty and Mini-muffs was used. This helped keep 
the infants soundly asleep and still during the scan, reducing image degradation 
from motion artefacts. Additional scanner-inbuilt acoustic noise reduction 
techniques were also employed. Experienced dedicated paediatric radiographers 
performed the scans; as we did not use any sedation, it was not necessary to have a 
paediatrician present. Diffusion images were acquired using a spin echo sequence 
with 24 contiguous axial slices of 3 mm thickness with in-plane isotropic resolution 
of 2 mm. Thirty-two gradient directions were applied using a b-factor of 700 s/mm2, 
and one image at b=0. Two averages were collected, giving a total scan time of 3 
minutes and 47 seconds. T2 weighted images were acquired using a turbo spin echo 
(TSE) sequence with a total scan time of 5 minutes (see table 4.1 for MRI 
sequences). 
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Figure 4.1: MRI Participant Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study 
MRI (N=69) 
IUGR                (N=18) 
 
TIPIT                              (N=51) 
 
IUGR              (N=9) 
Male               (N=5) 
Female           (N=4) 
 
 
Control           (N=9) 
Male                (N=7) 
Female            (N=2) 
 
 
Allocation 
Thyroxine     (N=39) 
Male              (N=17) 
Female          (N=12) 
 
 
Placebo         (N=22) 
Male              (N=11) 
Female          (N=11) 
 
 
Gestation 
Min    29wks 6 days 
Max   35wks 6 days          
Mean  32wks 4 days        
 
 
Min    29wks  
Max   35wks 6 days          
Mean  32wks 3 days        
 
 
    Min         813 grams 
    Max       1850 grams          
    Mean     1333 grams        
 
 
Min        1180 grams 
Max       2675 grams          
Mean     2001 grams        
 
 
Min    24wks  
Max   27wks 6 days          
Mean  26wks 1 
days        
 
 
Min   24wks 3 days 
Max 27wks 3 days          
Mean  26wks 
2days        
 
 
Birth Weight 
Min         540 grams 
Max       1320 grams          
Mean     864 grams        
 
 
Min         683 grams 
Max       1080 grams          
Mean     888 grams        
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No 
Yes 
Figure 4.2: TIPIT Consort Flow Chart 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n=267) Excluded (n= 114): 
Not meeting inclusion criteria     (n=0) 
Refused to participate               (n=57) 
Other reasons                            (n= 57) 
 Out of area (n=20) 
 Unable to give consent on time (n=3) 
 Language barriers (n=2) 
 Deaths before consent obtained (n=15) 
 Missed as delegated person not around (n=12) 
 Mothers too unwell to approach (n=5) 
 
Analysed (n= 62) 
Excluded from analysis (n= 0) 
 
 
 
Lost to follow-up (n= 13) 
Reasons: 
 Deaths occurred before 36 weeks (n= 12) 
 Withdrawal from study (n=1) 
Reasons: Baby became unwell and parents 
did not want further non-essential 
intervention 
 
     
Allocated to thyroxine        (n= 75) 
Received thyroxine            (n= 73) 
Did not receive thyroxine   (n= 2)  
Reasons: 
Baby died before thyroxine could be 
administered (n= 2) 
Lost to follow-up (n= 20) 
Reasons: 
 Deaths occurred before 36 weeks (n= 
16) 
 Withdrawal from study (n=4) 
Reasons: Baby became unwell and parents did 
not want further non-essential intervention 
 
 
 
 
Allocated to placebo       (n= 78) 
Received placebo           (n= 71) 
Did not receive placebo (n= 7) 
Reasons: 
Baby died before placebo could be 
administered (n= 7) 
 
 
Analysed (n= 58   ) 
Excluded from analysis (n= 0) 
Allocation 
Analysis 
Follow-Up at 36 weeks 
Randomised? 
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Table 4.1: MRI Sequences 
               Sequence Scan Parameters    Target Area 
 
1 
 
Midline sagittal T1 weighted Turbo Spin 
Echo (TSE) 
 
TR/TE  = 337/ 18ms 
Slice thickness = 3 
mm, 0.3 mm gap Scan 
Duration = 2 minutes 
 
 
Anatomical alignment  
 
 
2 
 
Coronal heavily T2 weighted TSE (whole 
brain) 
 
 
TR/TE = 5750 /150 ms 
Slice thickness = 
1.5 mm, contiguous 
Scan Duration = 5 
minutes 
 
 
Measurement of 
whole brain volume 
(cerebrum/cerebellu
m) and measurement 
of 
specific brain 
structures using 
stereology: 
 
• prefrontal cortex 
 
 
3 
 
Diffusion tensor imaging 2D single shot 
spin-echo Echo-Planar Imaging 
(SE-EPI) with SENSE factor of 2.5. 24 
contiguous axial slices of 3 mm thickness 
with in-plane isotropic resolution of 2 
mm.  
 
 
TR/TE = 3350/74 ms. 
32 gradient directions 
with a bfactor 
of 700 s/mm2. 2 
averages. Scan 
Duration = 3 minutes 
47 s. 
 
Measurement of 
degree of mean 
diffusivity and 
fractional anisotropy 
(as markers of water 
content and 
myelination) in: 
 
• posterior limb of 
internal capsule 
• anterior and 
posterior corpus 
callosum 
• frontal white matter 
• occipital white 
matter 
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4 
 
Axial T2-weighted TSE 
 
 
TR/TE = 3023/150 ms. 
Axial slices thickness= 
3mm 
In-plane isotropic 
resolution of 0.7mm. 
Scan duration = 
3minutes 
 
 
Same slice location as 
DTI to aid region 
drawing. 
 
 
IUGR 
The IUGR cohort were scanned at term equivalent age in natural sleep following a 
feed. Sedation was not used. Infants were scanned using 1.5 T (Philips Medical 
System) MR system based at the Wellcome Trust Clinical Research Facility, 
Manchester following discharge from the neonatal unit. A pillow was used for head 
immobilisation and ear putty was used for ear protection. Heart rate and oxygen 
saturation was monitored throughout the scan. The MRI protocol included a 2D 
turbo spin echo sequence to provide T2-weighted images for the estimation of brain 
volumes, with scan parameters: TR 5760 ms, TE 150 ms, 70 contiguous coronal 
slices of 1.5 mm thickness with in-plane isotropic resolution of 0.9 mm, scan 
duration 5 minutes. Diffusion-weighted images were also acquired using a 2D single 
shot spin-echo Echo-Planar Imaging sequence with SENSE factor of 2.5 and scan 
parameters: TR 3650 ms, TE 74 ms, 32 isotropic gradient directions with b-factor 
700 s/mm2, and one image at b = 0, 24 axial slices of 3mm thickness and 0.3mm gap 
with in-plane isotropic resolution of 2mm, 2 averages, scan duration just under 4 
minutes. 
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Image Analysis 
DTI 
DTI Studio was used to analyse diffusion images. Maps of apparent diffusion 
coefficient and fractional anisotropy were produced and regions of interest were 
drawn by hand (Table 4.2, Figure 4.3).  
Table 4.2 DTI Image Analysis 
Structure ROI ROI Size 
corpus callosum (anterior and 
posterior) 
frontal lobes 
occipital lobes 
Oval  
Oval  
20-25 
 
25-30 
25-30 
posterior limb of internal capsule  Free 25-30 
 
 
 
Figure 4.3: ROI’S shown in red 
Stereology 
The software Brain Voyager QX (version 1.9.10) was used for image realignment and 
demarcation of T2 weighted images. The images were aligned to correct for any 
differences in positioning of the head during scanning. When loading the data the 
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image is inverse (Figure 4.4) and was rotated 90 degrees on the X plane (Figure 4.5). 
For measurement of the prefrontal cortex the image was rotated on the Z field so 
that the subject’s nose was facing the left and the cerebellum is near the right of 
the screen (Figure 4.6). The image was rotated to correct for positioning differences 
during scanning (Figure 4.7). 
 
 
Figure 4.4 the inverse image.             Figure 4.5 the rotated image. 
 
 
 
Figure 4.6 the rotated image used for measurement of the prefrontal cortex, the red arrow indicates 
the cerebellum. 
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The prefrontal cortex was demarcated for measurement of the four subfields 
(dorsolateral, dorsomedial, orbitolateral, orbitomedial). A line was added to the 
AC/PC line just below the corpus callosum to demarcate lateral and medial fields. 
An additional line was added in front of the corpus callosum to demonstrate the 
dorsal/orbital boundary (Figure 4.8). The location of the sulcus was used to 
demarcate medial and lateral subfields (Figure 4.9). 
 
Figure 4.7 re-alignment for measuring the prefrontal cortex. The top row shows before and the 
bottom row after re-alignment. 
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Figure 4.8 demarcation of dorsal and ventral (A) and posterior boundary for the dorsal subfield (B). 
The red arrow indicates the corpus callosum (CC). 
 
 
Figure 4.9 left: sulcus is visible indicated by the red arrows, Right: sulcus is no longer visible on both 
sides of the brain. 
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The brain was rotated differently for measurements of the hemisphere volumes i.e. 
the cerebrum (Figure 4.10) and no demarcation was needed. 
 
 
Figure 4.10 re-alignment for measuring the cerebrum. The top row shows before and the bottom 
row after re-alignment. 
T2 weighted images were analysed using medical imaging software for structure- 
specific brain volume measurements (Easymeasure). Volume of the brain structures 
were estimated using Stereology (see chapter 3), a technique that uses Cavalieri 
and point counting methods (Ng et al. 2008). 
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Figure 4.11 Point Counting in the Dorsolateral Subfield of the Prefrontal Cortex 
                     After Counting    Before Counting 
 
SLICE 48 
 
 
SLICE 49 
 
 
SLICE 50 
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SLICE 51 
 
 
Figure 4.12 Point Counting in the Dorsomedial Subfield of the Prefrontal Cortex 
  
                     After Counting    Before Counting 
 
SLICE 67 
 
 
SLICE 71 
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SLICE 76 
 
SLICE 80 
 
Figure 4.13 Point Counting in the Orbitolateral Subfield of the Prefrontal Cortex 
                     After Counting    Before Counting 
 
SLICE 48 
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SLICE 49 
 
 
SLICE 50 
 
 
SLICE 51 
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Figure 4.14 Point Counting in the Orbitomedial Subfield of the Prefrontal Cortex 
                     After Counting    Before Counting 
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SLICE 71 
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SLICE 80 
 
Figure 4.15 Point Counting of the Cerebrum 
 
Before Counting                     Counting on the Right             Counting on the Left 
         
SLICE 6 
     
SLICE 7 
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SLICE 10 
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Figure 4.16 Point Counting of Intracranial Volume 
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                                       Before Counting            After Counting 
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SLICE 10 
 
 
SLICE 11 
 
 
SLICE 12  
 
  
100 
 
 
SLICE 13 
 
Statistical Analysis 
Statistical analysis was performed using software package SPSS version 19. The 
following hypotheses were tested (with a p value of <.05 considered significant): 
Summary of Hypotheses 
White Matter 
Higher FA/lower ADC will be found in: 
a) Females compared with males 
b) Infants with higher birth weight and gestational age at birth and with which 
they will significantly correlate. 
c) Infants treated with levothyroxine.  
d) The posterior part of the internal capsule and corpus callosum measured in 
both thyroxine and placebo groups.  
e) Preterm non-IUGR infants compared with preterm IUGR infants. 
 
Hemispheric and Regional Volumes 
1) Smaller brain structural volumes will be found in: 
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f) Males compared with females 
 
g) Infants with lower birth weight and gestational age at birth and with 
which they will significantly correlate. 
 
h) Infants receiving placebo 
 
i) Preterm IUGR infants compared with preterm non-IUGR infants. 
 
2) There will be no asymmetries present in the structures measured although 
asymmetry may be found in the occipital and frontal lobes and dorsal lateral 
prefrontal cortex and with which the right frontal lobe and left occipital lobe 
having higher FA and lower ADC. 
 
Thyroxine levels 
3) FT4 levels to have a temporary increase following thyroxine 
supplementation in comparison to the placebo group but that levels will 
stabilise between groups over time. T4 levels will positively correlate with 
gestational age and birth weight. 
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CHAPTER 5 
DTI Results and Thyroxine 
 
 
Aim of Chapter 
This chapter presents the results of the DTI study for: 
a) The preterm cohort 
b) The IUGR cohort 
 
The Preterm Cohort 
Descriptive statistics are shown in Table 5.1 and 5.2 for the preterm cohort.  
Structure  Min FA Max FA Mean FA Std.Deviation 
FLR Placebo  .10 .66 .17 .13 
Thyroxine .11 .32 .15 .04 
FLL Placebo  .10 .58 .19 .12 
Thyroxine .10 .48 .15 .08 
OLR Placebo  .09 .58 .20 .12 
Thyroxine .11 .40 .16 .06 
OLL Placebo  .09 .63 .20 .13 
Thyroxine .09 .42 .15 .07 
RPLIC Placebo  .34 .48 .40 .04 
Thyroxine .32 .47 .40 .04 
LPLIC Placebo  .33 .46 .39 .04 
Thyroxine .30 .49 .41 .04 
CCA Placebo  .23 .46 .34 .06 
Thyroxine .24 .42 .34 .05 
CCP Placebo  .25 .49 .38 .07 
Thyroxine .25 .51 .38 .07 
Table 5.1 FA Table of Descriptive Statistics (FLR= right frontal lobe, FLL= left frontal lobe, OLR= right 
occipital lobe, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= left 
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posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
 
Structure  Min ADC Max ADC Mean ADC Std.Deviation 
FLR Placebo  1.17 2.03 1.69 .21 
Thyroxine 1.35 2.00 1.67 .16 
FLL Placebo  1.42 2.39 1.75 .22 
Thyroxine 1.39 1.98 1.65 .15 
OLR Placebo  1.33 2.18 1.68 .23 
Thyroxine 1.48 1.93 1.74 .14 
OLL Placebo  1.38 2.05 1.72 .20 
Thyroxine 1.42 2.09 1.73 .16 
RPLIC Placebo  .97 1.17 1.09 .05 
Thyroxine 1.01 1.27 1.10 .06 
LPLIC Placebo  .96 1.24 1.10 .06 
Thyroxine 1.06 1.23 1.12 .04 
CCA Placebo  1.22 1.84 1.50 .15 
Thyroxine 1.30 1.85 1.51 .17 
CCP Placebo  1.14 1.90 1.59 .19 
Thyroxine 1.16 1.90 1.52 .18 
        Table 5.2 ADC Table of Descriptive Statistics (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
right occipital lobe, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
Comparison of Structures: FA 
FA is lower in the frontal and occipital lobes compared to the posterior limb of the 
internal capsule and corpus callosum (Figure 5.1).  
 
  
104 
 
 
Figure 5.1. Box Plot demonstrating FA means, the inter-quartile range and outliers (FLR= right frontal 
lobe, FLL= left frontal lobe, OLR= right occipital lobe, OLL= left occipital lobe, RPLIC= right posterior 
limb of the internal capsule, LPLIC= left posterior limb of the internal capsule, CCA= anterior corpus 
callosum, CCP= posterior corpus callosum). 
Comparison of Structures: ADC 
ADC is higher in the frontal and occipital lobes compared to the posterior limb of 
the internal capsule and corpus callosum (Figure 5.2).  
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Figure 5.2 Box plot demonstrating ADC means, the inter-quartile range and outlier (FLR= right frontal 
lobe, FLL= left frontal lobe, OLR= right occipital lobe, OLL= left occipital lobe, RPLIC= right posterior 
limb of the internal capsule, LPLIC= left posterior limb of the internal capsule, CCA= anterior corpus 
callosum, CCP= posterior corpus callosum). 
 
FA and ADC measures were entered into a repeated measures ANOVA with region 
and anterior/posterior as within subject factors and treatment group as between 
subject factor. As there was significant 3 way interaction (Table 5.3), the analysis 
was re-run for anterior and posterior structures separately. 
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DTI 
Measure 
Interaction  Mean 
Square 
F P 
 
 
FA 
Region *Treatment Linear .000 .052 .821 
Quadratic 3.334 .027 .871 
Ant_Post*Treatment Linear 4.77 .003 .957 
Region*Ant_Post*Treatment Linear .000 .170 .682 
Quadratic .005 5.45 .026 
 
 
ADC 
Region *Treatment Linear .000 .005 .944 
Quadratic .011 1.31 .260 
Ant_Post*Treatment Linear .001 .037 .849 
Region*Ant_Post*Treatment Linear .054 4.80 .035 
Quadratic .078 16.66 .000 
Table 5.3 Repeated Measures Anova for Region and Anterior/Posterior (Ant_Post= 
Anterior_Posterior). 
 
FA is significantly lower in the anterior compared to posterior regions in both the 
thyroxine and placebo group (Table 5.4 and Figure 5.3).  
 
 Anterior Structures Posterior Structures Wilks’ Lambda P 
 
FA 
CCA CCP .734 .001 
FLL ICPL .033 .000 
FLR ICPR .034 .000 
 
ADC 
CCA CCP .906 .069 
FLL LPLIC .062 .038 
FLR RPLIC .079 .000 
Table 5.4 FA and ADC in anterior vs. posterior structures. Occipital lobes were excluded due to a lack 
of anterior comparison (FLR= right frontal lobe, FLL= left frontal lobe, RPLIC= right posterior limb of 
the internal capsule, LPLIC= left posterior limb of the internal capsule, CCA= anterior corpus 
callosum, CCP= posterior corpus callosum). 
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Figure 5.3 Mean FA for the three anterior structures and posterior structures in the two groups. 
 
ADC is higher in the anterior compared to posterior regions, this difference is more 
pronounced in the thyroxine group (Figure 5.4).  
 
 
 
Figure 5.4 Mean ADC for the three anterior structures and posterior structures in the two groups. 
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The ADC differences in the corpus callosum only reached borderline significance 
and showed a different finding to the other structures which had significant 
differences between anterior and posterior regions (Table 5.4). 
FA in the anterior corpus callosum is significantly lower than posterior corpus 
callosum (Figure 5.5).  
 
Figure 5.5 Mean FA in the anterior and posterior corpus callosum (CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
ADC was very similar in the thyroxine group and lower in the anterior corpus 
callosum in the placebo group (Figure 5.6). 
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Figure 5.6 Mean ADC in the anterior and posterior corpus callosum (CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
 FA is significantly lower in the left frontal lobe compared to the ipsilateral posterior 
limb of the internal capsule (Figure 5.7).  
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Figure 5.7 Mean FA in the left frontal lobe and ispilateral posterior limb of the internal capsule (FLL= 
left frontal lobe, ICPL= left posterior limb of the internal capsule). 
 
ADC is significantly higher in the left frontal Lobe compared to the ipsilateral 
posterior limb of the internal capsule (Figure 5.8).   
 
 
  
111 
 
 
 
 
Figure 5.8 Mean ADC in the left frontal lobe and ipsilateral posterior limb of the internal capsule 
(FLL= left frontal lobe, ICPL= left posterior limb of the internal capsule). 
 
FA is significantly lower in the right frontal lobe compared to the ipsilateral 
posterior limb of the internal capsule (Figure 5.9). 
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Figure 5.9 Mean FA in the right frontal lobe and ipsilateral posterior limb of the internal capsule. 
(FLR= right frontal lobe, posterior limb of the internal capsule). 
 ADC is significantly higher in the right frontal lobe compared to the ipsilateral 
posterior limb of the internal capsule (Figure 5.10). 
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Figure 5.10 Mean ADC in the right frontal lobe and ipsilateral posterior limb of the internal capsule 
(FLR= right frontal lobe, RPLIC right posterior limb of the internal capsule). 
Interaction with Treatment 
A significant interaction with treatment was seen when looking at FA and ADC in the 
left Frontal Lobe and Posterior Limb of the Internal Capsule (Table 5.5). 
 Structures Value F P 
 
FA 
CCA and CCP 1 .13 .72 
Left FL and PLIC .88 5.39 .03 
Right FL and PLIC .98 .71 .41 
 
ADC 
CCA and CCP .91 3.28 .08 
Left FL and PLIC .89 4.60 .04 
Right FL and PLIC 1 .04 .84 
Table 5.5 Interaction with treatment (FL= Frontal Lobe, PLIC= Posterior Limb of the Internal Capsule, 
CCA= Anterior Corpus Callosum, CCP= Posterior Corpus Callosum).  
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A further one-way ANOVA found no significant difference between FA in the 
placebo and thyroxine group for left frontal lobe and a borderline significance 
between placebo and thyroxine groups in the left posterior limb of the internal 
capsule. One-way ANOVA for ADC measures found borderline significant difference 
between treatments groups in the left frontal lobe and no significant differences in 
the other structures (Table 5.6). 
 Structures Treatment Means F P 
FA FLL Placebo  .19 1.32 .26 
Thyroxine .15 
LPLIC Placebo  .39 3.87 .06 
Thyroxine .41 
ADC FLL Placebo  1.75 3.00 .09 
Thyroxine 1.65 
LPLIC Placebo  1.10 2.77 .10 
Thyroxine 1.12 
CCA Placebo  1.50 .01 .91 
Thyroxine 1.51 
CCP Placebo  1.59 1.35 .25 
Thyroxine 1.52 
Table 5.6 A Table of Differences in DTI measures between groups (FLL= left frontal lobe, ICPL= left 
posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
Laterality 
FA and ADC measures were entered into a repeated measure ANOVA with region 
and laterality as within subject factors and treatment group as between subject 
factor (Table 5.7).  
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DTI 
Measure 
Interaction  Mean 
Square 
F P 
 
 
FA 
Region *Treatment Linear .00 .15 .70 
Quadratic .00 3.70 .06 
Laterality*Region Linear .00 .81 .38 
Quadratic .00 6.44 .02 
Region*Laterality*Treatment Linear .01 16.49 .00 
Quadratic .00 1.17 .29 
 
ADC 
Region *Treatment Linear .04 1.68 .20 
Quadratic .06 3.24 .08 
Laterality*Region Linear .00 .31 .58 
Quadratic .01 1.95 .17 
Region*Laterality*Treatment Linear .01 2.7 .10 
Quadratic .01 .88 .36 
Table 5.7 Repeated Measures ANOVA for Region and Laterality. 
As there was a three way interaction the analysis was re-run for right and left 
structures separately, and as there was a 2 way interaction with laterality and 
region the analysis was also run separately for the regions. There was no significant 
difference in laterality although FA in the frontal and occipital Lobes and ADC in the 
posterior limb of the internal capsule were close to significance (Table 5.8). After 
splitting for treatment groups, differences between FA measures in the frontal lobe 
contra lateral were significant in the placebo group, borderline significant between 
occipital lobes contra lateral in the thyroxine group and significant between 
posterior limb of the internal capsule contra lateral in both the placebo and 
thyroxine group. Differences in ADC measures were significant between the 
occipital lobes contra lateral in the placebo group and borderline between posterior 
limb of the internal capsule contra lateral in the treatment group. 
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DTI 
Measure 
Right 
Structures 
Left 
Structures 
Wilks’ 
Lambda 
Sig Treatment 
Group 
Wilks’ 
Lambda 
P 
FA FLR FLL .92 .08 Placebo .74 .03 
Thyroxine .99 .59 
OLR OLL .92 .07 Placebo .98 .56 
Thyroxine .84 .05 
RPLIC LPLIC .99 .56 Placebo .75 .02 
Thyroxine .78 .02 
ADC FLR FLL 1.00 .97 Placebo .98 .54 
Thyroxine .92 .18 
OLR OLL .95 .17 Placebo .66 .01 
Thyroxine 1 .87 
RPLIC LPLIC .93 .09 Placebo .99 .69 
Thyroxine .86 .07 
Table 5.8 FA and ADC in right vs. left structures (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= 
left posterior limb of the internal capsule). 
 
Laterality of the structure did not interact with the groups mean FA or ADC with the 
exception of FA in the frontal lobes and posterior limb of the internal capsule (Table 
5.9, Figure 5.11 and 5.12). 
 
DTI Measure Structures Value F P 
 
FA 
FLR and FLL .87 5.87 .02 
OLR and OLL .97 1.07 .31 
RPLIC and LPLIC .79 10.86 .00 
 
ADC 
FLR and FLL .96 1.59 .22 
OLR and OLL .93 2.79 .10 
RPLIC and LPLIC .96 1.55 .22 
Table 5.9 Interaction with group (FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe 
right, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= left posterior 
limb of the internal capsule). 
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Figure 5.11 Interaction between laterality and frontal lobes. 
 
Figure 5.12 Interaction between laterality and posterior limb of the internal capsule. 
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Further analysis revealed only borderline significant differences between groups in 
the left posterior limb of the internal capsule with FA higher in the thyroxine group 
(Table 5.10).  
 
Structure Group Means Std Deviation T Sig 
Right FL Placebo .14 .04 -.77 .45 
Thyroxine .14 .03 
Left FL Placebo .15 .05 1.04 .30 
Thyroxine .14 .03 
Right PLIC Placebo .40 .04 .43 .67 
Thyroxine .40 .04 
Left PLIC Placebo .39 .04 .76 .06 
Thyroxine .41 .04 
Table 5.10 Group Difference (FL= frontal lobe, PLIC= posterior limb of the internal capsule). 
 
Thyroxine 
Total thyroxine levels (TT4) and free thyroxine levels (FT4) are generally higher in 
the thyroxine group, by week 36 levels in the placebo group increase and are higher 
in the placebo group (Table 5.11, Figure 5.13 and Figure 5.14).  
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  Mean  Std Dev Treatment Mean Std Dev 
TT4 Screening 66.36 30.53 Placebo  62.71 28.34 
Thyroxine 70.01 33.15 
14 Days 111.90 54.39 Placebo  64.86 19.14 
Thyroxine 147.87 43.76 
21 Days 107.86 55.20 Placebo  72.79 44.08 
Thyroxine 140.41 43.92 
28 Days 107.14 62.55 Placebo  102.52 75.11 
Thyroxine 110.33 55.32 
36 weeks 106.16 33.51 Placebo  109.70 30.08 
Thyroxine 102.61 37.41 
FT4 Screening 11.19 4.70 Placebo  9.77 3.84 
Thyroxine 12.41 5.12 
14 Days 19.11 9.37 Placebo  10.97 2.93 
Thyroxine 23.99 8.45 
21 Days 17.71 10.11 Placebo  10.89 4.18 
Thyroxine 23.33 10.17 
28 Days 14.14 6.15 Placebo  11.03 2.83 
Thyroxine 16.38 6.61 
36 weeks 15.21 3.51 Placebo  15.66 3.59 
Thyroxine 14.67 3.44 
TT3 Screening .95 .25 Placebo  .88 .22 
Thyroxine 1.02 .28 
14 Days 1.12 .17 Placebo  1.13 .19 
Thyroxine 1.11 .15 
21 Days 1.15 .32 Placebo  1.18 .35 
Thyroxine 1.13 .30 
28 Days 1.31 .37 Placebo  1.43 .38 
Thyroxine 1.2 .34 
36 weeks 2.0 .47 Placebo  2.08 .48 
Thyroxine 1.92 .47 
Table 5.11 Mean thyroxine and triiodothyronine levels (TT4= total thyroxine, FT4= free thyroxine, 
TT3= total triiodothyronine). 
 
Figure 5.13 Mean total thyroxine levels for placebo and thyroxine group. 
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Figure 5.14 Mean free thyroxine levels for placebo and thyroxine group. 
 
Total triiodothyronine levels (T) are generally lower in the thyroxine group (Table 
5.11 and Figure 5.15).  
 
 
Figure 5.15 Mean triiodothyronine levels in the placebo and thyroxine group. 
 
Differences between the placebo and thyroxine group were not significant at 
screening for TT4, FT4 and TT3. At day 14 and 21, TT4 and FT4 were significantly 
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higher in the infants treated with thyroxine. At day 28 FT4 was significantly higher in 
the thyroxine group but by week 36 there was no significant difference between 
groups for FT4, TT4 and TT3 levels (Figures 5.13-5.15 and Table 5.12). 
 
  Mean Square F P 
TT4 Screening 400.41 .42 .52 
Day 14 50760.03 40.56 .00 
Day 21 30823.6 15.93 .00 
Day 28 324.27 .08 .78 
Week 36 352.16 .31 .59 
FT4 Screening 67.17 3.21 .08 
Day 14 1272.05 26.29 .00 
Day 21 1188.82 18.31 .00 
Day 28 216.26 6.83 .01 
Week 36 8.5 .69 .41 
TT3 Screening .053 .84 .38 
Day 14 .001 .03 .86 
Day 21 .015 .14 .72 
Day 28 1.83 1.41 .26 
Week 36 .13 .57 .46 
Table 5.12 Difference between thyroxine and placebo group (TT4= total thyroxine, FT4= free 
thyroxine, TT3 = total triiodothyronine). 
 
Infants in the thyroxine group split to high and low levels of TT4, FT4 and TT3 at 
screening, had no significant difference between the two groups at day 14, day 21, 
day 28 and week 36 (Table 5.13). 
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 Screening 
Group 
N Mean Std Deviation T P 
TT4 
Screening 
Low 9 46.3 13.2 -7.77 .00 
High 6 105.58 16.33 
TT4 Day 
14 
Low 5 154 61.76 .21 .84 
High 6 147.47 43.05 
TT4 Day 
21 
Low 4 128 21.21 -1.72 .13 
High 5 157 28.72 
TT4 Day 
28 
Low 3 82.7 57.75 -.59 .57 
High 6 97.57 20.9 
TT4 Week 
36 
Low 5 85.2 29.1 -.66 .53 
High 4 95.95 15.79 
FT4 
Screening 
Low 11 8.64 3.17 -5.65 .00 
High 10 16.55 3.25 
FT4 Day 
14 
Low 8 24.13 10.37 -.11 .91 
High 9 24.6 7.28 
FT4 Day 
21 
Low 6 19.93 6.96 -.62 .55 
High 8 23.61 13.11 
FT4 Day 
28 
Low 7 16.4 8.94 -.09 .93 
High 7 16.71 3.91 
FT4 Week 
36 
Low 6 13.85 2.46 -.50 .63 
High 7 14.91 4.69 
TT3 
Screening 
Low 3 .80 .17 -3.25 .03 
High 3 1.23 .15 
TT3 Day 
14 
Low 3 1.13 .15 -.49 .66 
High 2 1.20 .14 
TT3 Day 
21 
Low 3 1.03 .12 -1.19 .43 
High 2 1.40 .42 
TT3 Day 
28 
Low 2 1.15 .07 2.89 .21 
High 1 .90  
TT3 Week 
36 
Low 3 1.67 .25 -1.45 .24 
High 2 2.05 .35 
Table 5.13 Thyroxine group split for low and high levels at screening (TT4= total thyroxine, FT4= free  
thyroxine levels, TT3= total triiodothyronine). 
 
Correlations 
DTI measures in the preterm population did not correlate with birth weight, 
gestational age at birth or gestation at scanning, with the exception of ADC 
measures in the right occipital lobe where there was a significant negative 
relationship with gestational age at birth, FA in the right frontal lobe where there 
was a significant positive relationship with gestation at scanning and ADC in the left 
frontal lobe where there was a significant negative relationship with gestation at 
scanning (Table 5.14 and Figure 5.16, 5.17 and 5.18). 
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Table 5.14 Correlations between DTI measures, birth weight and gestational age (FLR= right frontal 
lobe, FLL= left frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, RPLIC= right posterior 
limb of the internal capsule, LPLIC= left posterior limb of the internal capsule, CCA= anterior corpus 
callosum, CCP= posterior corpus callosum, Sig= significance). 
 
Figure 5.16 Correlation between ADC in the right occipital lobe and gestation at birth (OLR= right 
occipital lobe). 
 Birth weight Gestation at Birth Gestation at Scan 
 Pearson 
Correlation 
P Pearson 
Correlation 
P Pearson 
Correlation 
P 
FLR FA -.21 -.17 -.28 .06 .38 .01 
FLL FA -.11 -.47 -.19 .21 .23 .13 
OLR FA -.11 -.49 -.15 .33 .16 .29 
OLL FA -.09 .58 -.13 .41 .15 .35 
RPLIC FA .10 .51 .06 .73 .19 .23 
LPLIC FA -.10 .53 .11 .51 .11 .51 
CCA FA .08 .65 .21 .19 .08 .63 
CCP FA .04 .83 .05 .79 .08 .66 
FLR ADC .09 .57 .07 .66 -.27 .07 
FLL ADC .11 .49 .09 .56 -.39 .01 
OLR ADC -.11 .48 -.30 .05 -.11 .47 
OLL ADC .01 .94 -.13 .39 -.19 .22 
RPLIC ADC -.04 .82 -.24 .12 -.36 .02 
LPLIC ADC -.10 .52 -.27 .08 -.15 .36 
CCA ADC -.02 .92 -.13 .42 .03 .87 
CCP ADC .12 .49 -.03 .87 .33 .05 
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Figure 5.17 Correlation between FA in the right frontal lobe and gestation of baby at scanning (FLR= 
frontal lobe right). 
 
Figure 5.18 Correlation between ADC in the left frontal lobe and gestation of baby at scanning (FLL= 
frontal lobe left). 
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Total thyroxine levels (TT4) and free thyroxine levels (FT4) at screening positively 
correlated with gestational age at birth. TT4 at 36 weeks positively correlated with 
the infant’s birth weight and gestation at birth (Table 5.15 and Figures 5.19- 5.22). 
 Birth weight Gestation 
 Pearson 
Correlation 
P Pearson 
Correlation 
P 
TT4 Screening .18 .33 .42 .02 
TT4 Day 14 -.14 .45 -.08 .69 
TT4 Day 21 -.18 .38 -.16 .44 
TT4 Day 28 -.10 .66 -.16 .47 
TT4 Week 36 .58 .00 .44 .02 
FT4 Screening .20 .23 .45 .00 
FT4 Day 14 -.04 .81 -.06 .73 
FT4 Day 21 -.09 .64 -.16 .39 
FT4 Day 28 -.22 .23 -.10 .58 
FT4 Week 36 .23 .19 .25 .15 
TT3 Screening .19 .56 .17 .59 
TT3 Day 14 .00 1 .06 .81 
TT3 Day 21 .04 .85 -.06 .81 
TT3 Day 28 .15 .62 .33 .26 
TT3 Week 36 .37 .11 .15 .52 
Table 5.15 Correlations between TT4, FT4, TT3 with weight and gestation at birth (TT4= total 
thyroxine, FT4= free thyroxine, TT3= total triiodothyronine). 
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Figure 5.19 Positive Correlation between TT4 at screening and gestational age at birth. (TT4= total 
thyroxine).  
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Figure 5.20 Correlation between TT4 levels at week 36 and gestation at birth (TT4= total thyroxine). 
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Figure 5.21 Correlation between FT4 levels at screening and gestation at birth (FT4= free thyroxine). 
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Figure 5.22 Correlation between TT4 at 36 weeks and birth weight (TT4= total thyroxine). 
 
Gender Differences 
In the placebo group males had lower FA and higher ADC in comparison to females 
(Figure 5.23 and 5.24). 
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Figure 5.23 Gender differences in mean FA in the Placebo group (FLR= right frontal lobe, FLL= left 
frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the 
internal capsule, ICPL= left posterior limb of the internal capsule, CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
 
 
Figure 5.24 Gender differences in mean ADC in the Placebo group (FLR= right frontal lobe, FLL= left 
frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the 
internal capsule, ICPL= left posterior limb of the internal capsule, CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
FA was significantly lower in males in the right and left internal capsule, ADC was 
significantly higher in males in the anterior corpus callosum (Table 5.16).   
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Treatment Structure Gender Mean Std Deviation F P 
Placebo FLR - FA Male .19 .16 .32 .58 
Female .15 .07 
FLL- FA Male .18 .10 .07 .79 
Female .20 .14 
OLR- FA Male .18 .10 .36 .56 
Female .21 .14 
OLL- FA Male .18 .11 .47 .50 
Female .22 .15 
ICPR- FA Male .38 .04 5.25 .04 
Female .42 .04 
ICPL - FA Male .37 .03 6.07 .03 
Female .41 .04 
CCA- FA Male .35 .07 .86 .37 
Female .35 .05 
CCP- FA Male .36 .08 1.32 .27 
Female .40 .06 
FLR - ADC Male 1.71 .20 .28 .60 
Female 1.66 .23 
FLL- ADC Male 1.75 .17 .00 .95 
Female 1.75 .28 
OLR- ADC Male 1.74 .20 1.14 .30 
Female 1.63 .26 
OLL- ADC Male 1.77 .18 1.37 .26 
Female 1.67 .22 
ICPR- 
ADC 
Male 1.09 .04 1 .76 
Female 1.10 .06 
ICPL - 
ADC 
Male 1.10 .07 .09 .77 
Female 1.09 .07 
CCA-ADC Male 1.58 .13 .94 .01 
Female 1.39 .11 
CCP- ADC Male 1.60 .23 .06 .82 
Female 1.58 .14 
Thyroxine FLR - FA Male .15 .06 .05 .83 
Female .15 .02 
FLL- FA Male .16 .10 .05 .83 
Female .15 .04 
OLR- FA Male .17 .07 .71 .41 
Female .15 .04 
OLL- FA Male .15 .08 .00 1 
Female .15 .04 
ICPR- FA Male .40 .02 .11 .75 
Female .39 .05 
ICPL - FA Male .42 .03 .19 .679 
Female .41 .06 
CCA- FA Male .34 .05 .01 .93 
Female .34 .06 
CCP- FA Male .36 .07 2.37 .14 
Female .41 .08 
FLR - ADC Male 1.69 .15 .58 .46 
Female 1.64 .18 
FLL- ADC Male 1.67 .13 .31 .58 
Female 1.63 .18 
OLR- ADC Male 1.77 .11 1.21 .28 
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Female 1.70 .18 
OLL- ADC Male 1.78 .11 2.84 .11 
Female 1.66 .22 
ICPR- 
ADC 
Male 1.11 .06 .19 .67 
Female 1.10 .06 
ICPL - 
ADC 
Male 1.12 .02 .39 .54 
Female 1.13 .06 
CCA-ADC Male 1.55 .17 1.84 .19 
 Female 1.46 .16 
CCP- ADC Male 1.55 .20 .64 .43 
Female 1.48 .15 
Table 5.16 Gender differences (FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe 
right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= left posterior 
limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus callosum). 
In the thyroxine group the structural means were similar between males and 
females with no significant differences (Table 5.16, figures 5.25 and 5.26). 
 
Figure 5.25 Gender differences in mean FA in the thyroxine group (FLR= right frontal lobe, FLL= left 
frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the 
internal capsule, ICPL= left posterior limb of the internal capsule, CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
 
0 
0.05 
0.1 
0.15 
0.2 
0.25 
0.3 
0.35 
0.4 
0.45 
FLR FLL OLR OLL ICPR ICPL CCA CCP 
M
e
an
 F
A
- 
Th
yr
o
xi
n
e
 
Structure 
Male 
Female 
 
  
133 
 
 
Figure 5.26 Gender differences in mean ADC in the thyroxine group (FLR= right frontal lobe, FLL= left 
frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the 
internal capsule, ICPL= left posterior limb of the internal capsule, CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
Smoking 
There are considerably more smokers during and before pregnancy in the thyroxine 
group (Table 5.17). 
 
 
 
Table 5.17 Frequencies of smokers in the treatment groups. 
 
Differences in DTI measures between the groups demonstrated borderline 
significantly higher FA in the treatment group in the left posterior limb of the 
internal capsule and borderline significantly higher ADC in the placebo group in the 
left frontal lobe (Table 5.5). After exclusion of the smokers there were no significant 
differences in DTI measures between groups (Table 5.18). 
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 Structures Treatment Means F P 
FA FLL Placebo  .19 2.47 .62 
Thyroxine .17 
LPLIC Placebo  .39 2.67 .12 
Thyroxine .42 
ADC FLL Placebo  1.73 1.56 .22 
Thyroxine 1.63 
LPLIC Placebo  1.11 .53 .48 
Thyroxine 1.12 
CCA Placebo  1.50 .37 .55 
Thyroxine 1.54 
CCP Placebo  1.63 2.47 .13 
Thyroxine 1.53 
Table 5.18 Table of DTI Measures between groups excluding smokers (FLL= left frontal lobe, LPLIC= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
Alcohol 
A separate analysis was performed investigating the effects of alcohol. Data was 
divided into two groups, those who drank alcohol before or during pregnancy and 
those who didn’t drink alcohol. The alcohol free group were matched by treatment 
group and gender (Table 5.19). 
Group No Gender Gestational 
Age (GA) 
Birth 
weight 
(BW) 
Treatment 
Group 
No GA BW 
Alcohol 13 7 Female 
6 Male 
26.52 915.15 Placebo 6 26.52 895.33 
Thyroxine 7 26.51 932.14 
No 
Alcohol 
13 7 Female 
6 Male 
25.74 829.92 Placebo 6 26.05 874.83 
Thyroxine 7 25.47 791.43 
Table 5.19 Participant Information for Alcohol Sub-analysis. 
FA and ADC were generally similar between alcohol groups particularly in the 
placebo group (Figures 5.27 and 5.28). 
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Figure 5.27 Effect of alcohol on mean FA (FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital 
lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= left 
posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
 
Figure 5.28 Effect of alcohol on mean ADC (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
 
In the placebo group FA and ADC were higher in the alcohol group in the majority of 
the structures measured; none of these differences were significant. In the 
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thryoxine group differences were more pronounced with lower FA and higher ADC 
in the alcohol group for all structures. FA was significantly lower in the left occipital 
lobe and right internal capsule, ADC was significantly higher in the left occipital lobe 
and borderline significant in the left frontal lobe (Table 5.20). 
 
Treatment Structure Group Mean Std 
Deviation 
F P 
Placebo FLR - FA Alcohol .14 .03 .62 .45 
No Alcohol .15 .04 
FLL- FA Alcohol .16 .05 .34 .57 
No Alcohol .15 .02 
OLR- FA Alcohol .17 .05 .02 .88 
No Alcohol .16 .02 
OLL- FA Alcohol .16 .05 .03 .87 
No Alcohol .16 .03 
RPLIC- FA Alcohol .43 .04 1.40 .27 
No Alcohol .40 .04 
LPLIC - FA Alcohol .40 .04 .49 .50 
No Alcohol .38 .05 
CCA- FA Alcohol .35 .05 .68 .44 
No Alcohol .31 .08 
CCP- FA Alcohol .40 .06 .01 .92 
No Alcohol .40 .05 
FLR - ADC Alcohol 1.67 .16 2.64 .14 
No Alcohol 1.47 .24 
FLL- ADC Alcohol 1.69 .21 .04 .84 
No Alcohol 1.66 .20 
OLR- ADC Alcohol 1.62 .24 .01 .92 
No Alcohol 1.64 .17 
OLL- ADC Alcohol 1.71 .25 .02 .90 
No Alcohol 1.69 .16 
RPLIC- 
ADC 
Alcohol 1.05 .06 3.33 .10 
No Alcohol 1.11 .04 
LPLIC - 
ADC 
Alcohol 1.06 .07 2.20 .17 
No Alcohol 1.12 .06 
CCA-ADC Alcohol 1.50 .09 .14 .72 
No Alcohol 1.47 .17 
CCP- ADC Alcohol 1.60 .31 .01 .91 
No Alcohol 1.57 .12 
Thyroxine FLR - FA Alcohol .14 .02 .74 .41 
No Alcohol .15 .02 
FLL- FA Alcohol .14 .02 .60 .46 
No Alcohol .15 .03 
OLR- FA Alcohol .14 .02 .02 .89 
No Alcohol .15 .02 
OLL- FA Alcohol .12 .02 8.37 .02 
No Alcohol .16 .03 
RPLIC- FA Alcohol .37 .04 7.29 .02 
No Alcohol .42 .02 
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LPLIC - FA Alcohol .38 .04 2.78 .13 
No Alcohol .41 .03 
CCA- FA Alcohol .32 .042 .91 .36 
No Alcohol .35 .04 
CCP- FA Alcohol .35 .07 1.31 .28 
No Alcohol .40 .08 
FLR - ADC Alcohol 1.77 .18 2.26 .16 
No Alcohol 1.62 .16 
FLL- ADC Alcohol 1.75 .19 3.81 .08 
No Alcohol 1.59 .09 
OLR- ADC Alcohol 1.79 .10 2 .19 
No Alcohol 1.68 .16 
OLL- ADC Alcohol 1.86 .15 5.91 .04 
No Alcohol 1.66 .15 
RPLIC- 
ADC 
Alcohol 1.13 .05 .31 .59 
No Alcohol 1.11 .09 
LPLIC - 
ADC 
Alcohol 1.15 .06 1.22 .30 
No Alcohol 1.12 .04 
CCA-ADC Alcohol 1.57 .20 1.85 .20 
No Alcohol 1.44 .12 
CCP- ADC Alcohol 1.55 .12 .53 .49 
No Alcohol 1.49 .14 
Table 5.20 Differences in alcohol groups (FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital 
lobe right, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= left 
posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
 
The IUGR Cohort 
Descriptive statistics are shown in Table 5.21 and 5.22 for the IUGR cohort.  
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Structure  Min Max Mean  Std. Deviation 
FLR IUGR .12 .20 .15 .03 
Control .09 .23 .15 .04 
FLL IUGR .12 .20 .15 .03 
Control .10 .33 .16 .07 
OLR IUGR .10 .18 .13 .03 
Control .10 .21 .15 .03 
OLL IUGR .12 .20 .15 .03 
Control .08 .20 .14 .04 
ICPR IUGR .22 .43 .35 .07 
Control .34 .44 .40 .04 
ICPL IUGR .21 .44 .37 .08 
Control .32 .44 .38 .04 
CCA IUGR .25 .50 .37 .10 
Control .33 .53 .44 .07 
CCP IUGR .21 .50 .40 .10 
Control .40 .54 .46 .05 
Table 5.21 FA table of descriptive statistics (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
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Structure  Min Max Mean  Std. Deviation 
FLR IUGR 1.32 1.63 1.51 .16 
Control 1.45 1.96 1.67 .15 
FLL IUGR 1.24 1.66 1.49 .15 
Control 1.44 1.76 1.63 .11 
OLR IUGR 1.23 1.85 1.59 .20 
Control 1.49 1.80 1.69 .11 
OLL IUGR 1.24 1.78 1.56 .20 
Control 1.33 1.92 1.71 .17 
ICPR IUGR 1.00 1.16 1.09 .06 
Control 1.01 1.28 1.09 .09 
ICPL IUGR 1.01 1.18 1.09 .07 
Control .98 1.15 1.08 .06 
CCA IUGR 1.31 1.67 1.49 .12 
Control 1.35 1.71 1.50 .12 
CCP IUGR 1.29 1.54 1.43 .10 
Control 1.16 1.68 1.43 .15 
 Table 5.22 ADC table of descriptive statistics (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
Comparison of Structures: FA and ADC 
FA is higher in the internal capsule and corpus callosum in comparison to the 
occipital and frontal lobes in both groups (Figure 5.29).   
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Figure 5.29 Box plot demonstrating FA means (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
FA was lower in the left occipital but higher in the frontal lobe and right occipital 
lobe in the control group compared to the IUGR group (Table 5.21, figure 5.29). 
Higher ranges of scores were seen in the IUGR group for measures of FA in the 
internal capsule and corpus callosum. FA in the internal capsule was lower in the 
IUGR group compared to the control group. In the anterior corpus callosum FA was 
lower in the IUGR group. In the posterior corpus callosum FA was higher in the IUGR 
group. There were no significant differences in FA values between groups (Table 
5.23). 
ADC is higher in the frontal and occipital lobes compared to the internal capsule and 
corpus callosum (Figure 5.30). 
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Figure 5.30 Box plot demonstrating ADC means (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= 
left posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
 
ADC values in the right and left internal capsule were very similar between groups. 
In the posterior corpus callosum values were slightly lower in the control group 
whereas in the anterior corpus callosum values were slightly higher. Left and right 
frontal and occipital lobes had higher ADC values in the control group. ADC values 
were significantly lower in the IUGR group for the frontal lobes left and right and 
borderline significantly lower in the left occipital lobe (Table 5.23). 
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Structure Group Mean Std 
Deviation 
F P 
FLR - FA IUGR .15 .03 .07 .80 
Control .15 .04 
FLL- FA IUGR .15 .03 .05 .82 
Control .16 .07 
OLR- FA IUGR .13 .03 1.90 .19 
Control .15 .03 
OLL- FA IUGR .15 .03 .94 .35 
Control .14 .04 
RPLIC- FA IUGR .35 .07 2.76 .12 
Control .40 .04 
LPLIC - FA IUGR .37 .08 .21 .65 
Control .38 .04 
CCA- FA IUGR .37 .10 2.69 .12 
Control .44 .07 
CCP- FA IUGR .40 .10 2.31 .15 
Control .46 .05 
FLR - ADC IUGR 1.51 .16 6.23 .03 
Control 1.67 .15 
FLL- ADC IUGR 1.49 .15 4.69 .05 
Control 1.63 .11 
OLR- ADC IUGR 1.59 .20 1.93 .19 
Control 1.69 .11 
OLL- ADC IUGR 1.56 .20 3.15 .10 
Control 1.71 .17 
RPLIC- ADC IUGR 1.09 .06 .00 .98 
Control 1.09 .09 
LPLIC - 
ADC 
IUGR 1.09 .07 .13 .73 
Control 1.08 .06 
CCA-ADC IUGR 1.49 .12 .08 .79 
Control 1.50 .12 
CCP- ADC IUGR 1.43 .10 .01 .91 
Control 1.43 .15 
Table 5.23 A table of significant difference in ADC and FA means (FLR= right frontal lobe, FLL= left 
frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, RPLIC= right posterior limb of the 
internal capsule, LPLIC= left posterior limb of the internal capsule, CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
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Laterality 
FA is slightly lower in the right compared to left structures in both the IUGR and 
control group, differences between laterality were not significant (Table 5.24 and 
Figure 5.31).  
 Right Structures Left Structures Wilks’ Lambda P 
 
FA 
FLR FLL .974 .539 
OLR OLL .962 .452 
RPLIC LPLIC .997 .849 
 
ADC 
FLR FLL .926 .290 
OLR OLL .997 .831 
RPLIC LPLIC .925 .286 
Table 5.24 FA and ADC in right vs. left structures (FLR= right frontal lobe, FLL= left frontal lobe, OLR= 
occipital lobe right, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= 
left posterior limb of the internal capsule). 
 
Figure 5.31 Mean FA for the three right and left structures. 
There was no significant difference in mean ADC between the laterality of the 
structures (Table 5.24 and Figure 5.32).  
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Figure 5.32 Mean ADC for the three right and left structures. 
FA and ADC measures were entered into repeated measures ANOVA with region 
and laterality as within subject factors and treatment group as between subject 
factor. As there was a 2 way interaction with laterality and group (Table 5.25) 
additional analysis was performed. 
DTI 
Measure 
Interaction  Mean 
Square 
F P 
 
 
FA 
Region *Group Linear .003 .77 .39 
Quadratic .001 .62 .44 
Laterality*Group Linear .003 4.24 .06 
Laterality*Region Linear .000 .13 .72 
Quadratic 1.968 .00 .96 
Region*Laterality*Group Linear .001 1.06 .32 
Quadratic .001 .68 .42 
 
ADC 
Region *Group Linear .106 7.42 .01 
Quadratic .019 .81 .38 
Laterality*Group Linear .000 .02 .90 
Laterality*Region Linear .002 .79 .39 
Quadratic .001 .38 .55 
Region*Laterality*Group Linear .000 .12 .73 
Quadratic .007 1.93 .19 
Table 5.25 Repeated measures anova for region and laterality. 
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Laterality of the structure did not interact with the groups mean FA or ADC with the 
exception of FA in the occipital lobes (Table 5.26, Figure 5.33).  
 
 Structures Value F P 
 
FA 
FLR and FLL 1.00 .00 .96 
OLR and OLL .62 9.11 .01 
RPLIC and LPLIC .87 2.24 .16 
 
ADC 
FLR and FLL .98 .24 .63 
OLR and OLL .92 1.26 .28 
RPLIC andLPLIC .98 .35 .56 
Table 5.26 Interaction with Group (FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe 
right, OLL= left occipital lobe, RPLIC= right posterior limb of the internal capsule, LPLIC= left posterior 
limb of the internal capsule). 
 
Figure 5.33 Interaction between laterality and group. 
 
Further analysis revealed no significant difference between groups (Table 5.27). 
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Structure Group Mean Std Deviation t P 
FA OLR IUGR .13 .03 -1.38 .19 
Control .15 .03 
FA OLL IUGR .15 .03 .97 .35 
Control .14 .04 
Table 5.27 Group Difference (OLR= right occipital lobe, OLL= left occipital lobe). 
 
Correlations 
In the IUGR group Pearson’s correlations with birth weight and gestational age were 
mostly positive for FA and negative for ADC, these correlations were not significant. 
In the control group Pearson’s correlations were mostly negative for FA and positive 
for ADC (Table 5.28). 
In the control group there was a borderline significant correlation between FA in 
the right occipital lobe and birth weight (Figure 5.34). 
Similarly there was also a borderline significant correlation in the control group 
between FA in the right occipital lobe and gestational age (Figure 5.35). 
All other correlations in the control group were not significant (Table 5.28). 
Gender 
In the IUGR group males generally had higher FA than females with the exception of 
FA in the left internal capsule. ADC was lower in males in the frontal lobes and 
posterior corpus callosum but higher for all the other structures (occipital lobes, 
posterior limb of the internal capsule and anterior corpus callosum). There were no 
significant differences in FA and ADC measures between gender groups, although 
FA in the left frontal lobe and ADC in the anterior corpus callosum was borderline 
significantly higher in males. In the control group males generally had lower FA than 
females with the exception of the left frontal lobe and posterior corpus callosum. 
Males generally had higher ADC in the control group with the exception of the left 
frontal lobe. There were no significant differences in FA and ADC measures between 
gender groups in the control group (Table 5.29, Figures 5.36-5.39). 
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Table 5.28 Correlation between birth weight and DTI measures (FLR= right frontal lobe, FLL= left 
frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, RPLIC= right posterior limb of the 
  Birth weight Gestation at Birth 
Pearson 
Correlation 
P Pearson 
Correlation 
P 
FLR FA IUGR .28 .51 .01 .82 
Control -.46 .21 -.45 .22 
FLL FA IUGR .41 .31 .29 .48 
Control -.02 .96 .03 .95 
OLR FA IUGR .27 .52 .12 .79 
Control -.65 .06 -.64 .06 
OLL FA IUGR .38 .36 .06 .88 
Control -.48 .19 -.50 .18 
RPLIC FA IUGR .32 .44 .32 .44 
Control -.45 .22 -.40 .29 
LPLIC FA IUGR .46 .25 .61 .11 
Control -.25 .52 -.07 .85 
CCA FA IUGR -.06 .88 -.14 .75 
Control .04 .93 -.10 .79 
CCP FA IUGR .06 .89 -.06 .90 
Control -.04 .92 .16 .68 
FLR ADC IUGR -.28 .51 -.06 .88 
Control .03 .95 -.02 .96 
FLL ADC IUGR -.25 .56 -.01 .99 
Control .35 .36 .21 .60 
OLR ADC IUGR .03 .94 .10 .81 
Control .45 .22 .36 .35 
OLL ADC IUGR -.19 .65 -.02 .96 
Control .57 .11 .49 .18 
RPLIC ADC IUGR -.29 .49 -.31 .46 
Control .04 .93 -.09 .82 
LPLIC ADC IUGR -.31 .46 -.39 .34 
Control .34 .37 .20 .61 
CCA ADC IUGR .03 .95 -.09 .83 
Control .12 .77 .13 .74 
CCP ADC IUGR -.30 .47 -.43 .28 
Control -.01 .98 -.00 .99 
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internal capsule, LPLIC= left posterior limb of the internal capsule, CCA= anterior corpus callosum, 
CCP= posterior corpus callosum). 
 
Figure 5.34 Correlation between FA in the OLR and birth weight in the control group (OLR= right 
occipital lobe). 
                          
 Figure 5.35 Correlation between FA in the OLR and gestation at birth in the control group (OLR= 
right occipital lobe). 
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Group Structure Gender Mean Std Deviation F P 
IUGR FLR - FA Male .16 .04 1.20 .32 
Female .13 .02 
FLL- FA Male .17 .03 3.98 .09 
Female .13 .01 
OLR- FA Male .13 .03 .03 .88 
Female .13 .03 
OLL- FA Male .16 .03 .39 .55 
Female .14 .01 
RLIC- FA Male .35 .08 .02 .89 
Female .34 .08 
LPLIC- FA Male .35 .10 .53 .49 
Female .39 .01 
CCA- FA Male .39 .09 .34 .58 
Female .34 .14 
CCP- FA Male .44 .07 2.90 .14 
Female .33 .11 
FLR - ADC Male 1.49 .16 .09 .78 
Female 1.52 .08 
FLL- ADC Male 1.46 .18 .40 .55 
Female 1.53 .10 
OLR- ADC Male 1.61 .23 .15 .72 
Female 1.55 .15 
OLL- ADC Male 1.56 .24 .01 .94 
Female 1.55 .16 
RPLIC- 
ADC 
Male 1.10 .07 .32 .59 
Female 1.08 .038 
 LPLIC- 
ADC 
Male 1.11 .07 2.11 .20 
Female 1.05 .04 
CCA-ADC Male 1.54 .10 4.99 .07 
Female 1.39 .08 
CCP- ADC Male 1.43 .11 .08 .79 
Female 1.45 .10 
Control FLR - FA Male .14 .04 2.57 .15 
Female .19 .06 
FLL- FA Male .16 .08 .01 .92 
Female .16 .04 
OLR- FA Male .14 .03 1.72 .23 
Female .18 .05 
OLL- FA Male .13 .03 .63 .45 
Female .16 .06 
RPLIC- FA Male .39 .04 2.38 .17 
Female .43 .01 
LPLIC - FA Male .37 .04 .72 .42 
Female .41 .05 
CCA- FA Male .42 .07 2.39 .17 
Female .50 .00 
CCP- FA Male .46 .057 .29 .61 
Female .44 .06 
FLR - ADC Male 1.70 .15 1.42 .27 
Female 1.57 .12 
FLL- ADC Male 1.62 .11 .01 .91 
Female 1.64 .18 
OLR- ADC Male 1.71 .11 .63 .45 
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Female 1.64 .15 
OLL- ADC Male 1.75 .09 1.80 .22 
Female 1.58 .35 
RPLIC- 
ADC 
Male 1.11 .09 .81 .40 
Female 1.05 .05 
LPLIC - 
ADC 
Male 1.09 .06 .97 .36 
Female 1.04 .06 
CCA-ADC Male 1.52 .13 .97 .36 
Female 1.43 .04 
CCP- ADC Male 1.45 .12 .76 .41 
Female 1.35 .26 
Table 5.29 Gender differences (FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe 
right, OLL= left occipital lobe, RPLPIC= right posterior limb of the internal capsule, LPLIC= left 
posterior limb of the internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus 
callosum). 
 
 
Figure 5.36 Line graph showing mean FA in both genders for the IUGR group (FLR= right frontal 
lobe, FLL= left frontal lobe, OLR= occipital lobe right, OLL= left occipital lobe, ICPR= right posterior 
limb of the internal capsule, ICPL= left posterior limb of the internal capsule, CCA= anterior corpus 
callosum, CCP= posterior corpus callosum). 
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Figure 5.37 Line graph showing mean ADC in both genders for the IUGR group (IUGR= intrauterine 
growth restriction FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe right, OLL= left 
occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= left posterior limb of the 
internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus callosum). 
 
Figure 5.38 A line graph showing FA in both genders for the control group (IUGR= intrauterine 
growth restriction, FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe right, OLL= left 
occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= left posterior limb of the 
internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus callosum). 
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Figure 5.39 A line graph showing ADC in both genders for the control group (IUGR= intrauterine 
growth restriction, FLR= right frontal lobe, FLL= left frontal lobe, OLR= occipital lobe right, OLL= left 
occipital lobe, ICPR= right posterior limb of the internal capsule, ICPL= left posterior limb of the 
internal capsule, CCA= anterior corpus callosum, CCP= posterior corpus callosum). 
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CHAPTER 6 
Stereology Results 
 
 
 
Aim of Chapter 
This chapter presents the results of the stereology study for: 
a) The preterm cohort 
b) The IUGR cohort 
 
 
The Preterm Cohort 
 
Descriptive statistics are shown in Table 6.1 for the preterm cohort. Structural 
volumes were lower in the placebo group for the dorsal lateral prefrontal cortex, 
left dorsal medial prefrontal cortex, orbital lateral prefrontal cortex, right and left 
hemisphere volumes. Structural volumes were higher in the placebo group for the 
right dorsal medial prefrontal cortex, right and left orbital medial prefrontal cortex 
(Table 6.1, Figures 6.1 and 6.2). 
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Structure  Min Max Mean  Std.Deviation 
RDLPFC Placebo  87.61 2496.87 1034.28 666.73 
Thyroxine 131.41 11433.05 2106.14 2198.69 
LDLPFC Placebo  131.41 2584.48 1158.39 680.82 
Thyroxine 350.44 18003.77 2561.71 3466.05 
RDMPFC Placebo  10294.13 22603.28 15042.08 3009.57 
Thyroxine 4380.48 23523.18 14823.54 4246.58 
LDMPFC Placebo  10732.18 19449.33 16334.32 2714.85 
Thyroxine 4030.40 22471.86 16449.59 4691.08 
ROLPFC Placebo  .00 525.66 183.87 193.10 
Thyroxine .00 4088.45 485.16 888.46 
LOLPFC Placebo  .00 506.19 160.08 166.08 
Thyroxine .00 6619.39 541.23 1328.55 
ROMPFC Placebo  282.45 8760.96 4726.06 1961.29 
Thyroxine 2258.38 6930.89 4293.26 1434.08 
LOMPFC Placebo  2589.35 8254.77 5172.21 1807.14 
Thyroxine 1557.50 8468.93 5092.26 1773.4 
RHEMISPHERE Placebo  58041.36 104766.50 85865.52 13529.71 
Thyroxine 58771.44 121558.30 91946.28 15624.51 
LHEMISPHERE Placebo  60961.68 113527.40 89353.68 14855.22 
Thyroxine 8839.68 120463.20 90547.67 22534.43 
Table 6.1 Structural volumes table of descriptive statistics (RDLPFC= right dorsal lateral prefrontal 
cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= 
left hemisphere). 
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Figure 6.1 A line graph to show mean volume in structures between treatment groups (RDLPFC= 
right dorsal lateral prefrontal cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right 
dorsal medial prefrontal cortex, LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital 
lateral prefrontal cortex, LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial 
prefrontal cortex, LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, 
LHEMISPHERE= left hemisphere). 
 
 
Figure 6.2 Hemisphere volumes between groups. 
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Laterality 
Structural volumes in the right dorsal lateral prefrontal cortex were significantly 
lower in the placebo group. All other differences between treatment groups for the 
other structures were non-significant (Table 6.2). 
 
Structure F Significance 
RDLPFC 3.99 .05 
LDLPFC 2.85 .10 
RDMPFC .04 .85 
LDMPFC .01 .93 
ROLPFC 1.99 .17 
LOLPFC 1.46 .24 
ROMPFC .70 .41 
LOMPFC .02 .89 
Right Hemisphere 1.77 .19 
Left Hemisphere .04 .85 
Table 6.2 One-Way ANOVA results of difference between treatment groups (RDLPFC= right dorsal 
lateral prefrontal cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial 
prefrontal cortex, LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral 
prefrontal cortex, LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial 
prefrontal cortex, LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, 
LHEMISPHERE= left hemisphere). 
 
Structural volumes were generally lower in the right (Table 6.1 and Figures 6.3 and 
6.4).   
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Figure 6.3 Volumes of structures in the placebo group between left and right (DLPFC= dorsal lateral 
prefrontal cortex, DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex, 
OMPFC= orbital medial prefrontal cortex). 
 
 
Figure 6.4 Volumes of structures in the thyroxine group between left and right (DLPFC= dorsal lateral 
prefrontal cortex, DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex 
OMPFC= orbital medial prefrontal cortex). 
Although in the thyroxine group the left hemisphere had lower volume (Figure 6.5).  
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Figure 6.5 Hemisphere volumes between left and right for both groups. 
 
Differences in laterality were significant for the medial structures (Table 6.3). 
 
Structure Wilks’ Lambda P 
DLPFC .96 .22 
DMPFC .88 .02 
OLPFC 1 .84 
OMPFC .78 .00 
Hemisphere .99 .62 
Table 6.3 Laterality differences (DLPFC= dorsal lateral prefrontal cortex, DMPFC= dorsal medial 
prefrontal cortex, OLPFC= orbital lateral prefrontal cortex, OMPFC= orbital medial prefrontal cortex). 
Comparison of Structures 
Volumes were significantly higher in the medial cortex compared to the lateral 
cortex (Table 6.4 and Figure 6.6). 
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Structures Means Wilks’ Lambda Sig 
Right DLPFC 1657.45 .12 .00 
Right DMPFC 14915.03 
Left DLPFC 1974.27 .14 .00 
Left DMPFC 16401.34 
Right OLPFC 359.04 .16 .00 
Right OMPFC 4474.43 
Left OLPFC 381.68 .17 .00 
Left OMPFC 5125.73 
Table 6.4.Comparison of Lateral and Medial Structures (RDLPFC= right dorsal lateral prefrontal 
cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex). 
 
 
Figure 6.6 Graph demonstrating lateral and medial differences. 
 
Volumes were significantly higher in the dorsal compared to orbital regions (Table 
6.5 and Figure 6.7) 
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Structures Means Wilks’ Lambda Sig 
Right DLPFC 1657.45 .45 .00 
Right OLPFC 359.04 
Left DLPFC 1974.27 .55 .00 
Left OLPFC 381.68 
Right DMPFC 14915.03 .10 .00 
Right OMPFC 4474.43 
Left DMPFC 16401.34 .09 .00 
Left OMPFC 5125.73 
Table 6.5 Comparison of dorsal and orbital Structures (RDLPFC= right dorsal lateral prefrontal cortex, 
LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex). 
 
 
 
Figure 6.7 Comparison of dorsal and orbital Structures. 
Sex Differences 
In the placebo group males had lower structural volumes with the exception of the 
left dorsal medial prefrontal cortex (Figure 6.8 and 6.9). 
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Figure 6.8 Gender differences in the placebo group (RDLPFC= right dorsal lateral prefrontal cortex, 
LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex). 
 
Figure 6.9 Gender differences in hemisphere volumes in the placebo group. 
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In the thyroxine group females had lower structural volumes with the exception of 
the left dorsal medial prefrontal cortex (Figure 6.10 and 6.11).  
 
Figure 6.10 Gender Differences in the thyroxine group (RDLPFC= right dorsal lateral prefrontal 
cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex). 
 
Figure 6.11 Gender differences in the hemisphere volumes in the thyroxine group.  
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In the placebo group males had significantly lower volume in the orbital medial 
prefrontal cortex. In the thyroxine group volumes were significantly lower in 
females in the right orbital lateral and both hemispheres. (Table 6.6). 
Treatment Structure Gender Mean Std Deviation F P 
Placebo RDLPFC Male 1012.99 723.37 .01 .91 
Female 1051.32 657.23 
LDLPFC Male 1155.35 476.38 .00 .99 
Female 1160.83 836.06 
RDMPFC Male 14472.01 2017.32 .50 .49 
Female 15498.14 3663.8 
LDMPFC Male 16563.69 2382.71 .10 .76 
Female 16150.83 3069.53 
ROLPFC Male 148.45 168.43 .47 .50 
Female 212.21 215.32 
LOLPFC Male 92.48 95.8 2.61 .13 
Female 214.16 194.04 
ROMPFC Male 3515.35 1459.24 7.63 .01 
Female 5694.63 1806.77 
LOMPFC Male 4268.54 1031.75 4.30 .06 
Female 5895.15 2008.50 
RHEMISPHERE Male 82225.26 16289.78 1.05 .32 
Female 88777.73 10870.87 
LHEMISPHERE Male 84734.91 17923.03 1.43 .25 
Female 93048.7 11526.18 
Thyroxine RDLPFC Male 2816.02 2668.05 3.69 .07 
 Female 1202.64 862.94 
LDLPFC Male 3526.29 4407.01 2.63 .12 
 Female 1334.06 789.79 
RDMPFC Male 14868.60 4994.03 .00 .95 
 Female 14766.2 3294.14 
LDMPFC Male 16010.68 5763.56 .27 .61 
 Female 17008.21 3002.98 
ROLPFC Male 789.88 1102.56 4.25 .05 
 Female 97.35 136.84 
LOLPFC Male 895.57 1716.67 2.40 .14 
 Female 90.27 74.53 
ROMPFC Male 4591.86 1372.26 1.40 2.48 
 Female 3913.23 1484.62 
LOMPFC Male 5321.94 1482.73 .52 .48 
 Female 4799.95 2126.5 
RHEMISPHERE Male 97283.16 14964.07 4.21 .05 
 Female 85153.88 14288.97 
LHEMISPHERE Male 99395.17 11773.43 .59 .02 
 Female 79287.21 28097.26 
Table 6.6 Gender Differences (RDLPFC= right dorsal lateral prefrontal cortex, LDLPFC= left dorsal 
lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, LDMPFC= left dorsal medial 
prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, LOLPFC= left orbital lateral 
prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, LOMPFC= left orbital medial 
prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= left hemisphere). 
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Correlations 
Structural volumes measured by stereology did not correlate with birth weight, 
gestation at scanning or gestation at birth with the exception of the orbital medial 
prefrontal cortex (Table 6.7).  
Table 6.7 Correlation between stereology measures, birth weight, gestational age and gestation at 
scanning (RDLPFC= right dorsal lateral prefrontal cortex, LDLPFC= left dorsal lateral prefrontal cortex, 
RDMPFC= right dorsal medial prefrontal cortex, LDMPFC= left dorsal medial prefrontal cortex, 
ROLPFC= right orbital lateral prefrontal cortex, LOLPFC= left orbital lateral prefrontal cortex, 
ROMPFC= right orbital medial prefrontal cortex, LOMPFC= left orbital medial prefrontal cortex, 
RHEMISPHERE = right hemisphere, LHEMISPHERE= left hemisphere). 
There was a significant positive correlation with the right and contra lateral orbital 
medial prefrontal cortex and gestation at birth and a borderline significant 
correlation between the left orbital medial prefrontal cortex and birth weight (Table 
6.7 and figures 6.12-14). 
 Birth weight Gestation at Birth Gestation at Scanning 
 Pearson 
Correlation 
P Pearson 
Correlation 
P Pearson 
Correlation 
P 
R DLPFC -.06 .70 -.14 .36 .04 .79 
L DLPFC -.07 .65 -.15 .33 .05 .75 
R DMPFC .06 .71 .00 1 -.14 .38 
L DMPFC -.12 .43 -.14 .37 .10 .51 
R OLPFC .10 .55 .04 .81 .13 .42 
L OLPFC .03 .87 .00 .99 .05 .74 
R OMPFC .21 .19 .43 .00 .04 .81 
L OMPFC .28 .07 .45 .00 .08 .62 
R Hemisphere .11 .48 .12 .45 .19 .23 
L Hemisphere .19 .24 .20 .21 .14 .37 
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Figure 6.12.Correlation between birth weight and left orbital medial prefrontal cortex (L_OMPFC). 
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Figure 6.13 Correlation between gestation at birth and left orbital medial prefrontal cortex 
(L_OMPFC). 
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Figure 6.14 Correlation between gestation at birth and right orbital medial prefrontal cortex 
(R_OMPFC). 
Smoking 
As there was considerably more smokers in the thyroxine group (Table 5.17) a one-
way anova was repeated after excluding smokers. Prior to exclusion of smokers 
volume in the right dorsal lateral prefrontal cortex was significantly lower in the 
placebo group (Table 6.2). After exclusion of smokers this was no longer significant; 
volume in the right hemisphere is lower in the placebo group and this difference 
became borderline significant after excluding smokers (Table 6.8). 
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Structures Treatment Means F P 
R_DLPFC Placebo  1044.58 2.50 .13 
Thyroxine 2302.88 
L_DLPFC Placebo  1260.23 2.21 .15 
Thyroxine 3125.79 
R_DMPFC Placebo  14822.87 .42 .52 
Thyroxine 13851.70 
L_DMPFC Placebo  15773.10 .26 .62 
Thyroxine 16548.83 
R_OLPFC Placebo  184.21 1.63 .21 
Thyroxine 575.72 
L_OLPFC Placebo  191.69 1.23 .28 
Thyroxine 728.69 
R_OMPFC Placebo  4742.16 .39 .54 
Thyroxine 4297.04 
L_OMPFC Placebo  5156.24 .00 .98 
Thyroxine 5177.31 
R_Hemisphere Placebo  81797.04 3.96 
 
.06 
Thyroxine 94023.88 
L_Hemisphere Placebo  84127.69 .32 .58 
Thyroxine 89231.83 
Table 6.8 Table of Stereology Measures between groups excluding smokers (RDLPFC= right dorsal 
lateral prefrontal cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial 
prefrontal cortex, LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral 
prefrontal cortex, LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial 
prefrontal cortex, LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, 
LHEMISPHERE= left hemisphere). 
Alcohol 
A separate analysis was performed investigating the effects of alcohol (Table 6.9). 
Structural volume was generally similar between groups (Figure 6.15 and 6.16).  
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Figure 6.15 Effect of alcohol on volume (RDLPFC= right dorsal lateral prefrontal cortex, LDLPFC= left 
dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, LDMPFC= left dorsal 
medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, LOLPFC= left orbital lateral 
prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, LOMPFC= left orbital medial 
prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= left hemisphere). 
 
Figure 6.16 Effect of alcohol on hemisphere volume. 
 
In the placebo group volumes were generally higher in the alcohol group (except 
the left dorsal medial prefrontal cortex). Volumes were significantly higher in the 
alcohol group in the right and contra lateral hemisphere and borderline significantly 
higher in the ipsilateral orbital medial prefrontal cortex. In the thyroxine group 
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volumes were generally lower in the alcohol group with the exception of the right 
dorsal medial prefrontal cortex. Differences in the thyroxine group were generally 
non significant (Table 6.9). 
Treatment Structure Group Mean Std 
Deviation 
F Sig 
Placebo R_DLPFC Alcohol 1025.03 688.17 .22 .66 
No Alcohol 832.29 622.58 
L_DLPFC Alcohol 1235.29 1164.91 .16 .70 
No Alcohol 998.75 594.52 
R_DMPFC Alcohol 15095.13 3228.6 .03 .86 
No Alcohol 14779.74 2081.9 
L_DMPFC Alcohol 15971.23 3218.77 .02 .88 
No Alcohol 16251.58 2593.75 
R_OLPFC Alcohol 237.52 172.71 .53 .49 
No Alcohol 151.86 199.21 
L_OLPFC Alcohol 249.2 182.84 2.04 .19 
No Alcohol 109.03 121.27 
R_OMPFC Alcohol 5867.9 1196.23 3.53 .10 
No Alcohol 3673.79 2321.86 
L_OMPFC Alcohol 6093.73 1688.69 1.29 .29 
No Alcohol 4672.51 2229.88 
R_Hemisphere Alcohol 94764.38 8789.81 5.04 .06 
No Alcohol 77680.51 14575.11 
L_Hemisphere Alcohol 97173.64 10703.19 5.45 .05 
No Alcohol 78848.64 13909.89 
Thyroxine R_DLPFC Alcohol 1595.75 708.98 1.15 .30 
No Alcohol 3172.72 3823.91 
L_DLPFC Alcohol 1483.11 1436.78 1.37 .27 
No Alcohol 4255.32 6111.12 
R_DMPFC Alcohol 16445.57 4231.94 1.17 .30 
No Alcohol 13836.06 4774.08 
L_DMPFC Alcohol 16038.87 6420.66 .00 1 
No Alcohol 16045.07 5520.08 
R_OLPFC Alcohol 203.03 344.04 1.58 .23 
No Alcohol 915.04 1460.98 
L_OLPFC Alcohol 133.50 137.86 1.28 .28 
No Alcohol 1179.25 2438.45 
R_OMPFC Alcohol 3985.54 1562.15 .09 .77 
No Alcohol 4255.32 1776.71 
L_OMPFC Alcohol 4430.54 2026.40 .14 .72 
No Alcohol 4789.33 15622.2 
R_Hemisphere Alcohol 85471.51 14532.13 2.11 .17 
No Alcohol 98143.61 17961.83 
L_Hemisphere Alcohol 89486.95 12058.17 .62 .45 
No Alcohol 96057.66 18554.21 
Table 6.9 Differences in Alcohol groups (RDLPFC= right dorsal lateral prefrontal cortex, LDLPFC= left 
dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, LDMPFC= left dorsal 
medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, LOLPFC= left orbital lateral 
prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, LOMPFC= left orbital medial 
prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= left hemisphere). 
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The IUGR Cohort 
Descriptive statistics are shown in Table 6.10 for the IUGR cohort.  
Structure  Min Max Mean  Std.Deviation 
R DLPFC IUGR .00 1007.51 413.71 387.56 
Control 262.83 1971.22 890.7 596.21 
L DLPFC IUGR .00 788.49 403.98 321.73 
Control 306.63 1401.75 764.15 367.88 
R DMPFC IUGR .00 17215.29 9194.14 6193.79 
Control 11389.25 22778.50 16576.05 3734.45 
L DMPFC IUGR .00 18310.41 9345.02 6705.25 
Control 9856.08 24618.30 16531.45 4871.55 
R OLPFC IUGR .00 447.78 97.34 141.06 
Control .00 564.60 255.26 204.99 
L OLPFC IUGR .00 428.31 108.16 147.66 
Control .00 311.50 121.14 117.93 
R OMPFC IUGR .00 6599.92 3603.89 2397.22 
Control 1538.04 9753.87 5483.71 2340.81 
L OMPFC IUGR .00 6794.61 3536.83 2293.83 
Control 2238.91 11097.22 5676.24 2646.02 
Prefrontal 
Cortex 
IUGR .00 47416.27 26703.08 17695.92 
Control 32271.97 63911.21 46298.7 11060.25 
R 
Hemisphere 
IUGR .00 141336.19 87587.7 39634.07 
Control 92252.91 136013.90 118864.32 14171.18 
L 
Hemisphere 
IUGR .00 136605.27 86142.14 39276.82 
Control 86339.26 141336.19 117747.3 15970.81 
Cerebrum IUGR .00 277941.46 173729.84 78791.89 
Control 178592.17 274984.64 236611.62 29731.08 
Table 6.10 Structural Volumes Table of Descriptive Statistics (RDLPFC= right dorsal lateral prefrontal 
cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= 
left hemisphere). 
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Structural volume was higher in the medial compared to lateral structures in both 
groups and highest in the dorsal medial prefrontal cortex. Volumes were higher in 
the dorsal compared to orbital regions (Figure 6.17). 
 
 
Figure 6.17 Box plot demonstrating Volume in the Dorsal and Orbital structures (RDLPFC= right 
dorsal lateral prefrontal cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal 
medial prefrontal cortex, LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral 
prefrontal cortex, LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial 
prefrontal cortex, LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, 
LHEMISPHERE= left hemisphere). 
Total prefrontal cortex, right and contra lateral hemisphere volumes and cerebrum 
volume were higher in the control group (Figure 6.18).  
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Figure 6.18 Box plot demonstrating volume for the total prefrontal cortex and hemispheres. 
 
Volumes were lower in the IUGR group and differences between groups were 
generally significant apart from the left orbital lateral and contra lateral orbital 
medial prefrontal cortex, which did not reach significance (Table 6.11). 
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Structures  Means F Sig 
R_DLPFC IUGR 414 4.05 .06 
Control 891 
L_DLPFC IUGR 404 4.89 .04 
Control 764 
R_DMPFC IUGR 9194 9.38 .01 
Control 16576 
L_DMPFC IUGR 9345 6.77 .02 
Control 16532 
R_OLPFC IUGR 97 3.63 .08 
Control 255 
L_OLPFC IUGR 108 .04 .84 
Control 121 
R_OMPFC IUGR 3604 2.83 .11 
Control 5484 
L_OMPFC IUGR 3537 3.36 .09 
Control 5676 
Prefrontal 
Cortex 
IUGR 26703 7.94 .01 
Control 46299 
R_Hemisphere IUGR 87588 4.97 .04 
Control 118864 
L_Hemisphere IUGR 86142 5.00 .04 
Control 117747 
Cerebrum IUGR 173730 5.02 .04 
Control 236612 
Table 6.11 Table of stereology measures between groups (RDLPFC= right dorsal lateral prefrontal 
cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= 
left hemisphere). 
Laterality 
Structural and hemisphere volumes were generally very similar between left and 
contra lateral, except that in the orbital lateral prefrontal cortex there was a 
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significant difference between left and contra lateral  (Table 6.12 and Figures 6.19 - 
6.21).  
Structure Wilks’ Lambda Sig 
DLPFC .95 .37 
DMPFC 1 .92 
OLPFC .75 .04 
OMPFC .99 .68 
Hemisphere .93 .28 
Table 6.12 Laterality differences (DLPFC= dorsal lateral prefrontal cortex, DMPFC= dorsal medial 
prefrontal cortex, OLPFC= orbital lateral prefrontal cortex OMPFC= orbital medial prefrontal cortex).  
 
Figure 6.19 Volumes of structures on left and contra lateral in the IUGR group (DLPFC= dorsal lateral 
prefrontal cortex, DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex 
OMPFC= orbital medial prefrontal cortex). 
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Figure 6.20 Volumes of structures on left and contra lateral in the control group (DLPFC= dorsal 
lateral prefrontal cortex, DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal 
cortex OMPFC= orbital medial prefrontal cortex). 
 
Figure 6.21 Differences between left and contra lateral hemisphere volumes.  
Volume was entered into repeated measures ANOVA with structure and laterality 
as within subject factors and subject group (intrauterine growth restriction or 
control) as between subject factor. There was a 2 way interaction with structure 
and subject group (Table 6.13). 
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Interaction  Mean 
Square 
F P 
Structure *Subject Group Linear 2.90 4.47 .05 
Quadratic 1.89 4.41 .05 
Laterality*Subject Group Linear 7709.90 .00 .96 
Laterality*Structure Linear 5256424.00 1.18 .29 
Quadratic 4656733.33 1.58 .23 
Structure*Laterality*Subject 
Group 
Linear 407496.13 .092 .77 
Quadratic 67739.85 0.23 .88 
Table 6.13 Repeated measures ANOVA for region and laterality. 
Although overall there was no interaction between laterality and subject group 
when analysing the structure which had statistically significant differences in 
laterality (orbital lateral prefrontal cortex) separately there was a significant 
interaction with subject group (Table 6.14). 
 
Interaction Mean Square F Significance 
Laterality 34207.12 5.22 .036 
Laterality*Subject Group 47263.49 7.21 .016 
Table 6.14 Interaction with laterality and subject group in the orbital lateral prefrontal cortex. 
After splitting the dataset and analysing the groups separately there was no longer 
a difference between left and contra lateral in the orbital lateral prefrontal cortex 
(Table 6.15). 
Structure Group Wilks’ Lambda Sig 
OLPFC IUGR .89 .35 
CONTROL .95 .54 
Table 6.15 Difference between laterality in the different groups (OLPFC= orbital lateral prefrontal 
cortex). 
Comparison of Structures 
Volumes were significantly higher in the medial cortex compared to the lateral 
cortex (Table 6.16 and Figure 6.22).  
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Structures Means Wilks’ 
Lambda 
Sig 
Right DLPFC 652.20 .13 .00 
Right DMPFC 12885.10 
Left DLPFC 584.06 .16 .00 
Left DMPFC 12938.24 
Right OLPFC 176.30 .20 .00 
Right OMPFC 4543.80 
Left OLPFC 114.65 .21 .00 
Left OMPFC 4606.54 
Table 6.16 Comparison of lateral and medial structures (DLPFC= dorsal lateral prefrontal cortex, 
DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex OMPFC= orbital 
medial prefrontal cortex). 
 
 
Figure 6.22 Graph demonstrating lateral and medial differences. 
A significant interaction with subject group was seen when looking at volumes in 
the right and contra lateral dorsal prefrontal cortex and close to significant in the 
left orbital prefrontal cortex (Table 6.17). 
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Structures Value F Sig 
Right DLPFC .64 8.96 .01 
Right DMPFC 
Left DLPFC .71 6.49 .02 
Left DMPFC 
Right OLPFC .86 2.56 .13 
Right OMPFC 
Left OLPFC .82 3.43 .08 
Left OMPFC 
Table 6.17 Interaction with subject group (DLPFC= dorsal lateral prefrontal cortex, DMPFC= dorsal 
medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex, OMPFC= orbital medial prefrontal 
cortex). 
Further analysis splitting for groups showed volumes to be significantly higher in the 
medial cortex for both the intrauterine growth restriction and control group (Table 
6.18). 
Structures IUGR CONTROL 
Wilk’s_Lamda Sig Wilk’s_Lamda Sig 
Right DLPFC .29 .00 .04 .00 
Right DMPFC 
Left DLPFC .31 .00 .08 .00 
 Left DMPFC 
Left OLPFC .27 .00 .17 .00 
Left OMPFC 
Table 6.18 Comparison of lateral and medial split for group (DLPFC= dorsal lateral prefrontal cortex, 
DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex, OMPFC= orbital 
medial prefrontal cortex). 
Volumes were significantly higher in dorsal compared to orbital regions (Table 6.19 
and Figure 6.23).  
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Structures Means Wilks’ 
Lambda 
Sig 
Right DLPFC 652.20 .43 .00 
Right OLPFC 176.30 
Left DLPFC 584.06 .33 .00 
Left OLPFC 114.65 
Right DMPFC 12885.1 .25 .00 
Right OMPFC 4543.80 
Left DMPFC 12938.24 .28 .00 
Left OMPFC 4606.54 
Table 6.19 Comparison of dorsal and orbital structures (DLPFC= dorsal lateral prefrontal cortex, 
DMPFC= dorsal medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex, OMPFC= orbital 
medial prefrontal cortex). 
 
 
 
Figure 6.23 Comparing dorsal and orbital regions. 
A significant interaction with subject group was seen when looking at volumes in 
the left dorsal and orbital lateral prefrontal cortex and in both the right and contra 
lateral dorsal and orbital medial prefrontal cortex (Table 6.20). 
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Structures Value F Sig 
Right DLPFC .85 2.76 .12 
Right OLPFC 
Left DLPFC .72 6.36 .02 
Left OLPFC 
Right DMPFC .68 7.56 .01 
Right OMPFC 
Left DMPFC .76 5.08 .04 
Left OMPFC 
Table 6.20 Interaction with subject group (DLPFC= dorsal lateral prefrontal cortex, DMPFC= dorsal 
medial prefrontal cortex, OLPFC= orbital lateral prefrontal cortex, OMPFC= orbital medial prefrontal 
cortex). 
Further analysis splitting for groups showed significantly higher volumes in dorsal 
compared to orbital regions in both the IUGR and Control group (Table 6.21). 
Structures IUGR CONTROL 
Wilk’s_Lamda P Wilk’s_Lamda P 
Left DLPFC .46 .02 .16 .00 
Left OLPFC 
Right DMPFC .32 .00 .12 .00 
Right OMPFC 
Left DMPFC .39 .01 .14 .00 
Left OMPFC 
Table 6.21 Comparison of dorsal and orbital split for group (DLPFC= dorsal lateral prefrontal cortex, 
OLPFC= orbital lateral prefrontal cortex, DMPFC= dorsal medial prefrontal cortex, OMPFC= orbital 
medial prefrontal cortex) 
Sex Differences 
In the IUGR group differences between genders were minimal although males had 
higher volumes in the dorsal medial prefrontal cortex, hemisphere volumes and 
cerebrum (Table 6.22, figures 6.24 and 6.25).  
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Figure 6.24 Gender differences in the IUGR group. 
 
Figure 6.25 Gender differences in the IUGR group in the prefrontal cortex, hemisphere and cerebrum 
volumes. 
These gender differences were not significant. In the control group males generally 
had higher volumes, which reached significance in the right orbital lateral prefrontal 
cortex. The right dorsal medial prefrontal cortex was the exception with lower 
volumes (Table 6.22, Figures 6.26 and 6.27). 
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Figure 6.26 Gender differences in the control group. (RDLPFC= right dorsal lateral prefrontal cortex, 
LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, 
LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, 
LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, 
LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere). 
Treatment Structure Gender Mean Std Deviation F Sig 
IUGR RDLPFC Male 516.90 462.97 .78 .41 
Female 284.73 273.56 
LDLPFC Male 490.61 391.07 .80 .40 
Female 295.68 209.70 
RDMPFC Male 9426.79 6736.29 .01 .91 
Female 8903.33 6449.42 
LDMPFC Male 10320.41 7712.92 .22 .66 
Female 8125.79 6083.40 
ROLPFC Male 140.18 182.32 1.04 .34 
Female 43.81 43.17 
LOLPFC Male 101.24 183.36 .02 .89 
Female 116.82 114.63 
ROMPFC Male 3558.90 2376.25 .00 .96 
Female 3630.93 2790.72 
LOMPFC Male 3461.55 2154.56 .01 .92 
Female 3630.93 2796.49 
Prefrontal 
Cortex 
Male 28016.58 19532.31 .06 .82 
Female 25061.21 17885.86 
RHEMISPHERE Male 99349.29 30321.51 .99 .35 
Female 72885.71 49440.30 
LHEMISPHERE Male 96983.83 29839.03 .84 .39 
Female 72590.03 49858.23 
Cerebrum Male 196333.12 59963.05 .92 .37 
Female 145475.74 99222.49 
Control RDLPFC Male 1051.31 580.59 2.80 .14 
Female 328.54 92.92 
LDLPFC Male 844.81 374.88 1.63 .24 
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Female 481.86 185.85 
RDMPFC Male 15930.33 3928.48 .93 .37 
Female 18836.07 2416.02 
LDMPFC Male 16586.38 5131.29 .00 .95 
Female 16339.19 5637.40 
ROLPFC Male 325.41 137.67 5.99 .04 
Female 9.74 13.77 
LOLPFC Male 155.75 110.70 3.59 .10 
Female .00 .00 
ROMPFC Male 6121.55 2047.34 2.89 .13 
Female 3251.29 2422.90 
LOMPFC Male 6293.99 2605.71 1.91 .21 
Female 3514.12 1803.42 
Prefrontal 
Cortex 
Male 47309.53 12467.33 .24 .64 
Female 42760.79 3720.4 
RHEMISPHERE Male 121821.14 14886.27 1.45 .27 
Female 108515.44 1254.48 
LHEMISPHERE Male 120469.45 17300.88 .90 .37 
Female 108219.76 3345.27 
Cerebrum Male 242290.60 31713.4 1.17 .31 
Female 216735.20 4599.74 
Table 6.22 Gender Differences.  (RDLPFC= right dorsal lateral prefrontal cortex, LDLPFC= left dorsal 
lateral prefrontal cortex, RDMPFC= right dorsal medial prefrontal cortex, LDMPFC= left dorsal medial 
prefrontal cortex, ROLPFC= right orbital lateral prefrontal cortex, LOLPFC= left orbital lateral 
prefrontal cortex, ROMPFC= right orbital medial prefrontal cortex, LOMPFC= left orbital medial 
prefrontal cortex, RHEMISPHERE = right hemisphere, LHEMISPHERE= left hemisphere). 
 
Figure 6.27 Gender differences in the control group for the prefrontal cortex, hemisphere and 
cerebrum volumes. 
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Correlations 
Birth weight had a positive significant correlation with volume in the majority of the 
structures although the correlation in the left lateral structures (left dorsal lateral 
prefrontal cortex and left orbital lateral prefrontal cortex) was not significant (Table 
6.23, Figures 6.28-6.37).  
 
 
 
 
 
 
 
 
 
Table 6.23 Correlation between stereology measures, birth weight and gestational age. (RDLPFC= 
right dorsal lateral prefrontal cortex, LDLPFC= left dorsal lateral prefrontal cortex, RDMPFC= right 
dorsal medial prefrontal cortex, LDMPFC= left dorsal medial prefrontal cortex, ROLPFC= right orbital 
lateral prefrontal cortex, LOLPFC= left orbital lateral prefrontal cortex, ROMPFC= right orbital medial 
prefrontal cortex, LOMPFC= left orbital medial prefrontal cortex, RHEMISPHERE = right hemisphere, 
LHEMISPHERE= left hemisphere). 
 
 Birth weight Gestation at Birth 
 Pearson 
Correlation 
Significance Pearson 
Correlation 
Significance 
R DLPFC .47 .05 .23 .37 
L DLPFC .39 .11 .12 .62 
R DMPFC .49 .04 .15 .56 
L DMPFC .56 .02 .24 .33 
R OLPFC .49 .04 .27 .28 
L OLPFC .09 .73 .11 .67 
R OMPFC .54 .02 .40 .10 
L OMPFC .55 .02 .38 .12 
Prefrontal Cortex .58 .01 .27 .27 
R Hemisphere .68 .00 .42 .08 
L Hemisphere .67 .00 .42 .08 
Cerebrum .68 .00 .42 .08 
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Figure 6.28 Correlation between birth weight and volume in the right DLPFC (DLPFC = dorsal lateral 
prefrontal cortex). 
 
 
Figure 6.29 Correlation between birth weight and volume in the right DMPFC (R_DMPFC = right 
dorsal medial prefrontal cortex). 
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Figure 6.30 Correlation between birth weight and volume in the left DMPFC (L_DMPFC = left dorsal 
medial prefrontal cortex). 
 
 
Figure 6.31 Correlation between birth weight and volume in the right OLPFC (R_OLPFC= right orbital 
lateral prefrontal cortex). 
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Figure 6.32 Correlation between birth weight and volume in the right OMPFC (R_OMPFC= right 
orbital medial prefrontal cortex). 
 
 
Figure 6.33 Correlation between birth weight and volume in the left OMPFC (L_OMPFC= left orbital 
medial prefrontal cortex). 
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Figure 6.34 Correlation between birth weight and volume in the prefrontal cortex. 
 
 
Figure 6.35 Correlation between birth weight and volume in the right hemisphere. 
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Figure 6.36 Correlation between birth weight and volume in the left hemisphere. 
 
 
Figure 6.37 Correlation between birth weight and volume in the cerebrum. 
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Correlations between gestation at birth and volume were positive but generally not 
significant (Table 6.23). Positive significant correlations were found in the 
hemisphere volumes and total cerebrum (Table 6.23, Figures 6.38- 6.40). 
 
Figure 6.38 Correlation between gestation at birth and volume in the right hemisphere. 
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Figure 6.39 Correlation between gestation at birth and volume in the left hemisphere. 
 
 
 
Figure 6.40 Correlations between gestation at birth and volume in the cerebrum. 
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CHAPTER 7 
Discussion 
 
 
Aim of Chapter 
This chapter aims to discuss and interpret the results of this thesis in the light of 
current research and is split into five sections: 
a) Limitations 
b) DTI in the preterm cohort 
c) DTI in the IUGR cohort 
d) Stereology in the preterm cohort 
e) Stereology in the IUGR cohort 
Limitations 
A limitation of this study is the limited age range of participants, preterm infants 
age ranged from 24-28 weeks, IUGR and the preterm controls ranged from 29-36 
weeks. Another limitation is that infants were scanned without sedation increasing 
the risk of motion artefact. 
DTI in Preterm Infants 
ADC and anisotropy measures are known to change dramatically during 
development (Cascio, Gerig & Piven 2007; Drobyshevsky et al. 2005; Dubois et al. 
2006; Neil 2002). ADC decreases with age whereas FA increases (Drobyshevsky et al. 
2005). The hypothesis that higher FA and lower ADC will be found in infants with a 
higher birth weight and gestational age at birth (Drobyshevsky et al. 2005; Neil et 
al. 1998) and with which they will significantly correlate is refuted. DTI measures 
did not significantly correlate with birth weight except ADC in the right frontal lobe 
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which had a significant negative correlation. The only structure whose ADC 
correlated with gestational age in the right occipital lobe which had a negative 
relationship. Previous research has found DTI measures to vary with age (Neil 2002) 
with ADC decreasing and FA increasing (Drobyshevsky et al. 2007). Miller et al 
(2002) found anisotropy increased with age in all white matter regions in newborns 
classified as normal. Our research has not generally confirmed this finding although 
this could be due to small age range (24-27 weeks) available in this cohort. 
Differences may have been more likely to be observed with a larger age range. 
Other research has found FA to decrease with decreasing gestational age but no 
difference in ADC (Tatsuji 2011). 
Comparison of Structures 
In normal development the internal capsule and corpus callosum generally develop 
early with the internal capsule myelinating around term age (Cowana & de Vriesb 
2005; O'Shea et al. 2005). They have a higher FA and lower ADC in comparison to 
other slower developing structures (Partridge et al. 2004).  The hypothesis that 
higher FA and lower ADC will be found in the  posterior part of the internal capsule 
and corpus callosum measured in both thyroxine and placebo groups is accepted 
with the results demonstrating higher FA and lower ADC in the posterior limb of the 
internal capsule and corpus callosum compared to the frontal and occipital lobes. 
Furthermore there was higher FA and lower ADC in the posterior compared to 
anterior corpus callosum and generally in posterior compared to anterior regions. 
 The results of DTI in this cohort of preterm infants are similar to the development 
pattern described above in previous research of normal development. However 
other research claims that anisotropy in white matter differs between preterm and 
term infants (Dudink 2008) and higher ADC values and lower relative anisotropy 
values have been found in the central white matter of preterm infants at term age 
compared to term infants born at term. Relative anisotropy values were also lower 
in the posterior limb of the internal capsule in preterm infants (Counsell et al. 2008). 
Preterm infants have been found to have reduced FA in the corpus callosum and 
increased FA in the posterior limb of the internal capsule (Padilla et al 2013) 
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although are study found higher FA in the corpus callosum and posterior limb of the 
internal capsule compared to frontal and occipital lobes. This study did not have 
infants born at term to confirm these findings but suggests even if the anisotropy 
parameters are lower in preterm infants, the pattern of development is still the 
same with the internal capsule and corpus callosum generally developing earlier. 
Dudink et al refer to their sample as preterm infants with normal white matter 
development and normal developmental outcome (Dudink 2007). Their FA and ADC 
measures in the posterior limb of the internal capsule was similar to the present 
data (Table 7.1) although I found slightly higher FA and lower ADC suggesting the 
posterior limb of the internal capsule in the present cohort to show normal white 
matter maturation. The higher FA and lower ADC in the present cohort might be 
explained by the infants in this cohort being at a slightly higher postnatal age at 
time of scanning; for example scans were performed around 10 days post delivery 
compared to 4 days post delivery in Dudink et al’s cohort. 
Structure Mean FA Mean ADC 
 Atkinson et al Dudink et al Atkinson et al Dudink et al 
PLIC 0.40 0.35 1.11 1.09 
CCA 0.34 0.42 1.49 1.24 
CCP 0.38 0.44 1.56 1.27 
Table 7.1:  Comparing our FA and ADC measures with Dudink et al’s 
As no effect of treatment or laterality was found our FA and ADC measures combine treatment groups and left and right 
Posterior Internal Capsule to make them more comparable with Dudink et al’s measures (Dudink 2007). 
Comparing our FA and ADC values in the corpus callosum to Dudink’s (Dudink 2007) 
are not as similar (table 7.1). Our findings show lower FA values and higher ADC 
values, which may reflect abnormal white matter maturation in the corpus callosum 
which if true may lead to later minor motor deficits (Abernethy, Cooke & Foulder-
Hughes 2004). 
Myelination sites begin to myelinate at different times and take different time 
periods to progress to maturity (Kinney 1988). The posterior limb of the internal 
capsule begins myelinating between 32 and 35 weeks gestation and is visible on 
MRI by 36-38 weeks(Cowana & de Vriesb 2005). Myelination within the internal 
capsule progresses towards the anterior interior capsule and should be complete by 
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4-5 months of age (Cowana & de Vriesb 2005; Kinney 1988). A lower ADC and 
higher FA are associated with more extensive myelination (Partridge et al. 2004). 
A similar anterior-posterior pattern as described above was found within the corpus 
callosum. FA was significantly higher in posterior corpus callosum in comparison to 
the anterior in both the placebo and treated group. ADC values were lower in the 
anterior compared to posterior corpus callosum but this difference only reached 
significance in the placebo group. This is similar to previous research findings of 
myelination in the corpus callosum beginning in the body (between anterior and 
posterior) and splenium (posterior) before the rostrum (near the anterior or genu) 
(Kinney 1988) and further confirms the hypothesis that the posterior part of the 
corpus callosum will have higher FA and lower ADC. Furthermore statistically 
significant differences were found between the genu and splenium of the corpus 
callosum of rats as well as significant differences between anterior and posterior 
commissures (Sargon et al. 2003). Thus it seems possible that development follows 
an antero-posterior gradient with earlier development in the posterior part of the 
brain. This is further supported by previous research finding an increase in the 
number of myelinated and unmyelinated axons of white matter towards the more 
posterior regions (Ginus Partadiredja 2003). 
There was a general pattern of significantly higher FA and lower ADC in posterior 
compared to anterior regions. The left posterior limb of the internal capsule had a 
significantly higher FA and lower ADC than the left frontal lobe and similarly the 
right posterior limb of the internal capsule had significantly higher FA and lower 
ADC than the right frontal lobe. 
Marin-Padilla (1997) claim there is a progressive increase in the axonic fibres that 
follow the antero-posterior gradient, meaning the white matter of the frontal 
regions are more developed than the parieto-occipital at any prenatal age. 
Therefore we would expect the different structures in the brain will inherently have 
different FA and ADC measures (Marin-Padilla 1997). 
In terms of the development of white matter tracts, the limbic fibres are first to 
develop, the commissural and projection fibres develop from the core to the 
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periphery and from anterior to posterior, the association fibres are last to develop 
(Huang 2006, 2010; Marin-Padilla 1997). As development of white matter tracts 
follows an antero-posterior gradient, at any prenatal age the frontal regions of the 
WM are more developed than the parieto-occipital regions (Marin-Padilla 1997). 
The last process to occur is the maturation of white matter (Lagercrantz 2002) 
which forms from the core of the brain to the periphery and from the anterior to 
posterior regions (Huang et al. 2006). Therefore maturation proceeds from the 
occipital region anteriorly to the frontal and temporal lobes. This is confirmed by 
previous research which has found significant differences in number of myelinated 
and unmyelinated axons in white matter of Frontal compared to occipital regions 
with numbers increasing from frontal to parietal to occipital although the axons 
were larger in the frontal compared to occipital regions (Ginus Partadiredja 2003). 
Even in the fully developed adult brain FA is expected to be higher and ADC lower in 
the corpus callosum and internal capsule compared to the frontal and occipital 
white matter due to the structure being less organised in the frontal and occipital 
white matter. This same pattern as expected has been shown here with generally 
significantly higher FA and lower ADC values in the corpus callosum and internal 
capsule in comparison to the occipital lobe and frontal lobe. Previous research also 
found higher FA in the corpus callosum and internal capsule in comparison to the 
other structures they measured (Dudink 2007; Partridge et al. 2004). However 
whereas Partridge et al found FA to be highest in the corpus callosum, this study 
found FA to be higher in the posterior limb of the internal capsule and found the 
difference to generally be significant.  
A high FA is usually equated with a low ADC and represents extensive myelination 
(Partridge et al. 2004) and an increase in the complexity of white matter (Dudink 
2008; Huppi et al. 1998). However despite significantly higher FA values in the 
posterior corpus callosum in both groups ADC values were also higher in the 
posterior corpus callosum whereas with extensive myelination you would expect to 
see lower ADC values. These differences in anterior-posterior ADC values only 
reached significance in the placebo group, so the treated group may possibly have 
 
  
198 
 
more extensive myelination and increased complexity of white matter. Furthermore 
abnormal neurodevelopment in preterm infants has been related to reduced 
development in the posterior corpus callosum (Counsell et al. 2008; Rose et al. 
2009) and DTI measures of the corpus callosum in comparison to the other 
structures measured suggests this cohort may not have abnormal development 
particularly those in the treatment group. 
This study has found the corpus callosum to have a significantly higher FA and lower 
ADC than most of the other structures (frontal lobes and occipital lobes) which can 
be equated to extensive myelination in the corpus callosum. Previous research has 
also found FA to be high in the corpus callosum particularly the splenium (aka 
posterior) and genu (aka anterior) (Partridge et al. 2004) which are measured in this 
study. Therefore at around term age FA in the corpus callosum generally seems to 
be quite high in comparison to other structures which can be associated with 
extensive myelination, despite this the corpus callosum is a structure found to be 
smaller in preterm infants in later childhood; aged 8 (Peterson et al. 2000) and 14 
(Nosarti et al. 2004). 
Thus it may be assumed the other parts of the brain found to have lower FA at term 
age in preterm infants (frontal lobes and occipital lobes) would have further 
diminished size later on in life than the corpus callosum. Although this may not be 
the case because of the complex process of human development where different 
parts of the brain develop at different rates (den Ouden 1996). Kinney et al found 
differences in the myelination sequences of different white matter sites during the 
first two years of postnatal life and that myelination not only begins at different 
times but also progresses to maturation over different time intervals (Kinney 1988). 
The cerebellum (Allin et al. 2001; Peterson et al. 2000), basal ganglia, amygdala 
(Peterson et al. 2000) and hippocampus (Lodygensky et al. 2005; Nosarti et al. 
2002a; Peterson et al. 2000) have been found to have smaller volumes suggesting  
the corpus callosum is not the only structure influenced by preterm birth even 
continuing into later childhood and adolescence. Furthermore Nagy found altered 
diffusion characteristics of preterm infants to remain prevalent once the infants 
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reached 11 years of age in the posterior limb of the internal capsule and the corpus 
callosum (NAGY 2003). The question arises about the effect of preterm birth on the 
other structures investigated in this study but not seen in other research later in 
childhood including the frontal lobe and occipital lobe. This is a suggestion for 
future research and a subject for exploration in later articles from this cohort when 
developmental follow up is available. 
Another possible reason for the finding of high FA values in the corpus callosum of 
preterm infants at term, yet small size later on in childhood, is that although high FA 
is associated with extensive myelination it has also been found prior to myelination 
and could be related to changes in the development of fibre tracts in central white 
matter such as the ‘early wrapping of axons by oligodendroglial processes’ (Barrett 
2010; Huppi et al. 1998; Snell 2010). This has been confirmed by previous research 
finding high anisotropy values in the corpus callosum of preterm infants even 
though it is mostly unmyelinated (Partridge et al. 2004). Furthermore both the 
unmyelinated corpus callosum at 28 weeks gestation and the posterior limb of the 
internal capsule which at 28 weeks gestation is in the process of myelination 
demonstrated anisotropy indicating that anisotropy can be caused by both 
unmyelinated and myelinated fibres (Huppi et al. 1998). 
Asymmetry 
In healthy individuals brain structures are generally found to be symmetrical (Filipek 
et al. 1994; Snook, Plewes & Beaulieu 2007), however asymmetries have been 
found in the occipital and frontal lobes.  The left occipital lobe is often wider than 
the contra lateral and the contra lateral frontal lobe usually extends further than 
the left (Le May & Kido 1978) i.e.  the left occipital lobe is larger than the right and 
the right frontal lobe is larger than the left (Petty 1999). This has been confirmed by 
Weinberger et al who also found the right frontal lobe and contra lateral occipital 
lobe to be larger in the majority of brains measured. These asymmetries were 
observed in foetuses as young as 20 weeks gestation indicating that this asymmetry 
is an early manifestation of human brain development (Weinberger et al. 1982). The 
hypothesis that generally there will be no asymmetries present in the structures 
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measured is refuted. Although asymmetry may be found in the occipital and 
frontal lobes and dorsal lateral prefrontal cortex is accepted. Significant 
differences between the right and contra lateral sides of a structure has been found 
in FA in the posterior limb of the internal capsule in both the placebo and thyroxine 
group, occipital lobe in the thyroxine group and frontal lobe in the placebo group. 
ADC measures demonstrated less asymmetry with only significant differences in the 
left occipital lobe although the ADC differences between right and contra lateral in 
the posterior limb of the internal capsule were close to significance. 
The second part of the hypothesis that the right frontal lobe and left occipital lobe 
will have higher FA and lower ADC is refuted. In both the placebo and thyroxine 
groups FA was higher in the left compared to contra lateral frontal lobes and 
reached significance in the placebo group,although ADC findings of the frontal lobes 
was similar to the hypothesis in the placebo group with lower ADC in the right 
frontal lobe. However this finding was not significant and not true in the thyroxine 
group where lower ADC was seen in the left frontal lobe. Opposite to the 
hypothesis, FA was significantly higher in the right occipital lobe in the thyroxine 
group although the ADC measure was similar to the hypothesis with lower ADC in 
the left Occipital lobe in the thyroxine group although this finding was not 
significant. Similar to the hypothesis, FA was higher in the occipital lobe in the 
placebo group but this finding was not significant and not associated with lower 
ADC as ADC was significantly higher in the left occipital lobe. 
I hypothesised higher FA and lower ADC in the right frontal lobe and left occipital 
lobe based on findings of larger right frontal and contra lateral occipital lobe (Le 
May & Kido 1978; Petty 1999; Weinberger et al. 1982). The hypothesis was refuted 
as FA was higher in the left frontal lobe (both treatment groups) and contra lateral 
occipital lobe (thyroxine group) and when there were any similarities to the 
hypothesis the findings were not generally significant. FA is the same between left 
and contra lateral occipital lobe in the placebo group and higher in the contra 
lateral in the thyroxine group. ADC was significantly higher in the left occipital lobe 
in the placebo group. In the thyroxine group ADC was similar to the hypothesis with 
lower ADC in the left although this was not significant. Thus although previous 
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research has found larger right and left frontal lobes, a larger structure does not 
necessarily mean higher FA and lower ADC. 
Laterality 
In the placebo group FA was higher in the right and contra lateral occipital lobe but 
significantly higher in the right in the thyroxine group suggesting extensive 
myelination in the right compared to contra lateral occipital lobe in the thyroxine 
group. Reductions in FA can indicate reduced myelination, axonal damage or 
decreased fibre coherence (Counsell et al. 2008) so the right occipital lobe may have 
reduced myelination, decreased fibre coherence or axonal damage in comparison to 
the left occipital lobe in preterm infants who have received levothyroxine. 
FA measures show extensive myelination in the right occipital lobe in the thyroxine 
group and ADC measures show the same in the placebo group. The significantly 
higher FA in left compared to contra lateral frontal lobe in the placebo group 
suggests extensive myelination in the left frontal lobe in the placebo group. 
FA was found to be significantly higher in the left posterior limb of the internal 
capsule compared to the contra lateral in the treatment group but lower in the 
control group receiving placebo. ADC was lower in the right posterior limb of the 
internal capsule in both the treated and non-treated group. Abnormal motor 
outcome can be predicted around 36-38 weeks gestation by the absence of myelin 
in the posterior limb of the internal capsule (Counsell et al. 2002; Rose et al. 2009) 
and Evensen et al (2011) found lower FA values in the major central, anterior and 
posterior tracts to be related to lower scores on the Movement Assessment Battery 
for Children-2 and on the High-Mobility-Tool (Evensen et al. 2011). 
Differences in FA and ADC measures between the laterality of a structure have been 
observed in this study and previous research (Rose et al. 2009; Szeszko 2003). 
Previous studies have shown the importance of these laterality differences to be 
significant for later development. FA has been found to be higher in the left 
hemisphere of woman healthy volunteers which correlated with better verbal 
comprehension and long term recall of words (Szeszko 2003). Rose has shown that 
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in normal development of preterm infants the left side has lower FA whereas 
infants with abnormal neurodevelopment had higher FA in the left although this 
finding was only within the posterior limb of the internal capsule (Rose et al. 2009) 
and has not been replicated so should be taken with caution, particularly as other 
researchers have found asymmetry to be a sign of abnormality . Further analysis of 
laterality showed a significant laterality by treatment effect in the frontal lobe and 
posterior limb of the internal capsule, meaning the administration of thyroxine 
affects these structures on different sides of the brain differently, however the 
effect of treatment was non-significant although with even further analysis the left 
internal capsule was found to have significantly higher FA in the treated group. This 
suggests a possible improvement in development of the internal capsule in treated 
infants as FA increases with age (Drobyshevsky et al. 2005) and therefore 
development. 
Thyroxine 
Thyroid hormones have an important role in the developing brain (Bernal & Nunez 
1995; Morreale de Escobar 2001; Ng et al. 2008; PORTERFIELD & HENDRICH 1993; 
Williams, Visser & Hume 2006) and contribute to the regulation of the myelination 
process (Ng et al. 2008). Low levels of this hormone have been associated with poor 
neurodevelopmental outcome (Caroline Delahunty 2001; den Ouden 1996; Ishaik et 
al. 2000; Morreale de Escobar 2001; Ng et al. 2008; Osborn 2009; Reuss et al. 1996; 
Siu 2002; Van Wassenaer 2002; Williams, Visser & Hume 2006) and have been 
found to be common in the first few weeks of life in preterm and low birth weight 
infants (Siu 2002). It has been thought by raising these low levels to norm with 
levothyroxine administration will minimise any poor neurodevelopmental outcome. 
Researchers of congenital hypothyroidism (CH: lack of thyroid hormone) have 
argued that levothyroxine treatment is needed to minimise neurocognitive 
impairment. When the dose of levothyroxine is tailored according to severity, FT4 
i.e. free thyroxine (Lafranchi 2008) and TSH i.e. thyrotropin levels have been found 
to quickly normalise resulting in an improvement in IQ aged 4 (Salerno et al. 2002). 
Total thyroxine (T4) levels have also been found to be higher in infants treated with 
thyroxine (Siu 2002). 
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However other previous research has generally found no positive effect of 
levothyroxine supplementation (Oden 2002; Osborn 2001; Smit et al. 1998; Smith 
2000; van Wassenaer 1997; van Wassenaer et al. 1997a; Vanhole et al. 1997) and 
has concluded further research is needed (Briet et al. 2001). Sub analysis in van 
Wassenaer et al’s study found a possible benefit of levothyroxine in infants born 
under 27 weeks gestation (van Wassenaer 1997; van Wassenaer et al. 1997a) and 
another found benefit under 29 weeks with infants born at 25/26 weeks gestation 
benefiting especially (Briet et al. 2001),although the results from Van Wassenaer’s 
articles (van Wassenaer 1997; van Wassenaer et al. 1997a) should be treated with 
caution (Osborn 2001). This study found a significant interaction when investigating 
anterior vs. posterior structures and laterality of structures with treatment in the 
frontal lobes and posterior limb of the internal capsule suggesting a group 
difference between infants treated with levothyroxine and those receiving placebo.  
Thus the hypothesis that supplementation with levothyroxine will be associated 
with the DTI measures FA and ADC is confirmed.  Further analysis revealed FA to be 
borderline significantly higher in thyroxine group in the posterior limb of the 
internal capsule and ADC to be borderline significantly higher in the placebo group 
in the left frontal lobe. There was no significant difference between treatment 
groups in FA of the left frontal lobe, ADC of the left posterior limb of the internal 
capsule, anterior and posterior corpus callosum. The hypothesis that within the 
thyroxine group there will be higher FA and lower ADC is refuted as generally the 
findings were not significant. 
In this study total T4 (TT4) and FT4 levels were higher in the thyroxine group until 
week 36 and free T3 (FT3) levels post screening were lower in the thyroxine group. 
Previous research has found higher TT4 levels in infants treated with levothyroxine  
although by week 3 levels were close to those in the placebo group (Vanhole et al. 
1997) and FT4 levels to be significantly higher in a thyroxine compared to placebo 
group (van Wassenaer et al. 1997a). At screening there was no significant difference 
between groups. At day 14 and 21 TT4 and FT4 were significantly higher in the 
thyroxine group. At Day 28 FT4 was significantly higher in the thyroxine group but 
by week 36 there were no significant differences between groups thus the 
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hypothesis that FT4 levels will have a temporary increase following thyroxine 
supplementation in comparison to the placebo group but that levels will stabilise 
between groups over time is confirmed. Supplementation with thyroxine causes a 
temporary increase in thyroxine levels although by week 36 those who received 
placebo have also increased and are similar to the levels of the thyroxine group. 
Similarly in previous research TT4 and FT4 levels at screening were similar and then 
rose in the treated group with FT4 remaining higher in the treatment group until 
week 8 and TT4 is considerably higher in the treatment group until week 3, after 
which it remains higher but with minimal difference between groups (van 
Wassenaer et al. 1997a; Vanhole et al. 1997). 
In the thyroxine group split for high and low levels of TT4, FT4 and TT3 at screening, 
there was no significant differences between levels at day 14, 21, 28 and week 36. 
In the placebo group split for high and low levels of TT4, FT4 and TT3 at screening, 
there was no difference between levels at day 14 and 28 but at day 21 and week 36 
TT4 and FT4 levels were significantly lower in the low level group.  As there is no 
difference in the treatment group between those that had low or high levels at 
screening but TT4 and FT4 levels are significantly lower in the low group in the 
placebo group suggests a need for thyroxine in those with low levels at screening.  
Comparing the pattern of increases in TT4, FT4 and TT3 (see figure 7.1) between our 
results and those of previous research by Van Wassenaer demonstrated an increase 
in TT4 levels from after day 14 to day 28. Van Wassenaer found this increase to 
begin as early as 7 days but this research has no data from day 7 although it is quite 
possible there was a gradual increase prior to day 14 also (van Wassenaer 1997). 
Van Wassenaer found lower levels of FT4 in infants born under 28 weeks gestation 
continually (van Wassenaer 1997) and this study found FT4 levels to be rising since 
screening at day 14 and day 21 but by day 38 levels had lowered slightly. Both 
studies show an increase in T3 levels over time from day 7 until week eight. 
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Figure 7.1 Comparison of FT4, TT4 and TT3 levels in van Wassenaer (1997) and this study overtime. Red = van Wassenaer, blue= the present cohort. 
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TT4 and FT4 levels at screening significantly correlated in a positive direction with 
gestational age and at 36 weeks TT4 levels significantly positively correlated with gestational 
age and birth weight confirming the hypothesis that T4 levels will positively correlate with 
gestational age and birth weight. The older the premature infants were at birth the higher 
TT4 and FT4 levels they had at screening. The higher the infants birth weight and the older 
they were at birth the higher TT4 levels were at 36 weeks. Similarly previous research has 
found younger infants (23-28 weeks gestation) to have significantly lower T4 and T3 values 
compared to older infants (29-31 weeks gestation) (Mercado et al. 1988). The age range at 
birth in this cohort was 24- 27 weeks so this research has shown small differences in 
gestational age impact levels of thyroxine in the blood significantly. 
Furthermore other research found the percent of infants with low levels of thyroxine (three 
standard deviations below the mean) to increase with decreasing gestational age (den 
Ouden 1996). These low levels of thyroxine have been found to affect later development 
with neurologic dysfunction age five and school failure age nine significantly related to 
lower levels of thyroxine.  (den Ouden 1996). Another study found low thyroxine values 
were associated with a delay in psychomotor development, infants with lower levels of 
thyroxine had a significantly increased risk of developmental delay (Meijer 1992). Also 
severe hypothyroxinemia (clinically defined low levels of thyroxine 3 standard deviations 
below the mean) in infants demonstrated an increased risk for cerebral palsy (Reuss et al. 
1996). This cohort will be followed up throughout development as part of the TIPIT project 
(Ng et al. 2008). 
Negative Effects of Administering Levothyroxine  
Negative effects of levothyroxine supplementation have included refractory hypotension 
(Okada et al. 2011) in the short term and behavioural problems longitudinally (Briet et al. 
1999). In one study 44% of infants who received levothyroxine treatment developed 
refractory hypotension and the occurrence of refractory hypotension was associated with 
prolonged mechanical ventilation and increased hospitalisation. Although those who 
developed refractory hypotension had significantly lower free T4 (FT4) values prior to 
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treatment (Okada et al. 2011). Behavioural problems aged 2 have been found in infants 
born under 27 weeks gestation who received treatment with levothyroxine although the 
authors concluded these problems were not related to treatment (Briet et al. 1999). 
Furthermore a review article found evidence of behavioural problems to be weak although 
this specifically looked at high starting doses (Hrytsiuk et al. 2002). 
Gender 
Previous research has generally found sex differences in the development of the brain after 
premature birth, with males seeming to be more vulnerable to the effects of prematurity 
(Kesler et al. 2008; NuÑEz & McCarthy 2003; Rose et al. 2009). DTI measures in this study 
demonstrated sex differences in the placebo group but not the thyroxine group. FA was 
significantly lower in males in the right and left posterior limb of the internal capsule and 
ADC was significantly higher in the anterior corpus callosum supporting the hypothesis that 
males will have lower FA and higher ADC than females. Thyroxine treatment may be of 
particular benefit in males as the lower FA and higher ADC in males observed in the placebo 
group was not replicated in the treatment group. Previous research has also found lower FA 
in males particularly in the left frontal lobe (Szeszko 2003). FA in the placebo group of our 
study was lower in males in the left frontal lobe but not significantly. 
Smoking 
After excluding those mothers who smoked during and prior to pregnancy there was no 
significant difference in DTI measures between the infants treated with thyroxine and those 
receiving placebo. Smoking may have influenced DTI measures in the thyroxine group 
resulting in higher FA in the left posterior limb of the internal capsule and lower ADC in the 
left frontal lobe,although with the low numbers of participants this finding needs to be 
taken with caution. 
Alcohol 
The effects of alcohol were also explored with a small sample of infants from the full cohort 
(table 5.19). In the placebo alcohol group there was higher FA and ADC but this difference 
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was not significant. In the thyroxine alcohol group there was lower FA and higher ADC, FA 
was significantly lower in the left occipital lobe and contra lateral posterior limb of the 
internal capsule and ADC was significantly higher in the left  occipital lobe and borderline 
significant in the left frontal lobe.  The effects of alcohol on DTI measures seemed to be 
exaggerated in the thyroxine group.  The low number of participants in each group limits the 
strength of the results. Alcohol decreases the activity of the central nervous system 
(Rajendram 2005). In the thyroxine group our results add to this finding, showing reduced 
FA and higher ADC. 
DTI in IUGR Infants 
The preterm infants in the IUGR cohort also demonstrated higher FA and lower ADC in the 
posterior limb of the internal capsule and corpus callosum compared to the frontal and 
occipital lobes suggesting the overall developmental program remains intact despite the 
lower values in preterm compared to term infants in previous research (Counsell et al. 2008; 
Dudink 2008; Partridge et al. 2004). The hypothesis that the posterior part of the internal 
capsule and corpus callosum will have higher FA and lower ADC than the other structures 
is further confirmed in the IUGR cohort. 
There was generally lower FA in the IUGR infants (lower in frontal lobes, right occipital lobe, 
posterior limb of the internal capsule and corpus callosum) although in the left occipital lobe 
FA was lower in the control group suggesting that in the majority of structures there are less 
barriers to diffusion in the IUGR group. Thus there may reduced myelination, axonal damage 
or decreased fibre coherence (Counsell et al. 2008) in the IUGR compared to controls. 
However a low FA is usually equated with a high ADC and in this cohort ADC was generally 
lower in the majority of structures (frontal, occipital lobes and corpus callosum). ADC values 
were similar between groups in the internal capsule. This did not support previous research 
which found higher ADC in IUGR infants at birth and term although our findings of lower FA 
values in the corpus callosum are similar to the findings of lower relative anisotropy in this 
structure (Zimine 2002). The hypothesis that lower FA will be found in the IUGR group is 
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confirmed although the hypothesised higher ADC was not observed in this cohort of IUGR 
infants. 
Similar to our results lower FA has been found in IUGR group of a rabbit model of IUGR, 
although their findings reached significance whereas in our cohort of IUGR infants the 
differences were not significant. Their ADC findings are different to ours as they found non 
significantly higher ADC in the IUGR group (Eixarch 2012) but matched other previous 
research (Zimine 2002). 
Padilla et al (2014) found FA in the splenium of the corpus callosum to be decreased in IUGR 
infants where as we found FA to be higher in the posterior corpus callosum and to be 
decreased in the anterior corpus callosum. They also found IUGR infants to have increased 
FA in the fronto-occipital white matter tracts. Similarly we found FA to be higher in the left 
occipital lobe in the IUGR group although we found FA to be lower in the IUGR group in the 
left and contra lateral frontal lobe as well as the right occipital lobe.  In our research FA in 
the posterior limb of the internal capsule was lower in the IUGR compared to the control 
group. In the anterior corpus callosum FA was lower in the IUGR group where as Padilla et al 
(2014) found IUGR infants to have higher FA in the anterior regions involving commissural 
fibres (genu, the body and forceps minor of the CC); projection fibres (anterior, superior and 
posterior corona radiate, the left anterior limb of the internal capsule) and association tracts 
(right frontal course of the uncinate fasciculum and inferior fronto-occipital fasciculum and 
left external capsule including the superior longitudinal fasciculum). 
Difference between FA values in groups was not significant but ADC values were 
significantly lower in the IUGR group in the frontal lobes and close to significance in the left 
occipital lobe. It seems there may be more barriers in the form of structure development in 
the frontal lobes and left occipital lobe of the IUGR group. Previous research also found 
differences in the structure of IUGR infants’ brain at 12 months corrected age compared to 
appropriate for gestational age preterm infants and argued that their findings suggests that 
IUGR cause a deviation in the development of the brain (Padilla et al. 2011). 
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Laterality 
FA was lower and ADC generally higher in the right structures compared to contra lateral 
although these differences were not significant.  This confirms the hypothesis that 
generally there will be no asymmetries present in the structures measured although 
asymmetry may be found in the occipital and frontal lobes. Indeed with further analysis 
structural asymmetry was found in the occipital lobe. There was a significant interaction 
between laterality and group in the occipital lobe and further analysis revealed significantly 
higher FA in the left compared to contra lateral occipital lobe in the IUGR group but no 
significant difference in the control group. The second part of the hypothesis that the right 
frontal lobe and left occipital lobe will have higher FA and lower ADC is refuted as 
although there is a finding of significantly higher FA in the left compared to contra lateral 
occipital lobe this was not associated with the lower ADC, furthermore FA and ADC 
differences between right and contra lateral frontal lobe were not significant. 
Previous research has also found lower FA in right occipital lobe (Sarina et al. 2011) but this 
was in healthy adults where as our infants were all born preterm and the finding was only 
present in those with IUGR. It is strange that the IUGR cohort should be similar to healthy 
adults as IUGR infants are said to be of higher vulnerability (Esteban et al. 2010). Differences 
between the present study and their’s were observed in the frontal lobes where they found 
higher FA in the right frontal lobe and we found lower FA (Sarina et al. 2011) although our 
finding of lower FA is not significant. They argue their findings of greater FA and less 
perpendicular diffusion in the left occipital tracts may be due to greater myelin in these 
axons compared to the right, however in our study this was found in the IUGR but not 
control infants. Furthermore previous research refutes their idea of greater myelin in the 
axons of the left occipital tracts by finding no difference in the number of myelinated and 
unmyelinated axons in white matter between left and right hemisphere in any region (Ginus 
Partadiredja 2003). 
A further study looking at both male and female healthy adults found higher FA in the left 
hemisphere in 83% of the subjects (Kang, Herron & Woods 2011). Our finding supports this 
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with FA generally being lower in right structures, suggesting hemispheric asymmetries begin 
early in development. FA in grey matter showed no significant differences between the 
whole hemisphere however when looking at the different cortical lobes differences were 
found with higher FA in the right frontal lobe and higher FA in the left temporal, parietal and 
occipital lobes (Kang, Herron & Woods 2011). These FA findings in the frontal lobe match 
those of another study mentioned earlier on healthy males but are the opposite of our 
findings where FA was higher in the left frontal lobe. Similarly their findings match with 
lower FA in the parietal lobes in both studies. However their results differ in the occipital 
lobes. Sarina et al found higher FA in the left which matched our findings in the IUGR group 
whereas Kang et al found lower FA in the left which matched the findings in our controls 
(Kang, Herron & Woods 2011; Sarina et al. 2011). 
FA was higher in the left posterior limb of the internal capsule in the IUGR group but higher 
in the right in the control group, which based on previous research would suggest abnormal 
development in the IUGR group and normal development in the control group (Rose et al. 
2009) IUGR infants are said to be of higher vulnerability so abnormal development is to be 
expected(Esteban et al. 2010). Although as mentioned previously Rose et al’s results should 
be taken with caution as there results have not been replicated and other researchers argue 
asymmetry is a sign of abnormality (Filipek et al. 1994; Snook, Plewes & Beaulieu 2007). 
Correlations 
In the IUGR FA positively correlated with birth weight and gestational age at birth whereas 
ADC negatively correlated. The older the infants were at birth and the higher the birth 
weight the higher the FA values and the lower the ADC values although the differences were 
not significant. In the control group the opposite was seen with FA negatively correlating 
with birth weight and gestation at birth, whereas ADC positively correlated. The older the 
infants at birth and the higher their birth weight the lower the FA values and the higher the 
ADC values. In the control group these differences almost reached significance, with FA in 
the right occipital lobe and birth weight and FA in the right occipital lobe and gestational age 
at birth. In the control group the hypothesis that DTI measures will correlate with 
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gestational age with FA positively correlating and ADC negative correlating is confirmed., 
Only the first part of the hypothesis that DTI measures will correlate is true for the control 
group. The findings in the control infants are not similar to previous research which has 
found FA to increase with increasing gestational age (Drobyshevsky et al. 2007; Tatsuji 2011) 
and ADC to decrease (Drobyshevsky et al. 2007) but this is similar to our findings in the IUGR 
group. Possibly higher birth weight and gestational age at birth is a protective factor for 
infants born with IUGR. 
Gender 
Differences in DTI values between male and female infants were observed in this study and 
the gender affect on DTI values was different between groups. In the IUGR group higher FA 
was observed in males except in the left posterior limb of the internal capsule, lower ADC in 
the frontal lobes and posterior corpus callosum and higher ADC in the occipital lobes, 
posterior limb of the internal capsule and the anterior corpus callosum. These findings were 
not significant although the higher ADC in males in the anterior corpus callosum was close 
to significance. In the control group males had lower FA in all structures except the left 
frontal lobe and posterior corpus callosum and higher ADC in all structures except the left 
frontal lobe. These findings were not significant. In the control group the hypothesis that 
males will have lower FA and higher ADC is confirmed but in the IUGR group only higher 
ADC in the occipital lobes, posterior limb of the internal capsule and corpus callosum 
support the hypothesis. 
Previous research has found significant gender differences in FA, with FA being higher in 
males in regions surrounding the temporal/ parietal/ occipital junction (Kang, Herron & 
Woods 2011) and in the corpus callosum (Westerhausen et al. 2004). This is similar to our 
finding in the IUGR group in the posterior limb of the internal capsule but the opposite of 
the findings in the control group. Higher FA in males was also observed in our cohort of 
normal preterm infants. It has been demonstrated in previous research that the higher FA in 
the corpus callosum of males may be due to increased brain size in males as demonstrated 
when brain size as a covariate removed the gender differences (Westerhausen et al. 2004).  
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ADC values have been found to be significantly higher in women less than 60 years of age 
compared to men in right frontal, bilateral thalamus and temporal but no difference 
between males and females over 60 years (Naganawa et al. 2003). Our results show a 
similar result of ADC measures in preterm infants and infants born with IUGR with ADC 
values in the frontal lobes to be lower in males except for the right frontal lobe in the 
control group. 
Stereology in the Preterm Cohort 
In the preterm cohort lower volumes were found in the placebo group in the dorsal lateral 
prefrontal cortex, orbital lateral prefrontal cortex, left dorsal medial prefrontal cortex, right 
and left hemisphere volumes compared to the thyroxine group. The hypothesis that 
supplementation with levothyroxine will be associated with volume of brain structures 
and the hypothesis that within the thyroxine group there will be larger hemisphere and 
brain structure volumes than the placebo group is confirmed. There were higher volumes 
in the right dorsal medial prefrontal cortex and orbital medial prefrontal cortex.  In the right 
dorsal lateral prefrontal cortex the lower volumes in the placebo group were significant and 
in the contra lateral the difference between groups were close to significance. No other 
significant differences between groups in volumes were observed. In previous research 
there is evidence of smaller structural volumes in preterm infants in the cerebellum (Allin et 
al. 2001). IUGR infants have been shown to have a reduction in structural volume including 
intracranial volume, cortical gray matter , total brain volume (Tolsa et al. 2004), the 
hippocampus (Lodygensky et al. 2008; Padilla et al. 2014), insular, temporal lobe (Padilla et 
al. 2011; Padilla et al. 2014; Sanz-Cortes et al. 2010b), absolute gray matter, the amygdala, 
the right perirolandic area, right frontal lobe, left parietal lobe, basal ganglia, thalami, 
angular gyrus and right frontal lobe (Padilla et al. 2014). Padilla et al (2011) also found 
reduced gray matter in the temporal, parietal, frontal and insular regions and reduced white 
matter in the cerebellum but increased white matter in temporal, frontal, parietal, occipital 
and insular regions. 
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Higher dorsal and orbital volumes have been associated with better neurocognitive 
performance (R.E. Gur. 2000) and generally there were higher dorsal and orbital volumes in 
the thyroxine group for the majority of regions ( right and left dorsal lateral, right and left 
orbital lateral and left dorsal medial). Thus thyroxine treatment may have a positive effect 
on the volume of dorsal and orbital structures which may later result in improved 
neurocognitive performance.  
This research found significantly higher volumes in the medial compared to lateral cortex 
and dorsal compared to orbital regions. This is the same as previous research in healthy 
adults and patients which found dorsal regions to be larger (Howard 2003). 
Asymmetry 
Some previous research has found asymmetry in the volumes of structures such as larger 
right dorsal lateral regions in healthy controls (R.E. Gur. 2000)  where as other previous 
research has found no significant difference between the weight of the right and contra 
lateral hemispheres (Ginus Partadiredja 2003).  
Asymmetry in this research demonstrated lower volumes in the right hemisphere except in 
the thyroxine group the contra lateral hemisphere had lower volumes, although differences 
between right and contra lateral were only significant for the medial structures and thus the 
hypothesis that there will be no asymmetries present in the structures measured is 
accepted. However the second part of the hypothesis that there will be asymmetry in the 
volume of the dorsal lateral prefrontal cortex is refuted, as although there were differences 
between left and contra lateral dorsal lateral prefrontal cortex these differences were not 
significant. Furthermore the differences observed between left and contra lateral dorsal 
lateral prefrontal cortex do not match the differences found in previous research, Kang et al 
found the fibre tracts connecting the dorsal lateral prefrontal cortex to have greater FA in 
the right hemisphere (Kang, Herron & Woods 2011) similar to Gur’s finding of larger dorsal 
lateral regions on the ipsilateral (R.E. Gur. 2000), whereas we found lower volume in the 
ipsilateral hemisphere. Furthermore Howard found the right dorsal lateral prefrontal cortex 
to be larger than contra lateral (Howard 2003), whereas our results demonstrate a larger 
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left dorsal lateral prefrontal cortex. The differences between these findings and previous 
research could be because the present cohort is of preterm infants whereas previous 
studies were of healthy adults and patients (Howard 2003; Kang, Herron & Woods 2011; 
R.E. Gur. 2000). 
The hemisphere volume in the thyroxine group was similar to previous research in young 
adult normal subjects, where volume was lower in the left compared to contra lateral 
hemisphere (Kang, Herron & Woods 2011). Thus thyroxine supplementation may normalise 
laterality in the hemispheres volumes, and infants born preterm may have different brain 
lateralisation to infants born at term.  
Gender 
Males seem to be more vulnerable to the effects of preterm birth and male gender has been 
reported as a risk factor for poor neonatal outcome, poor neurological outcome, poor 
respiratory outcome (Peacock et al. 2012) and even mortality (Kusuda et al. 2012). Similarly 
Britt et al 2011 found boys to have significantly lower Apgar score and a longer ventilation 
period (Britt J. M. 2011). 
Previous research has found sex differences in brain volume; male brains being larger in 
volume overall and in all brain regions (Filipek et al. 1994; Shah et al. 2006; Thompson et al. 
2007). This research has found sex differences in the volumes of various regions of the 
prefrontal cortex.  In the placebo group males had lower volumes except in the left dorsal 
medial prefrontal cortex. These differences reached significance in the orbital medial 
prefrontal cortex, and accept the hypothesis that males will have lower structural volumes 
than females. In the thyroxine group females had lower volumes except the left dorsal 
medial prefrontal cortex. These differences reached significance in the right orbital lateral 
prefrontal cortex and hemisphere volumes. The lower volume in the right dorsal lateral 
prefrontal cortex in females was close to significance. In the thyroxine group the hypothesis 
is refuted with males having higher structural volumes than females. Similar to the finding 
of lower left dorsal medial prefrontal cortex volume in the placebo group, Shah et al (2006) 
found females to have lower dorsal prefrontal region volumes. Results in the thyroxine 
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group differed to the findings in the placebo group and Shah et al’s (2006) research with 
higher volumes in the dorsal medial prefrontal cortex.  
Correlations 
The only structural volume found to correlate with birth weight and gestational age was the 
orbital medial prefrontal cortex. No structures volume correlated with gestation at 
scanning. There was a significant positive correlation with the right and left orbital medial 
prefrontal cortex and gestation at birth and a borderline significant correlation between the 
left orbital medial prefrontal cortex and birth weight. Previous research has generally been 
mixed, Peterson et al (2003) found regional volumes not to correlate with gestation at birth 
where as Peterson et al (2000) found volume in the right sensori motor to positively 
correlate with gestational age and Nosarti et al (2002) found the more premature the 
subject the smaller the white matter volume although no other brain regions varied 
according to gestational age or birth weight. Similarly Peterson et al (2000) found birth 
weight was not significantly associated with regional volumes where as Ivanovic et al (2004) 
found brain volume to significantly positively correlate with birth weight. Padilla et al (2013) 
found FA to positively correlate with birth weight and gestational age where as in this 
research DTI measures in preterm infants did not correlate with birth weight or gestational 
age. 
Smoking 
After excluding those mothers who smoked during and prior to pregnancy, volumes were 
generally lower in the placebo group. In the right dorsal lateral prefrontal cortex the 
difference was no longer significant and the lower volume in the placebo group in the 
ipsilateral hemisphere became borderline significant. 
Alcohol 
The effects of alcohol on structural volumes were different between the two treatment 
groups. In the placebo group volumes were higher in the alcohol group except in the left 
dorsal medial prefrontal cortex and significantly higher in the right and contra lateral 
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hemisphere volumes. Higher volumes in the placebo-alcohol group were close to 
significance in the right orbital medial prefrontal cortex. In the thyroxine group structural 
volumes were generally lower in the alcohol group except for the right dorsal medial 
prefrontal cortex. Differences in the thyroxine group were not significant.  
Stereology in the IUGR Cohort 
Structural volumes were significantly higher in the medial compared to lateral cortex and 
dorsal compared to orbital regions. As this finding is based on the whole cohort I tested for 
interaction with group. When comparing medial and lateral there was a significant 
interaction in the dorsal regions and close to significant interaction in the left orbital region 
and when comparing dorsal and orbital regions there was significant interaction in both the 
medial regions and the left lateral region. This interaction with group suggests there is a 
difference between the group’s structural volumes. Further analysis showed structural 
volumes to be significantly higher in the medial compared to lateral cortex and dorsal 
compared to orbital regions in both the IUGR and control group. This adds to and confirms 
previous research in healthy adults and patients which found dorsal regions to be larger 
than orbital regions (Howard 2003). Highest volumes were observed in the dorsal medial 
prefrontal cortex. Total prefrontal cortex, right and left hemisphere and cerebrum volumes 
were higher in the control group suggest IUGR to affect volume. Furthermore volumes were 
significantly lower in the IUGR group except for the left orbital lateral prefrontal cortex and 
right orbital medial prefrontal cortex. Thus the hypothesis that IUGR infants will have 
smaller brain structure volumes than controls is accepted. This supports previous findings 
of significantly lower brain volumes in IUGR infants (Esteban et al. 2010; Padilla et al. 2011; 
Sanz-Cortes et al. 2010a; Thompson et al. 2007; Tolsa et al. 2004). 
Laterality 
Volumes were similar between the left and contra lateral of structures including hemisphere 
volumes although there was a significant difference between left and contra lateral orbital 
lateral prefrontal cortex. There was also a significant interaction with group. In the IUGR 
group volume was higher in the left orbital lateral prefrontal cortex whereas in the control 
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group volumes were higher in the contra lateral orbital lateral prefrontal cortex. After 
analysing laterality in the groups separately there was no significant difference between 
right and contra lateral orbital lateral prefrontal cortex. Thus the hypothesis that there may 
be no asymmetries present in the structures measured is accepted but the second part 
exclaiming there will be asymmetry in the volume of the dorsal lateral prefrontal cortex is 
refuted.  These findings support previous research that found all structures to be symmetric 
or nearly symmetric in volume (Filipek et al. 1994; Ginus Partadiredja 2003) but not other 
research which found asymmetries in the dorsal lateral prefrontal cortex (Gur Re & et al. 
2000; Howard 2003; Lancefield et al. 2006; Petty 1999). 
Gender 
In the intrauterine growth restriction group there was minimal gender differences. Males 
had higher volumes in the dorsal medial prefrontal cortex, right and contra lateral 
hemisphere and the cerebrum but these differences were not significant. In the control 
group males generally had higher volumes except in the right dorsal medial prefrontal 
cortex. Volumes were significantly higher in males in the right orbital lateral prefrontal 
cortices. The general higher finding of volumes in males refutes the hypothesis that males 
will have lower hemisphere and brain structure volumes and is similar to the findings of 
Filipek et al (1994), Thompson et al (2007) and van Soelen et al (2010) who found male 
brains to be larger in volume and males to have larger volumes of all brain regions. However 
the differences were generally not significant and other previous research has found no sex 
difference in prefrontal cortex (Gur Re & et al. 2000) and regional volumes (Eckerman, 
Sturm & Gross 1985). 
Correlations 
Birth weight and gestational age positively correlated with brain structures volume. The 
correlation for birth weight was significant except for the left dorsal lateral prefrontal cortex 
and the left orbital lateral prefrontal cortex. The correlation with gestational age at birth 
was only significant in the hemisphere volumes and the cerebrum volume. This confirms the 
hypothesis that smaller brain structural volumes will be found in infants with lower birth 
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weight and gestational age at birth and with which they will significantly correlate. Other 
previous research has found GA to be associated with cerebrum volume (Inge et al. 2010; 
van Soelen et al. 2010), white matter volume  (Nosarti et al. 2002b) and volume in the right 
sensori motor cortex positively correlated with gestational age (Peterson Bs & et al. 2000). 
Although unlike our results Nosarti et al (2002b) found total cerebral volume not to vary 
according to gestational age or birth weight. Other structures they found not to correlate 
include grey matter volume and right and left hippocampus volume. Similarly other previous 
research has found birth weight not to correlate with structural volumes (Peterson et al. 
2003; Peterson Bs & et al. 2000; van Soelen et al. 2010). However the positive correlation 
between birth weight and brain volume found in this thesis has been previously found to be 
significant in other previous research (Ivanovic et al. 2004; Ivanovic et al. 2000). 
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 CHAPTER 8 
Conclusions and Future Research 
 
Aim of Chapter 
This chapter aims to summarise the findings of this research in the context of previous 
research and suggests possible future research. 
 
Conclusions 
Birth weight and gestational age: Similar to previous research ADC and anisotropy 
measures varied with age and birth weight in the IUGR and control infants. Furthermore 
brain volumes positively correlated with gestational age and birth weight. There is a possible 
protective factor of higher birth weight and gestational age in infants born with intrauterine 
growth restriction. These correlations were not replicated in the preterm cohort, FA and 
ADC measures did not vary with gestational age or birth weight and neither did structural 
volumes. This supports previous research findings of no association between birth weight, 
gestational age and structural volumes in preterm infants. However they concluded their 
ADC measures did not vary with age  due to the narrow range (37-44 weeks) (Counsell et al. 
2003) and the same can be said for the present study as our age range is even narrower (24-
28 weeks). Also other previous research has found ADC values to decrease with increasing 
age (Huppi et al. 1998). The influences of birth weight and gestational age are more 
pronounced in preterm infants born with intrauterine growth restriction. 
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Anterior vs. Posterior: Higher FA and lower ADC was found in the posterior part of the 
internal capsule and corpus callosum in preterm infants receiving placebo, preterm infants 
receiving thyroxine, IUGR infants and control infants. This supports previous research of 
brain development occurring in posterior regions prior to anterior regions. This finding is 
further supported by a general pattern of significantly higher FA and lower ADC in posterior 
compared to anterior regions. The pattern of development in the posterior prior to anterior 
regions is similar to the pattern of normal development suggesting the overall 
developmental program remains intact despite the lower values in preterm compared to 
term infants in previous research. 
Asymmetry:  Some asymmetries have been found in FA and ADC measures in preterm 
infants, IUGR and control infants although differences were not significant in IUGR and 
control infants. These measures significantly interacted with treatment and laterality and 
IUGR and control in some of the structures. Thus the administration of thyroxine affects 
these structures on different sides of the brain differently as does IUGR. Previous research  
has argued asymmetry to be a sign of abnormality, thus there may be some abnormality in 
these infants. Structural volumes were lower in the right hemisphere in the placebo group 
but lower in the contra lateral hemisphere in the thyroxine group, although these findings 
were generally not significant. These findings are different to previous research, although 
the thyroxine group was similar to previous research in young adult normal subjects. Thus 
thyroxine supplementation may normalise laterality in the hemisphere volume and infants 
born preterm may have different lateralisation to infants born at term. In IUGR and control 
infants volumes were similar between right and contra lateral structures, supporting 
previous research that found all structures to be symmetric or nearly symmetrical in 
volume. 
Thyroxine administration:  Higher FA and lower ADC was found in the thyroxine group 
although the differences between treatment groups were generally not significant thus 
thyroxine does not have a significant positive effect on DTI measures. Larger brain structural 
volumes were observed in the thyroxine compared to placebo group thus thyroxine 
treatment may have a positive effect on structural volumes. Supplementation with 
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thyroxine causes a temporary increase in thyroxine levels although by week 36 those who 
received placebo have also increased and are similar to the levels of the thyroxine group. 
This is similar to the findings of previous research. There was no difference in the treatment 
group between those that had low or high levels at screening but TT4 and FT4 levels are 
significantly lower in the low group in the placebo group suggesting a need for thyroxine in 
those with low levels at screening. 
Sex differences: Generally males are thought to be of particular vulnerability to prematurity 
and this research confirms this in the placebo group where FA was significantly lower. 
Thyroxine treatment may be of particular benefit in males as the lower FA and higher ADC in 
males observed in the placebo group was not seen in the treatment group. Sex differences 
were also observed in IUGR and control infants. The gender affect on DTI values was 
different in the different groups but overall in the IUGR and control infants’ sex differences 
were not significant. Previous research has found males to have larger brain volumes; this 
was confirmed in the thyroxine treated group, IUGR infants and control infants but not the 
placebo group. Thyroxine treatment may normalise the sex difference observed in preterm 
infants. 
Medial compared to lateral and dorsal compared to orbital regions: Volumes were 
significantly higher in medial compared to lateral regions in all infants studied. Higher 
volumes were observed in orbital compared to dorsal regions in preterm infants and dorsal 
compared to orbital regions in the IUGR and control infants. Previous research in healthy 
adults is similar to the findings in IUGR and control infants with larger dorsal regions. 
IUGR vs. Control: Lower FA and lower structural volumes were found in IUGR infants 
compared to controls although the expected higher ADC associated with lower FA was not 
found. Previous research has also found lower FA in IUGR infants. Infants born with IUGR 
are of higher vulnerability than appropriate for gestational age preterm infants and 
demonstrate lower FA and structural volumes. 
Correlations: DTI measures did not generally correlate with birth weight, gestational age or 
gestation at scanning in the preterm or the IUGR cohort. This is unlike previous research 
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which generally found FA to increase and ADC to decrease with increasing gestational age. 
TT4 and FT4 at screening positively correlated with gestational age and TT4 at 36 weeks 
positively correlated with birth weight and gestation at birth. Stereology did not generally 
correlate with birth weight, gestational age or gestation at scanning in the preterm cohort. 
In the IUGR stereology generally correlated with birth weight and correlated with 
gestational age in the right and left hemisphere and the cerebrum. 
Future research 
The corpus callosum has been found to be smaller in preterm infants in later childhood 
despite the higher FA and lower ADC seen at term age. The question arises about the other 
structures which have lower FA and higher ADC than corpus callosum at term age (frontal 
and occipital lobes), are they further diminished in size later on in comparison to the corpus 
callosum or due to the complex process of human brain development are they less affected 
in later childhood. Future research could explore the effects of preterm birth on the frontal 
and occipital lobes in comparison to the corpus callosum in later childhood, adolescence 
and adult hood. 
Research into the asymmetry of structures in preterm infants and IUGR infants is generally 
mixed. Functional asymmetries have been well demonstrated, future research is needed to 
clarify whether these functional asymmetries represent structural asymmetries. 
Future research could look at the effects of administering levothyroxine to specifically those 
infants who have low levels of thyroxine in their blood (hypothyroxinemia) and male 
preterm infants. 
Future research will be conducted on the cohorts used in this thesis. The preterm infants 
will be followed up as part of the TIPIT study and the IUGR infants will also be followed up 
by colleagues. 
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